000142528712/312024Q3false0.050.053http://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNethttp://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNet0.05xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:purewkhs:employeewkhs:trading_daywkhs:class_of_stockwkhs:votewkhs:claim00014252872024-01-012024-09-3000014252872024-11-1900014252872024-09-3000014252872023-12-3100014252872024-07-012024-09-3000014252872023-07-012023-09-3000014252872023-01-012023-09-3000014252872024-06-172024-06-170001425287us-gaap:CommonStockMember2023-06-300001425287us-gaap:AdditionalPaidInCapitalMember2023-06-300001425287us-gaap:RetainedEarningsMember2023-06-3000014252872023-06-300001425287us-gaap:CommonStockMember2023-07-012023-09-300001425287us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001425287us-gaap:CommonStockMemberwkhs:AtTheMarketOfferingMember2023-07-012023-09-300001425287us-gaap:AdditionalPaidInCapitalMemberwkhs:AtTheMarketOfferingMember2023-07-012023-09-300001425287wkhs:AtTheMarketOfferingMember2023-07-012023-09-300001425287us-gaap:RetainedEarningsMember2023-07-012023-09-300001425287us-gaap:CommonStockMember2023-09-300001425287us-gaap:AdditionalPaidInCapitalMember2023-09-300001425287us-gaap:RetainedEarningsMember2023-09-3000014252872023-09-300001425287us-gaap:CommonStockMember2022-12-310001425287us-gaap:AdditionalPaidInCapitalMember2022-12-310001425287us-gaap:RetainedEarningsMember2022-12-3100014252872022-12-310001425287us-gaap:CommonStockMember2023-01-012023-09-300001425287us-gaap:AdditionalPaidInCapitalMember2023-01-012023-09-300001425287us-gaap:CommonStockMemberwkhs:AtTheMarketOfferingMember2023-01-012023-09-300001425287us-gaap:AdditionalPaidInCapitalMemberwkhs:AtTheMarketOfferingMember2023-01-012023-09-300001425287wkhs:AtTheMarketOfferingMember2023-01-012023-09-300001425287us-gaap:CommonStockMemberus-gaap:PrivatePlacementMember2023-01-012023-09-300001425287us-gaap:AdditionalPaidInCapitalMemberus-gaap:PrivatePlacementMember2023-01-012023-09-300001425287us-gaap:PrivatePlacementMember2023-01-012023-09-300001425287us-gaap:RetainedEarningsMember2023-01-012023-09-300001425287us-gaap:CommonStockMember2024-06-300001425287us-gaap:AdditionalPaidInCapitalMember2024-06-300001425287us-gaap:RetainedEarningsMember2024-06-3000014252872024-06-300001425287us-gaap:CommonStockMemberwkhs:A2024SecuritiesPurchaseAgreementMember2024-07-012024-09-300001425287us-gaap:AdditionalPaidInCapitalMemberwkhs:A2024SecuritiesPurchaseAgreementMember2024-07-012024-09-300001425287wkhs:A2024SecuritiesPurchaseAgreementMember2024-07-012024-09-300001425287us-gaap:CommonStockMember2024-07-012024-09-300001425287us-gaap:AdditionalPaidInCapitalMember2024-07-012024-09-300001425287us-gaap:RetainedEarningsMember2024-07-012024-09-300001425287us-gaap:CommonStockMember2024-09-300001425287us-gaap:AdditionalPaidInCapitalMember2024-09-300001425287us-gaap:RetainedEarningsMember2024-09-300001425287us-gaap:CommonStockMember2023-12-310001425287us-gaap:AdditionalPaidInCapitalMember2023-12-310001425287us-gaap:RetainedEarningsMember2023-12-310001425287us-gaap:CommonStockMember2024-01-012024-09-300001425287us-gaap:AdditionalPaidInCapitalMember2024-01-012024-09-300001425287wkhs:A2023WarrantsMemberus-gaap:CommonStockMember2024-01-012024-09-300001425287wkhs:A2023WarrantsMemberus-gaap:AdditionalPaidInCapitalMember2024-01-012024-09-300001425287wkhs:A2023WarrantsMember2024-01-012024-09-300001425287us-gaap:CommonStockMemberwkhs:TwoThousandTwentySixNotesMember2024-01-012024-09-300001425287us-gaap:AdditionalPaidInCapitalMemberwkhs:TwoThousandTwentySixNotesMember2024-01-012024-09-300001425287wkhs:TwoThousandTwentySixNotesMember2024-01-012024-09-300001425287us-gaap:CommonStockMemberwkhs:A2024SecuritiesPurchaseAgreementMember2024-01-012024-09-300001425287us-gaap:AdditionalPaidInCapitalMemberwkhs:A2024SecuritiesPurchaseAgreementMember2024-01-012024-09-300001425287wkhs:A2024SecuritiesPurchaseAgreementMember2024-01-012024-09-300001425287us-gaap:RetainedEarningsMember2024-01-012024-09-300001425287wkhs:A2023WarrantsMember2023-01-012023-09-300001425287wkhs:A2024WarrantsMember2024-01-012024-09-300001425287wkhs:A2024WarrantsMember2023-01-012023-09-300001425287wkhs:TwoThousandTwentyFourNotesMemberus-gaap:ConvertibleNotesPayableMemberus-gaap:SubsequentEventMember2024-11-180001425287wkhs:TwoThousandTwentyFourNotesMemberus-gaap:ConvertibleNotesPayableMember2024-03-1500014252872024-03-150001425287wkhs:TwoThousandTwentyFourNotesIssuanceMemberus-gaap:ConvertibleNotesPayableMember2024-03-150001425287wkhs:TwoThousandTwentyFourNotesJuly18IssuanceMemberus-gaap:ConvertibleNotesPayableMember2024-07-180001425287wkhs:TwoThousandTwentyFourNotesAugust23IssuanceMemberus-gaap:ConvertibleNotesPayableMember2024-08-230001425287wkhs:TwoThousandTwentyFourNotesSeptember30IssuanceMemberus-gaap:ConvertibleNotesPayableMember2024-09-300001425287wkhs:A2024WarrantsIssuanceMember2024-09-300001425287wkhs:A2024WarrantsJuly18IssuanceMember2024-07-180001425287wkhs:A2024WarrantsAugust23IssuanceMember2024-08-230001425287wkhs:A2024WarrantsSeptember30IssuanceMember2024-09-300001425287wkhs:TheNotesMemberus-gaap:ConvertibleNotesPayableMember2024-09-300001425287wkhs:TheWarrantsMember2024-09-300001425287wkhs:PriorNotesMemberus-gaap:ConvertibleNotesPayableMember2024-09-3000014252872024-01-3100014252872024-01-012024-03-310001425287us-gaap:SubsequentEventMember2024-10-282024-10-280001425287us-gaap:SubsequentEventMember2024-10-2700014252872024-04-012024-04-300001425287us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberwkhs:AeroDivestitureMember2024-06-062024-06-060001425287us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberwkhs:AeroDivestitureMember2024-01-012024-09-300001425287wkhs:AeroDivestitureMemberus-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:DiscontinuedOperationsDisposedOfBySaleMember2024-01-012024-09-300001425287wkhs:AeroDivestitureMemberus-gaap:CostOfSalesMemberus-gaap:DiscontinuedOperationsDisposedOfBySaleMember2024-01-012024-09-300001425287srt:AffiliatedEntityMemberwkhs:TroposTechnologiesIncMember2022-07-012022-09-300001425287srt:AffiliatedEntityMemberwkhs:TroposTechnologiesIncMemberwkhs:DepositForFutureServicesMember2022-07-012022-09-300001425287srt:AffiliatedEntityMemberwkhs:TroposTechnologiesIncMember2024-01-012024-09-300001425287wkhs:TroposTechnologiesIncMember2023-01-012023-12-310001425287wkhs:AssemblyServiceMember2024-09-300001425287wkhs:AssemblyServiceMember2023-12-310001425287wkhs:SalesNetOfReturnsAndAllowancesMember2024-07-012024-09-300001425287wkhs:SalesNetOfReturnsAndAllowancesMember2023-07-012023-09-300001425287wkhs:SalesNetOfReturnsAndAllowancesMember2024-01-012024-09-300001425287wkhs:SalesNetOfReturnsAndAllowancesMember2023-01-012023-09-300001425287wkhs:OtherRevenuesMember2024-07-012024-09-300001425287wkhs:OtherRevenuesMember2023-07-012023-09-300001425287wkhs:OtherRevenuesMember2024-01-012024-09-300001425287wkhs:OtherRevenuesMember2023-01-012023-09-3000014252872024-10-012024-09-300001425287us-gaap:ConvertibleNotesPayableMember2023-12-310001425287us-gaap:ConvertibleNotesPayableMember2024-01-012024-09-300001425287us-gaap:ConvertibleNotesPayableMember2024-09-300001425287wkhs:TheNotesMemberus-gaap:ConvertibleNotesPayableMember2024-01-012024-09-300001425287wkhs:TwoThousandTwentyFourNotesMemberus-gaap:ConvertibleNotesPayableMember2024-01-012024-09-300001425287wkhs:TwoThousandTwentyFourNotesMemberus-gaap:ConvertibleNotesPayableMember2024-03-142024-03-140001425287wkhs:TwoThousandTwentyFourNotesMemberus-gaap:ConvertibleNotesPayableMember2024-03-152024-03-150001425287wkhs:TwoThousandTwentyFourNotesMemberus-gaap:ConvertibleNotesPayableMember2024-09-300001425287wkhs:TwoThousandTwentyFourNotesMemberus-gaap:ConvertibleNotesPayableMember2024-07-012024-09-300001425287wkhs:TwoThousandTwentySixNotesMemberus-gaap:ConvertibleNotesPayableMember2024-03-150001425287wkhs:TwoThousandTwentySixNotesMemberus-gaap:ConvertibleNotesPayableMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-03-150001425287wkhs:TwoThousandTwentySixNotesMemberus-gaap:ConvertibleNotesPayableMemberwkhs:MeasurementInputBondYieldMember2024-03-150001425287wkhs:TwoThousandTwentySixNotesMemberus-gaap:ConvertibleNotesPayableMemberus-gaap:MeasurementInputPriceVolatilityMember2024-03-150001425287wkhs:TwoThousandTwentyFourNotesMay10IssuanceMemberus-gaap:ConvertibleNotesPayableMember2024-05-100001425287wkhs:TwoThousandTwentyFourNotesMay10IssuanceMemberus-gaap:ConvertibleNotesPayableMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-05-100001425287wkhs:TwoThousandTwentyFourNotesMay10IssuanceMemberus-gaap:ConvertibleNotesPayableMemberwkhs:MeasurementInputBondYieldMember2024-05-100001425287wkhs:TwoThousandTwentyFourNotesMay10IssuanceMemberus-gaap:ConvertibleNotesPayableMemberus-gaap:MeasurementInputPriceVolatilityMember2024-05-100001425287wkhs:TwoThousandTwentyFourNotesMay29IssuanceMemberus-gaap:ConvertibleNotesPayableMember2024-05-290001425287wkhs:TwoThousandTwentyFourNotesMay29IssuanceMemberus-gaap:ConvertibleNotesPayableMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-05-290001425287wkhs:TwoThousandTwentyFourNotesMay29IssuanceMemberus-gaap:ConvertibleNotesPayableMemberwkhs:MeasurementInputBondYieldMember2024-05-290001425287wkhs:TwoThousandTwentyFourNotesMay29IssuanceMemberus-gaap:ConvertibleNotesPayableMemberus-gaap:MeasurementInputPriceVolatilityMember2024-05-290001425287wkhs:TwoThousandTwentyFourNotesJuly18IssuanceMemberus-gaap:ConvertibleNotesPayableMember2024-05-290001425287wkhs:TwoThousandTwentyFourNotesJuly18IssuanceMemberus-gaap:ConvertibleNotesPayableMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-05-290001425287wkhs:TwoThousandTwentyFourNotesJuly18IssuanceMemberus-gaap:ConvertibleNotesPayableMemberwkhs:MeasurementInputBondYieldMember2024-05-290001425287wkhs:TwoThousandTwentyFourNotesJuly18IssuanceMemberus-gaap:ConvertibleNotesPayableMemberus-gaap:MeasurementInputPriceVolatilityMember2024-05-290001425287wkhs:TwoThousandTwentyFourNotesAugust23IssuanceMemberus-gaap:ConvertibleNotesPayableMember2024-05-290001425287wkhs:TwoThousandTwentyFourNotesAugust23IssuanceMemberus-gaap:ConvertibleNotesPayableMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-05-290001425287wkhs:TwoThousandTwentyFourNotesAugust23IssuanceMemberus-gaap:ConvertibleNotesPayableMemberwkhs:MeasurementInputBondYieldMember2024-05-290001425287wkhs:TwoThousandTwentyFourNotesAugust23IssuanceMemberus-gaap:ConvertibleNotesPayableMemberus-gaap:MeasurementInputPriceVolatilityMember2024-05-290001425287wkhs:TwoThousandTwentyFourNotesSeptember30IssuanceMemberus-gaap:ConvertibleNotesPayableMember2024-05-290001425287wkhs:TwoThousandTwentyFourNotesSeptember30IssuanceMemberus-gaap:ConvertibleNotesPayableMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-05-290001425287wkhs:TwoThousandTwentyFourNotesSeptember30IssuanceMemberus-gaap:ConvertibleNotesPayableMemberwkhs:MeasurementInputBondYieldMember2024-05-290001425287wkhs:TwoThousandTwentyFourNotesSeptember30IssuanceMemberus-gaap:ConvertibleNotesPayableMemberus-gaap:MeasurementInputPriceVolatilityMember2024-05-290001425287wkhs:A2024WarrantsMember2024-07-012024-09-300001425287wkhs:A2024WarrantsMembersrt:MinimumMember2024-09-300001425287wkhs:A2024WarrantsMembersrt:MaximumMember2024-09-300001425287wkhs:A2024WarrantsMember2024-09-300001425287wkhs:A2024WarrantsMarch15IssuanceMember2024-09-300001425287wkhs:A2024WarrantsMarch15IssuanceMember2024-05-100001425287wkhs:A2024WarrantsMarch15IssuanceMemberus-gaap:MeasurementInputPriceVolatilityMember2024-09-300001425287wkhs:A2024WarrantsMarch15IssuanceMemberus-gaap:MeasurementInputPriceVolatilityMember2024-05-100001425287wkhs:A2024WarrantsMarch15IssuanceMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-09-300001425287wkhs:A2024WarrantsMarch15IssuanceMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-05-100001425287wkhs:A2024WarrantsMarch15IssuanceMemberus-gaap:MeasurementInputExpectedDividendRateMember2024-09-300001425287wkhs:A2024WarrantsMarch15IssuanceMemberus-gaap:MeasurementInputExpectedDividendRateMember2024-05-100001425287wkhs:A2024WarrantsMay102024Member2024-09-300001425287wkhs:A2024WarrantsMay102024Member2024-05-100001425287wkhs:A2024WarrantsMay102024Memberus-gaap:MeasurementInputPriceVolatilityMember2024-09-300001425287wkhs:A2024WarrantsMay102024Memberus-gaap:MeasurementInputPriceVolatilityMember2024-05-100001425287wkhs:A2024WarrantsMay102024Memberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-09-300001425287wkhs:A2024WarrantsMay102024Memberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-05-100001425287wkhs:A2024WarrantsMay102024Memberus-gaap:MeasurementInputExpectedDividendRateMember2024-09-300001425287wkhs:A2024WarrantsMay102024Memberus-gaap:MeasurementInputExpectedDividendRateMember2024-05-100001425287wkhs:A2024WarrantsMay292024Member2024-09-300001425287wkhs:A2024WarrantsMay292024Member2024-05-290001425287wkhs:A2024WarrantsMay292024Memberus-gaap:MeasurementInputPriceVolatilityMember2024-09-300001425287wkhs:A2024WarrantsMay292024Memberus-gaap:MeasurementInputPriceVolatilityMember2024-05-290001425287wkhs:A2024WarrantsMay292024Memberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-09-300001425287wkhs:A2024WarrantsMay292024Memberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-05-290001425287wkhs:A2024WarrantsMay292024Memberus-gaap:MeasurementInputExpectedDividendRateMember2024-09-300001425287wkhs:A2024WarrantsMay292024Memberus-gaap:MeasurementInputExpectedDividendRateMember2024-05-290001425287wkhs:A2024WarrantsJuly182024Member2024-09-300001425287wkhs:A2024WarrantsJuly182024Member2024-07-180001425287wkhs:A2024WarrantsJuly182024Memberus-gaap:MeasurementInputPriceVolatilityMember2024-09-300001425287wkhs:A2024WarrantsJuly182024Memberus-gaap:MeasurementInputPriceVolatilityMember2024-07-180001425287wkhs:A2024WarrantsJuly182024Memberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-09-300001425287wkhs:A2024WarrantsJuly182024Memberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-07-180001425287wkhs:A2024WarrantsJuly182024Memberus-gaap:MeasurementInputExpectedDividendRateMember2024-09-300001425287wkhs:A2024WarrantsJuly182024Memberus-gaap:MeasurementInputExpectedDividendRateMember2024-07-180001425287wkhs:A2024WarrantsAugust242024Member2024-09-300001425287wkhs:A2024WarrantsAugust242024Member2024-08-240001425287wkhs:A2024WarrantsAugust242024Memberus-gaap:MeasurementInputPriceVolatilityMember2024-09-300001425287wkhs:A2024WarrantsAugust242024Memberus-gaap:MeasurementInputPriceVolatilityMember2024-08-240001425287wkhs:A2024WarrantsAugust242024Memberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-09-300001425287wkhs:A2024WarrantsAugust242024Memberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-08-240001425287wkhs:A2024WarrantsAugust242024Memberus-gaap:MeasurementInputExpectedDividendRateMember2024-09-300001425287wkhs:A2024WarrantsAugust242024Memberus-gaap:MeasurementInputExpectedDividendRateMember2024-08-240001425287wkhs:A2024WarrantsSeptember302024Member2024-09-300001425287wkhs:A2024WarrantsSeptember302024Memberus-gaap:MeasurementInputPriceVolatilityMember2024-09-300001425287wkhs:A2024WarrantsSeptember302024Memberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-09-300001425287wkhs:A2024WarrantsSeptember302024Memberus-gaap:MeasurementInputExpectedDividendRateMember2024-09-300001425287wkhs:TwoThousandTwentySixNotesMemberus-gaap:ConvertibleNotesPayableMember2023-12-122023-12-120001425287wkhs:TwoThousandTwentySixNotesMemberus-gaap:ConvertibleNotesPayableMember2023-12-120001425287wkhs:A2023WarrantsMember2023-12-120001425287wkhs:A2023WarrantsMember2023-12-310001425287wkhs:A2023WarrantsMember2024-06-300001425287wkhs:A2023WarrantsMember2024-01-012024-06-300001425287wkhs:AeroDivestitureMember2024-01-012024-09-300001425287wkhs:AeroDivestitureMember2024-07-012024-09-300001425287us-gaap:FairValueMeasurementsRecurringMember2024-09-300001425287us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001425287us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001425287us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001425287us-gaap:FairValueMeasurementsRecurringMember2023-12-310001425287us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001425287us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001425287us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001425287us-gaap:EmployeeStockOptionMember2024-07-012024-09-300001425287us-gaap:EmployeeStockOptionMember2023-07-012023-09-300001425287us-gaap:EmployeeStockOptionMember2024-01-012024-09-300001425287us-gaap:EmployeeStockOptionMember2023-01-012023-09-300001425287us-gaap:RestrictedStockMember2024-07-012024-09-300001425287us-gaap:RestrictedStockMember2023-07-012023-09-300001425287us-gaap:RestrictedStockMember2024-01-012024-09-300001425287us-gaap:RestrictedStockMember2023-01-012023-09-300001425287us-gaap:RestrictedStockUnitsRSUMember2024-07-012024-09-300001425287us-gaap:RestrictedStockUnitsRSUMember2023-07-012023-09-300001425287us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-09-300001425287us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001425287wkhs:PerformanceBasedShareUnitsMember2024-07-012024-09-300001425287wkhs:PerformanceBasedShareUnitsMember2023-07-012023-09-300001425287wkhs:PerformanceBasedShareUnitsMember2024-01-012024-09-300001425287wkhs:PerformanceBasedShareUnitsMember2023-01-012023-09-3000014252872023-01-012023-12-310001425287us-gaap:EmployeeStockOptionMember2024-09-300001425287us-gaap:RestrictedStockMember2023-12-310001425287us-gaap:RestrictedStockMember2024-09-300001425287us-gaap:RestrictedStockUnitsRSUMember2023-12-310001425287us-gaap:RestrictedStockUnitsRSUMember2024-09-300001425287us-gaap:PerformanceSharesMember2024-09-300001425287wkhs:PerformanceShareUnitsWithTotalShareholderReturnPerformanceObjectiveMember2024-01-012024-09-300001425287wkhs:EBITDATargetPerformanceShareUnitsEBITDAPSUsMember2024-01-012024-09-300001425287wkhs:RevenueTargetPerformanceShareUnitsRevenuePSUsMember2024-01-012024-09-300001425287us-gaap:PerformanceSharesMembersrt:MinimumMember2024-01-012024-09-300001425287us-gaap:PerformanceSharesMembersrt:MaximumMember2024-01-012024-09-300001425287wkhs:PerformanceSharesWithTotalShareholderReturnMetricMember2023-12-310001425287wkhs:PerformanceSharesWithTotalShareholderReturnMetricMember2024-01-012024-09-300001425287wkhs:PerformanceSharesWithTotalShareholderReturnMetricMember2024-09-300001425287us-gaap:PerformanceSharesMember2024-01-012024-09-300001425287wkhs:EBITDATargetPerformanceShareUnitsEBITDAPSUsMember2023-12-310001425287wkhs:EBITDATargetPerformanceShareUnitsEBITDAPSUsMember2024-09-300001425287wkhs:EBITDATargetPerformanceShareUnitsEBITDAPSUsMember2024-07-012024-09-3000014252872022-03-100001425287wkhs:LincolnParkCapitalFundLLCMember2023-12-122023-12-120001425287wkhs:LincolnParkCapitalFundLLCMember2024-01-012024-09-300001425287wkhs:LincolnParkCapitalFundLLCMembersrt:MinimumMember2024-09-300001425287wkhs:LincolnParkCapitalFundLLCMembersrt:MaximumMember2024-09-300001425287wkhs:ShareBasedPaymentArrangementOptionAndWarrantsMember2024-07-012024-09-300001425287wkhs:ShareBasedPaymentArrangementOptionAndWarrantsMember2023-07-012023-09-300001425287wkhs:ShareBasedPaymentArrangementOptionAndWarrantsMember2024-01-012024-09-300001425287wkhs:ShareBasedPaymentArrangementOptionAndWarrantsMember2023-01-012023-09-300001425287us-gaap:ConvertibleNotesPayableMember2024-07-012024-09-300001425287us-gaap:ConvertibleNotesPayableMember2023-07-012023-09-300001425287us-gaap:ConvertibleNotesPayableMember2024-01-012024-09-300001425287us-gaap:ConvertibleNotesPayableMember2023-01-012023-09-300001425287us-gaap:PendingLitigationMember2024-01-012024-09-300001425287us-gaap:PendingLitigationMember2024-04-192024-04-190001425287wkhs:SixthAdditionalNoteMemberus-gaap:ConvertibleNotesPayableMemberus-gaap:SubsequentEventMember2024-10-160001425287wkhs:A2024WarrantsMemberus-gaap:SubsequentEventMember2024-10-16























UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2024
or
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________ to __________
Commission file number: 001-37673
WORKHORSE GROUP INC.
(Exact name of registrant as specified in its charter)
Nevada26-1394771
(State or other jurisdiction of
incorporation or organization)		(I.R.S. Employer
Identification No.)
3600 Park 42 Drive, Suite 160E, Sharonville, Ohio 45241
(Address of principal executive offices, including zip code)
1 (888) 646-5205
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.001 par value per shareWKHSThe NASDAQ Capital Market
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒  No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒  No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer☐Accelerated filer☐
Non-accelerated filer☒Smaller reporting company☒
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐  No ☒
The number of shares of the Registrant’s Common Stock, $0.001 par value per share, outstanding as of November 19, 2024, was 40,981,553.

























TABLE OF CONTENTS


i























Forward-Looking Statements

The discussions in this Quarterly Report on Form 10-Q (this “Report”) contain forward-looking statements reflecting our current expectations that involve risks and uncertainties. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. When used in this Report, the words “anticipate,” “expect,” “plan,” “believe,” “seek,” “estimate” and similar expressions are intended to identify forward-looking statements. These are statements that relate to future periods and include, but are not limited to, statements about the features, benefits and performance of our products, our ability to introduce new product offerings and increase revenue from existing products, expected expenses including those related to selling and marketing, product development and general and administrative, our beliefs regarding the health and growth of the market for our products, anticipated increase in our customer base, expansion of our products functionalities, expected revenue levels and sources of revenue, expected impact, if any, of legal proceedings, the adequacy of our liquidity and capital resources, the likelihood of us obtaining additional financing in the immediate future and the expected terms of such financing, and expected growth in business. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from the forward-looking statements contained in this Report. Factors that could cause actual results to differ materially include, but are not limited to: our ability to develop and manufacture our new product portfolio, including the W4 CC, W750, W56 and other programs; our ability to attract and retain customers for our existing and new products; the possible implementation of changes to the existing tariff regime by the incoming Presidential Administration; risks associated with obtaining orders and executing upon such orders; the unavailability, reduction, elimination or adverse application of government subsidies and incentives or any failure by the federal government, states or other governmental entities to adopt or enforce regulations such as the California Air Resource Board’s Advanced Clean Fleet regulation; supply chain disruptions, including constraints on steel, semiconductors and other material inputs and resulting cost increases impacting our Company, our customers, our suppliers or the industry; our ability to capitalize on opportunities to deliver products to meet customer requirements; our limited operations and need to expand and enhance elements of our production process to fulfill product orders; our general inability to raise additional capital to fund our operations and business plan; our ability to obtain financing to meet our immediate liquidity needs and the potential costs, dilution and restrictions imposed by any such financing; our ability to regain compliance with the current and soon to be effective listing requirements of the Nasdaq Capital Market and otherwise maintain the listing of our securities thereon and the impact of the steps we take to regain such compliance, on our operations, stock price and future access to liquidity; our ability to protect our intellectual property; market acceptance of our products; our ability to obtain sufficient liquidity from operations and financing activities to continue as a going concern and, our ability to control our expenses; the effectiveness of our cost control measures and impact such measures could have on our operations, including the effects of furloughing employees; potential competition, including without limitation shifts in technology; volatility in and deterioration of national and international capital markets and economic conditions; global and local business conditions; acts of war (including without limitation the conflicts in Ukraine and Israel) and/or terrorism; the prices being charged by our competitors; our inability to retain key members of our management team; our inability to satisfy our customer warranty claims; the outcome of any regulatory or legal proceedings, including with Coulomb Solutions Inc.; our ability to consummate and realize the benefits of a potential sale and leaseback transaction of our Union City Facility; and other risks and uncertainties and other factors discussed from time to time in our filings with the Securities and Exchange Commission (“SEC”), including under the “Risk Factors” section of our filings with the SEC, including our Annual Report on Form 10-K for the year ended December 31, 2023 ("2023 Form 10-K"). Forward-looking statements speak only as of the date hereof. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based, except as required by law.

All references in this Report that refer to the “Company”, “Workhorse Group”, “Workhorse”, “we,” “us” or “our” are to Workhorse Group Inc.
ii























PART I – FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
Workhorse Group Inc.
Condensed Consolidated Balance Sheets
(Unaudited)

September 30,
2024		December 31,
2023
Assets
Current assets:
Cash and cash equivalents$3,244,806 $25,845,915 
Restricted cash— 10,000,000 
Accounts receivable, less allowance for credit losses of $0.2 million and $0.2 million as of September 30, 2024 and December 31, 2023, respectively
682,673 2,326,774 
Other receivables
3,002,143 2,143,435 
Inventory, net43,186,462 45,408,192 
Prepaid expenses and other current assets7,357,838 8,101,162 
      Total current assets57,473,922 93,825,478 
Property, plant and equipment, net
34,825,810 37,876,955 
Operating lease right-of-use assets, net
3,465,637 4,174,800 
Finance lease right-of-use assets, net
5,470,933 5,621,181 
Other assets176,310 176,310 
Total Assets$101,412,612 $141,674,724 
Liabilities
Current liabilities:
Accounts payable$10,572,525 $12,456,272 
Accrued and other current liabilities8,384,321 4,862,740 
Deferred revenue
6,350,581 4,714,331 
Warranty liability776,423 1,902,647 
Operating lease liabilities, current1,001,120 1,012,428 
Finance lease liabilities, current2,100,635 2,548,184 
  Warrant liability
7,229,919 5,605,325 
  Current portion of convertible notes
13,182,467 20,180,100 
      Total current liabilities49,597,991 53,282,027 
Operating lease liabilities, long-term
4,556,738 5,280,526 
Total Liabilities54,154,729 58,562,553 
Commitments and contingencies
Stockholders’ Equity:
Common stock, par value $0.001 per share, 450,000,000 shares authorized, 31,862,091
shares issued and outstanding as of September 30, 2024 and 14,299,042 shares issued and outstanding as of December 31, 2023 (presented on a reverse stock split-adjusted basis)
31,862 14,299 
Additional paid-in capital879,405,617 834,666,123 
Accumulated deficit(832,179,596)(751,568,251)
      Total stockholders’ equity47,257,883 83,112,171 
Total Liabilities and Stockholders’ Equity$101,412,612 $141,674,724 
See accompanying notes to the Condensed Consolidated Financial Statements.
1























Workhorse Group Inc.
Condensed Consolidated Statements of Operations
(Unaudited)

Three Months Ended
September 30,		Nine Months Ended
 September 30,
2024202320242023
Sales, net of returns and allowances$2,509,717 $3,028,545 $4,691,451 $8,688,423 
Cost of sales6,642,549 6,557,358 21,386,676 20,312,854 
Gross loss(4,132,832)(3,528,813)(16,695,225)(11,624,431)
Operating expenses
Selling, general and administrative7,722,014 11,756,291 33,883,845 40,448,651 
Research and development2,313,423 5,771,588 7,834,113 18,056,182 
Total operating expenses10,035,437 17,527,879 41,717,958 58,504,833 
Loss from operations(14,168,269)(21,056,692)(58,413,183)(70,129,264)
Interest income (expense), net(8,317,813)410,980 (15,109,136)1,466,839 
Fair value adjustment (loss) on warrants
(2,649,477)— (7,089,027)— 
Other income (loss)— (10,000,000)— (10,000,000)
Loss before benefit for income taxes(25,135,559)(30,645,712)(80,611,346)(78,662,425)
Benefit for income taxes— — — — 
Net loss$(25,135,559)$(30,645,712)$(80,611,346)$(78,662,425)
Net loss per share of common stock
Basic and Diluted*
$(0.98)$(2.84)$(4.06)$(8.29)
Weighted average shares used in computing net loss per share of common stock
Basic and Diluted*
25,589,725 10,793,926 19,879,290 9,487,842 
See accompanying notes to the Condensed Consolidated Financial Statements.
* Prior periods presented have been adjusted to reflect the 1-for-20 reverse stock split which was effective on June 17, 2024. Additional information regarding the reverse stock split may be found in Note 1 Summary of Business and Significant Accounting Principles.
2

Workhorse Group Inc.
Condensed Consolidated Statements of Stockholders’ Equity
(Unaudited)


Common StockAdditional
Paid-in
Capital**		Accumulated
Deficit		Total
Stockholders’
Equity
Number
of Shares**		Amount**
Balance as of June 30, 202310,261,058 $10,261 $783,043,235 $(675,665,775)$107,387,721 
Common stock issued for securities litigation settlement1,269,036 1,269 19,998,731 — 20,000,000 
Common stock issued through At-The-Market offering1,231,961 1,232 12,496,672 — 12,497,904 
Stock options and vesting of restricted shares*7,052 7 8,369 — 8,376 
Stock-based compensation— — 3,520,404 — 3,520,404 
Net loss for the three months ended September 30, 2023
— — — (30,645,712)(30,645,712)
Balance as of September 30, 2023
12,769,107 $12,769 $819,067,411 $(706,311,487)$112,768,693 


Common StockAdditional
Paid-in
Capital**		Accumulated
Deficit		Total
Stockholders’
Equity
Number
of Shares**		Amount**
Balance as of December 31, 20228,280,268 $8,280 $736,227,713 $(627,649,062)$108,586,931 
Common stock issued for securities litigation settlement1,269,036 1,269 19,998,731 — 20,000,000 
Common stock issued through At-The-Market offering3,166,168 3,166 52,786,346 — 52,789,512 
Issuance of common stock5,817 6 199,994 — 200,000 
Stock options and vesting of restricted shares*47,818 48 (467,262)— (467,214)
Stock-based compensation— — 10,321,889 — 10,321,889 
Net loss for the nine months ended September 30, 2023— — — (78,662,425)(78,662,425)
Balance as of September 30, 2023
12,769,107 $12,769 $819,067,411 $(706,311,487)$112,768,693 

See accompanying notes to the Condensed Consolidated Financial Statements.
*Net of tax payments related to shares withheld for option exercises and vested stock.
** Prior periods presented have been adjusted to reflect the 1-for-20 reverse stock split which was effective on June 17, 2024. Additional information regarding the reverse stock split may be found in Note 1 Summary of Business and Significant Accounting Principles.






3







Workhorse Group Inc.
Condensed Consolidated Statements of Stockholders’ Equity
(Unaudited)


Common Stock
Additional
Paid-in
Capital**
Accumulated
Deficit		Total
Stockholders’
Equity
Number
of Shares**
Amount**
Balance as of June 30, 202420,738,091 $20,738 $865,660,256 $(807,044,037)$58,636,957 
Common stock issued under 2024 Securities Purchase Agreement11,162,343 11,162 11,769,897 — 11,781,059 
Stock options and vesting of restricted shares*105,001 105 (2,866)— (2,761)
Stock-based compensation— — 1,978,330 — 1,978,330 
Other(143,344)(143)— — (143)
Net loss for the three months ended September 30, 2024
— — — (25,135,559)(25,135,559)
Balance as of September 30, 202431,862,091 $31,862 $879,405,617 $(832,179,596)$47,257,883 



Common Stock
Additional
Paid-in
Capital**
Accumulated
Deficit		Total
Stockholders’
Equity
Number
of Shares**
Amount**
Balance as of December 31, 202314,299,042 $14,299 $834,666,123 $(751,568,251)$83,112,171 
Common stock issued under ATM490,445 490 1,242,159 — 1,242,649 
Common stock issued under 2023 Warrant Exchange425,000 425 2,847,075 — 2,847,500 
Issuance of common stock under ELOC Purchase Agreement600,000 600 3,123,400 — 3,124,000 
Common stock issued under 2024 Securities Purchase Agreement16,111,989 16,112 29,675,462 — 29,691,574 
Stock options and vesting of restricted shares*206,993 207 (171,250)— (171,043)
Stock-based compensation— — 8,022,851 — 8,022,851 
Other(271,378)(271)(203)— (474)
Net loss for the nine months ended September 30, 2024
— — — (80,611,346)(80,611,346)
Balance as of September 30, 202431,862,091 $31,862 $879,405,617 $(832,179,596)$47,257,883 

See accompanying notes to the Condensed Consolidated Financial Statements.
*Net of tax payments related to shares withheld for option exercises and vested stock.
** Prior periods presented have been adjusted to reflect the 1-for-20 reverse stock split which was effective on June 17, 2024. Additional information regarding the reverse stock split may be found in Note 1 Summary of Business and Significant Accounting Principles.
4

Workhorse Group Inc.
Condensed Consolidated Statements of Cash Flows

(Unaudited)
Nine Months Ended
September 30,
20242023
Cash flows from operating activities:
Net loss$(80,611,346)$(78,662,425)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization5,959,822 2,468,832 
Deferred revenue1,636,250 (143,169)
Stock-based compensation8,206,673 10,321,889 
Change in inventory and prepaid purchases reserve1,084,906 550,090 
Non-cash lease expense580,123 583,348 
Change in fair value and gain on conversion of 2026 Notes and exchange of 2023 Warrants
(2,937,925)— 
Change in fair value and conversion of 2024 Notes and 2024 Warrants
18,939,100 — 
Other non-cash items2,917,251 200,000 
Impairment of investment in Tropos— 10,000,000 
Effects of changes in operating assets and liabilities:
Accounts receivable785,394 (5,295,003)
Inventory, net1,238,803 (28,492,532)
Prepaid expenses and other current assets641,345 (1,083,886)
Accounts payable, accrued liabilities and other2,570,035 (5,563,625)
Warranty liability(1,126,224)(430,154)
Net cash used in operating activities(40,115,793)(95,546,635)
Cash flows from investing activities:
Capital expenditures(4,027,565)(16,527,317)
Net cash used in investing activities(4,027,565)(16,527,317)
Cash flows from financing activities:
Proceeds on convertible notes
28,250,000 — 
Payments on convertible notes
(20,000,000)— 
Proceeds from issuance of common stock4,366,649 52,789,512 
Payments on finance lease(903,357)(659,582)
Exercise of options and restricted share award activity(171,043)(467,214)
Net cash provided by financing activities
11,542,249 51,662,716 
Change in cash and cash equivalents(32,601,109)(60,411,236)
Cash and cash equivalents, beginning of the period35,845,915 99,276,301 
Cash and cash equivalents, end of the period$3,244,806 $38,865,065 

See accompanying notes to the Condensed Consolidated Financial Statements.
5


Workhorse Group Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)

1.SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING PRINCIPLES
Overview

Workhorse Group Inc. (“Workhorse”, the “Company”, “we”, “us”, or “our”) is an American technology company with a vision to pioneer the transition to zero-emission commercial trucks. We design, develop, manufacture and sell fully electric trucks.

Liquidity, Capital Resources, and Going Concern

The accompanying Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) applicable to a going concern. The going concern basis of presentation assumes that the Company will continue in operation one year after the date these Condensed Consolidated Financial Statements are issued and will be able to realize assets and discharge its liabilities and commitments in the normal course of business. The Condensed Consolidated Financial Statements do not include any adjustments to the carrying amounts and classification of assets, liabilities, and reported expenses that may be necessary if the Company were unable to continue as a going concern.

Pursuant to the requirements of the Financial Accounting Standard Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 205-40, Presentation of Financial Statements - Going Concern (“ASC 205-40”), management must evaluate whether there are conditions and events, considered in aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for one year after the date these Condensed Consolidated Financial Statements are issued. In accordance with ASC 205-40, management’s analysis can only include the potential mitigating impact of management’s plans that have not been fully implemented as of the issuance date if (a) it is probable that management’s plans will be effectively implemented on a timely basis, and (b) it is probable that the plans, when implemented, will alleviate the relevant conditions or events that raise substantial doubt about the Company’s ability to continue as a going concern.

We had sales of $4.7 million, incurred a net loss of $80.6 million and used $40.1 million of cash in operating activities during the nine months ended September 30, 2024. As of September 30, 2024, the Company had $3.2 million of cash and cash equivalents, net accounts receivable of $0.7 million, other receivables of $3.0 million, inventory, net of $43.2 million and accounts payable of $10.6 million. As of September 30, 2024, the Company had working capital of $7.9 million and an accumulated deficit of $832.2 million.

As a result of our recurring losses from operations, accumulated deficit, projected capital needs, and delays in bringing our trucks to market and lower than expected market demand, substantial doubt exists regarding our ability to continue as a going concern within one year after the issuance date of the accompanying Condensed Consolidated Financial Statements. Our ability to continue as a going concern is contingent upon successful execution of management’s intended plan over the next twelve months to improve the Company’s liquidity and working capital, which includes, but is not limited to:

•Generating revenue by increasing sales of our trucks and other services.
•Reducing expenses and limiting non-contracted capital expenditures.
•Raising capital to fund operations through the issuance of debt or equity securities, including through our 2024 Securities Purchase Agreement (as defined below) and our At-the-Market Sales Agreement (“ATM Agreement”), the sale of assets, or other strategic transactions.

It is essential that we have access to capital as we bring our existing line of trucks to market, scale up production and sales of such trucks and continue to develop additional variations of our existing trucks and our next generation of trucks. There is no assurance that we will be successful in implementing management’s plans to generate liquidity to fund these activities or other aspects of our short and long-term strategy, that our projections of our future capital needs will prove accurate or that any additional funding would be available or sufficient to continue operations in future periods.

To the extent revenues from operations are insufficient to meet our liquidity requirements, our ability to continue as a going concern will be dependent on effectively raising capital through private or public placement of our equity, debt and equity-linked securities, including the continued access to the additional closings of, as of November 18, 2024, up to $105.5 million in aggregate principal amount of additional 2024 Notes (as defined below) and, if our share price makes such exercise feasible, the possible receipt of proceeds from the exercise of the corresponding 2024 Warrants (as defined below) pursuant to the 2024 Securities Purchase Agreement (as defined below), and the continued use of the ATM Agreement, for which there can be no
6

assurance we will be successful in such efforts. We will also rely on other debt financing or other sources of capital funding such as through the sale of assets to obtain sufficient financial resources to fund our operating activities. If we are unable to maintain sufficient financial resources, our business, financial condition and results of operations, as well as our ability to continue to develop, produce and market our truck programs and satisfy our obligations as they become due, the Company will be materially and adversely affected. This could affect future truck program production and sales. Failure to obtain additional financing will have a material, adverse impact on our business operations. There can be no assurance that we will be able to obtain the financing needed to achieve our goals on acceptable terms or at all. Additionally, any equity or equity-linked financings would likely have a dilutive effect on the holdings of our existing stockholders. The Company’s current level of cash and cash equivalents are not sufficient to execute our business plan. For the foreseeable future, we will incur significant operating expenses, capital expenditures and working capital funding that will deplete our cash on hand. These conditions raise substantial doubt regarding the Company’s ability to continue as a going concern for a period of at least one year from the date of issuance of these Condensed Consolidated Financial Statements.

Our ability to obtain additional financing is extremely limited under current market conditions including the significant amount of capital required, the market price of our stock and potential dilution from the issuance of any additional securities and our ability to regain compliance with the listing requirements of the Nasdaq Capital Market. If we are unable to identify other sources of funding, we may need to further adjust our operations and seek protection by filing a voluntary petition for relief under the Bankruptcy Code. If this were to occur, the value available to our various stakeholders, including our creditors and stockholders, is uncertain and trading prices for our securities may bear little or no relationship to the actual recovery, if any, by holders of our securities in bankruptcy proceedings, if any.

Due to these uncertainties and continued delays in market adoption of commercial electric trucks, the Company identified a triggering event under ASC 360-35-21 that required further analysis and concluded that no impairment was required.

Additional actions taken by the Company with regards to liquidity and its plan to manage operating capital include the following:

Financings under the 2024 Securities Purchase Agreement

As part of management's plan to raise capital to fund operations, we have entered into a financing arrangement that makes liquidity available in both the short term and over time. On March 15, 2024, we have entered into a securities purchase agreement (the “2024 Securities Purchase Agreement”) with an institutional investor (the “Investor”) under which we agreed to issue and sell, in one or more registered public offerings by the Company directly to the Investor in multiple tranches over a period beginning on March 15, 2024, (i) senior secured convertible notes for up to an aggregate principal amount of $139.0 million (the “2024 Notes”) that are convertible into shares of the Company’s common stock, par value of $0.001 per share (the “Common Stock”) and (ii) warrants (the “ 2024 Warrants”) to purchase shares of Common Stock.

Pursuant to the 2024 Securities Purchase Agreement, during the three months ended September 30, 2024 the Company issued and sold to the Investor (i) 2024 Notes in the original principal amount of $10.0 million ($4.0 million on July 18; $2.6 million on August 23, and $3.4 million on September 30) and (ii) 2024 Warrants to purchase up to 10.1 million (2.7 million on July 18; 2.9 million on August 23; and 4.5 million on September 30) shares of Common Stock.

As of September 30, 2024, $9.4 million aggregate principal amount remained outstanding under the 2024 Notes, and no shares had been issued pursuant to the 2024 Warrants. Upon our filing of one or more additional prospectus supplements, and our satisfaction of certain other conditions, as of September 30, 2024, the 2024 Securities Purchase Agreement contemplates additional closings of 2024 Notes of up to $106.7 million in aggregate principal amount of additional 2024 Notes and corresponding 2024 Warrants.

Sale Leaseback of Union City, Indiana Manufacturing Facility

Another strategic opportunity identified by management to raise capital to fund operations was to enter into a sale leaseback for our Union City, Indiana manufacturing facility. As previously reported, on January 31, 2024, a subsidiary of the Company entered into a purchase and sale agreement (the “Purchase and Sale Agreement”) with William Repny LLC (the “Union City Purchaser”) for the sale of the Company’s Union City, Indiana manufacturing facility for a purchase price, before fees and expenses, of approximately $34.5 million, in connection with which the Company would lease the property back from the Union City Purchaser. Although the Purchase and Sale Agreement has not been terminated, the Company does not believe the transaction will be consummated at the current purchase price. Accordingly, the Company is currently discussing alternative sale and leaseback transactions with other potential purchasers, as well as possible changes to the terms of the Purchase and Sale Agreement with the Union City Purchaser or other strategic alternatives. The Company expects that if a sale and leaseback transaction for the Union City facility is consummated, whether with the Union City Purchaser or another party, the purchase price in such transaction will be materially lower than the price provided in the Purchase and Sale Agreement. Moreover,
7

because the Union City facility is currently operating at a very limited portion of its capacity, the Company believes that it may not be possible to consummate a sale leaseback of the facility on acceptable terms unless the Company or an additional occupant begins using a larger portion of the facility and sales ramp up.

Cost-saving Measures

As previously disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 as filed with the Securities and Exchange Commission (the “SEC”) on March 12, 2024 (the “Form 10-K”) a vital component of management’s intended plan to improve our liquidity and working capital requirements is reducing our operating costs to, among other things, reduce demands on our available liquidity. During the first quarter of 2024, we initiated a reduction in force (the “RIF”) pursuant to which we terminated the approximately 20% of our total workforce, excluding direct labor, and our executive officers agreed to defer approximately 20% of their cash compensation into the third quarter of 2024. Effective for the pay period beginning October 28, 2024 the Company will no longer defer approximately 20% of the cash compensation of our executive officers described above. However, the previously deferred compensation of $0.4 million in Accrued and other current liabilities in the Condensed Consolidated Balance Sheet will remain deferred and the Company does not expect to pay such deferred amounts until it has adequate liquidity to do so.

In April 2024, the Company initially furloughed 73 employees at its Union City manufacturing facility without pay and from these 16, have since been reinstated as of September 30, 2024. The Company has not incurred, and does not expect to incur, material costs in connection with the RIF and furloughs. The Company is also currently working with certain of its vendors to extend or restructure the payment terms of certain of its accounts payable. The Company currently intends to reinstate furloughed employees when the Company’s financial and operational position permits. However, there can be no assurance that such furloughed employees will be available and willing to return to work.

Aero Drone Design and Manufacturing Operations

Management’s plan also included a decision to cease the production operations of our drone design and manufacturing business and transition exclusively to operating as a Drones as a Service business, as previously disclosed in the 2023 Form 10-K. On June 6, 2024, the Company completed the previously disclosed divestiture of its Aero business (the “Aero Divestiture”) to a third party. The Company expects the Aero Divestiture to provide monthly cost savings of approximately $0.4 million and enhance its ability to concentrate on its commercial electric truck business. Under the agreement’s earn-out provisions, the Company will receive a portion of the proceeds if the Aero business realizes positive net cash flow but these contingencies are indeterminable at this time. The loss on the Aero Divestiture was $0.7 million of which $0.4 million was included in Selling, general and administrative expenses and $0.3 million in Cost of sales in the Condensed Consolidated Statement of Operations for the nine months ended September 30, 2024.

NASDAQ Listing Requirements and Reverse Stock Split

In order to regain compliance with the Listing Requirements of Nasdaq, on June 17, 2024, the Company effected a 1-for-20 reverse stock split (the “Reverse Split”) of the Company’s then issued and outstanding shares of common stock, par value $0.001 per share (the “Common Stock”). The authorized number of shares of Common Stock was not affected by the Reverse Split. The Company adjusted the exercise price, number of shares issuable on exercise or vesting and/or other terms of its outstanding stock options, warrants, restricted stock, and restricted stock units to reflect the effects of the Reverse Split. Prior periods presented have also been adjusted to reflect this change. On July 3, 2024, Nasdaq confirmed that we were in compliance with the Minimum Bid Requirement.

On October 2, 2024, the Company received a second written notice from Nasdaq indicating that the Company was no longer in compliance with the $1.00 minimum bid price requirement.

The Company has been provided with a compliance period of 180 calendar days, or until March 31, 2025, to regain compliance with the minimum bid price. If the Company does not regain compliance by March 31, 2025, the Company may be eligible for an additional grace period subject to certain conditions.

The Company is currently evaluating various courses of action to regain compliance. There can be no assurance that the Company will regain compliance with the bid price requirement during the 180-day compliance period ending March 31, 2025, secure an extension of the compliance period beyond March 31, 2025 or maintain compliance with any other Nasdaq listing requirement.

In addition, Nasdaq has recently adopted new rules and proposed new rules that could hinder our ability to cure our deficiency
and maintain the continued listing of our common stock. These new rules and rule proposals would provide for the immediate
delisting with no grace period of any listed company that falls out of compliance with the minimum bid price requirement twice
in a twelve-month period, provide for the immediate delisting if a listed company effects a reverse stock split that causes it to
8

fall out of compliance with certain other listing requirements, and limits the ratio of reverse stock splits to a cumulative ratio of
1-to-250 in any two-year period. Delisting would likely have an adverse effect on the liquidity of our common stock, decrease
the market price of our common stock, result in the potential loss of confidence by investors, suppliers, customers, and
employees, and fewer business development opportunities, and adversely affect our ability to obtain financing for our
continuing operations, including our ability to issue and sell additional notes to the investors party to the 2024 Securities Purchase Agreement or secure other future financing agreements.

Basis of Presentation and Consolidation

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the SEC regarding interim financial reporting and include the accounts and operations of the Company and those of our wholly-owned subsidiaries. Accordingly, they do not include all of the information and footnotes required by GAAP for annual audited financial statements. All intercompany balances and transactions have been eliminated upon consolidation.
During the period, the Company identified that certain items in its prior year Condensed Consolidated Balance Sheets were presented as combined totals, including right-of-use (ROU) assets and lease liabilities related to operating and finance leases, accounts receivable and other receivables. The Company has reclassified these amounts to separately disclose the relevant components in the accompanying financial statements. These changes in presentation do not impact total assets, total liabilities, net income, or cash flows.
The Company has elected the fair value option for its convertible debt and associated warrants. This election was made to align the measurement of these financial instruments with their market values and simplify the accounting for the components. Changes in fair value are recognized in Interest income (loss) and Fair value adjustment (loss) on warrants, respectively in the Condensed Consolidated Statement of Operations.

In the opinion of our management, the unaudited Condensed Consolidated Financial Statements have been prepared on a basis consistent with the audited Consolidated Financial Statements and include all adjustments necessary for the fair presentation of Workhorse’s financial condition, results of operations and cash flows for the interim periods presented. Such adjustments are of a normal, recurring nature. The results of operations and cash flows for the interim periods presented may not necessarily be indicative of full-year results. Reference should be made to the financial statements contained in our 2023 Form 10-K.

Revenue Recognition

The Company recognizes revenue in accordance with Accounting Standards Codification 606, Revenue from Contracts with Customers.

Revenue is recognized when the Company transfers promised goods or services to customers in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. In determining the appropriate amount of revenue to be recognized as the Company fulfills its obligations under the agreement, the Company performs the following steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including any constraints on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. The Company only applies the five-step model to contracts when it is probable that it will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer.

The Company generates revenue through the sale of electric trucks (Workhorse W4 CC, W56 and W750) as well as service and parts directly to dealership customers and route revenue from the Company’s Stables by Workhorse. The Company reviews the performance obligations in the Company’s agreements, which is the Company’s promise to transfer the Company’s product to customers based on the performance of services, transfer of title or shipping terms in the arrangement and any other variable considerations. The revenue is allocated based on the Company's performance obligation, and an estimate of Sales returns and allowances are recognized. The Company offers concessions to certain customers and estimates the variable consideration based on historical sales activity. In addition, the Company considers the extent to which revenue should be constrained such that there is not a significant reversal of revenue in the future. In the current quarter, the Company constrained approximately $1.1 million of revenue.

On or before shipment of the trucks, the Company bills its customers the total consideration of its obligations under the agreement. Consistent with industry practice, the Company generally offers customers a limited warranty for work performed
9

on the truck under the builds/sales contract. The customers do not have a contractual right of return. The Company only offers a limited warranty for the work performed on the truck. If a customer disputes any work performed, the Company will attempt to remedy the work, however, it shall not be required to discount the transaction price. The Company considers this an assurance-type warranty and not a separate performance obligation.

The Company's agreements do not allow customers to return products. However, under certain conditions, such as defects or non-compliance with specifications, or other allowances, the Company may elect to allow limited returns in special situations. To account for these returns, the Company estimates and records a sales returns allowance as a reduction of gross revenue. This allowance is based on historical return rates and expectations of future returns, adjusted for any known factors that may affect return rates, such as changes in product quality or customer mix.

The Company provides for the estimated cost of product warranties at the time revenue is recognized. While the Company engages in product quality programs and processes, including quality control test driving trucks, the warranty obligation is calculated by historical warranty costs per truck. Should actual costs differ from the Company’s estimates, revisions to increase or decrease the estimated warranty liability may be required.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses and related disclosures in the accompanying notes.
2.    INVENTORY, NET

Inventory, net consisted of the following:

September 30, 2024December 31, 2023
Raw materials$46,097,429 $32,682,324 
Work in process4,123,097 2,892,329 
Finished goods5,476,095 18,309,829 
55,696,621 53,884,482 
Less: inventory reserves(12,510,159)(8,476,290)
Inventory, net$43,186,462 $45,408,192 
We reserve inventory for any excess or obsolete inventories or when we believe the net realizable value of inventories is less than the carrying value.
Inventory reserves represents the Company’s best estimate in value lost due to excessive inventory level, physical deterioration, obsolescence, changes in price levels, or other causes based on individual facts and circumstances. Inventory reserves relate to inventory items including finished goods, work-in-process and raw materials. Reductions to inventory reserves are recognized only when the related inventory has been consumed, sold, disposed or scrapped.
As of September 30, 2024 and December 31, 2023, we carried inventory reserves of $12.5 million and $8.5 million, respectively. The increase in inventory reserves was primarily attributable to excess inventory due to slower than anticipated truck sales.
3.     CONTRACT MANUFACTURING SERVICES AND INVESTMENT IN TROPOS

We have a minority ownership investment in Tropos Technologies, Inc. (“Tropos”). The investment was acquired during the third quarter of 2022 in exchange for a cash payment of $5.0 million and a $5.0 million contribution of non-cash consideration representing a deposit from Tropos for future assembly services under an Assembly Services Agreement. The $5.0 million non-cash consideration was recorded as deferred revenue and is recognized as revenue over time as assembly service performance obligations are satisfied.

We recorded our investment at cost less impairment, if applicable. In accordance with FASB ASC Topic 321, Investments - Equity Securities, we assessed our investment for impairment at each reporting period to determine if the fair value declined below its cost basis and if the impairment is other-than-temporary.

10

During the third quarter of 2023, we determined that our investment in Tropos was impaired based on the economic conditions and uncertainties that have significantly affected Tropos’ performance and financial position. The impairment is considered other-than-temporary as the decline in fair value of the investment is not expected to recover in the foreseeable future.

The impairment loss recognized for our investment was $10.0 million, which represents the difference between the original cost of the investment and its fair value as of the impairment assessment date. The impairment loss was recognized in Other income (loss) in the Consolidated Statements of Operations in the previous period.

The impairment of our investment did not release the Company from its obligation to perform assembly services under the Assembly Services Agreement and, accordingly, the Company continues to be obligated to perform assembly services and carry the balance of such obligations in Deferred revenue in the Condensed Consolidated Balance Sheets. As of September 30, 2024 and December 31, 2023, deferred revenue related to the Assembly Services Agreement was $4.7 million.

11

4.    PREPAID EXPENSES AND OTHER CURRENT ASSETS

Prepaid expenses and other current assets consisted of the following:

September 30, 2024December 31, 2023
Prepaid purchases(1)
$6,824,168 $7,908,087 
Less: prepaid purchases reserve(2)
(1,943,969)(1,999,068)
Prepaid purchases, net4,880,199 5,909,019 
Prepaid insurance864,110 1,283,146 
Other1,613,529 908,997 
Prepaid expenses and other current assets$7,357,838 $8,101,162 

(1) Our prepaid purchases consist of deposits made to our suppliers for non-recurring production parts and engineering costs. As of September 30, 2024 and December 31, 2023, net prepaid purchases primarily consisted of deposits for direct materials associated with our W4 CC and W750 trucks. The decrease in prepaid purchases as of September 30, 2024 as compared to December 31, 2023 is primarily due to receipts of direct materials associated with our W4 CC and W750 trucks.

(2) We record reserves on prepaid purchases that are significantly aged and for balances specifically identified as having a carrying value in excess of net realizable value. The prepaid purchases reserve represents our best estimate of deposits on orders that we do not expect to recover.

5.    REVENUE
The following table provides a summary of sales activity for the periods indicated:
Three Months Ended September 30,Nine Months Ended
September 30,
2024202320242023
Sales, net of returns and allowances$2,169,769 $2,570,250 $2,753,384 $7,292,417 
Other sales339,948 458,295 1,938,067 1,396,006 
Total sales, net of returns and allowances$2,509,717 $3,028,545 $4,691,451 $8,688,423 

Sales, net of returns and allowances, for the three and nine months ended September 30, 2024 consisted primarily of truck sales. Other sales for the three and nine months ended September 30, 2024 consisted of non-warranty after-sales truck services, parts and accessories and revenue generated from operating our Stables by Workhorse route, Drones as a Service prior to the Aero Divestiture, and other service revenue.

Deferred revenue was $6.4 million and $4.7 million as of September 30, 2024 and December 31, 2023, respectively, consisting of the total service fee allocated to the assembly service performance obligations under the Tropos Assembly Services Agreement of $4.7 million and certain performance obligations related to the sale of W4 CC trucks in the second quarter of 2024 that were unsatisfied as of September 30, 2024 of $1.7 million. The Company expects to recognize a portion of deferred revenue related to the sale of W4 CC trucks as revenue during the remainder of 2024.

12

6.    ACCRUED AND OTHER CURRENT LIABILITIES

Accrued and other current liabilities consisted of the following:

September 30, 2024December 31, 2023
Compensation and related costs$3,935,226 $2,083,808 
Accrued interest114,438 — 
Sales returns and allowances
1,102,005 — 
Other
3,232,652 2,778,932 
Total accrued and other current liabilities$8,384,321 $4,862,740 

Warranties

We provide a manufacturer's warranty on all new trucks we sell. We record a warranty liability for the products sold by us, which includes our best estimate of the projected costs to repair or replace items under warranties and recalls if identified. The amount of warranty liability accrued reflects management’s best estimate of the nature, frequency, and costs of future claims. Historically, the cost of fulfilling the warranty obligations has principally involved replacement parts, towing and transportation costs, labor and sometimes travel for any field retrofit campaigns. Our estimates are based on historical experience, the extent of pre-production testing, the number of units involved and the extent of features/components included in product models. Although we believe the estimates and judgments discussed herein are reasonable, actual results could differ and we may be exposed to increases or decreases in our warranty liability accrual that could be material.

Accrued warranty liability activity consisted of the following for the periods indicated:

Three Months Ended
September 30,		Nine Months Ended
September 30,
2024202320242023
Warranty liability, beginning of period$642,326 $1,922,580 $1,902,647 $2,207,674 
Warranty costs incurred(61,611)(289,404)(189,904)(884,717)
Provision for warranty(1)
195,708 144,344 (936,320)454,563 
Warranty liability, end of period$776,423 $1,777,520 $776,423 $1,777,520 

(1) We record a warranty liability for the products sold by us, which includes our best estimate of the projected costs to repair or replace items under warranties and recalls if identified. The negative provision for warranty for the nine months ended September 30, 2024, is driven by the expiration of the warranty liability related to non-current truck models.

7.    DEBT
A reconciliation of the fair value of the convertible notes is as follows:
Nine Months Ended September 30, 2024
Fair value of convertible notes, beginning of period$20,180,100 
Fair value of convertible notes issued during period45,829,120 
Payments on convertible notes
(20,180,100)
Change in fair value of convertible notes (1)
(1,488,754)
Fair value of convertible notes exchanged for common stock(31,157,899)
Fair value of convertible notes, end of period$13,182,467 
13

(1) The Company recognizes changes in fair value of convertible notes for Common Stock in Interest income (expense), net in the Condensed Consolidated Statements of Operations. The negative provision for warranty for the nine months ended September 30, 2024, is driven by the expiration of the warranty liability related to non-current truck models.
Senior Secured Convertible Notes
2024 Securities Purchase Agreement

On March 15, 2024, we entered into the 2024 Securities Purchase Agreement with the Investor under which the Company agreed to issue and sell, in one or more registered public offerings by the Company directly to the Investor in multiple tranches over a period beginning on March 15, 2024, (i) 2024 Notes for up to an aggregate principal amount of $139.0 million that will be convertible into shares of the Company’s Common Stock and (ii) 2024 Warrants to purchase shares of Common Stock.

During the three months ended September 30, 2024, the Company issued and sold to the Investor (i) 2024 Notes in the original principal amount of $10.0 million ($4.0 million on July 18; $2.6 million on August 23, and $3.4 million on September 30) and (ii) 2024 Warrants to purchase up to 10.1 million (2.7 million on July 18; 2.9 million on August 23; and 4.5 million on September 30) shares of Common Stock.

During the nine months ended September 30, 2024, the Company issued and sold to the Investor (i) 2024 Notes in aggregate original principal amount of $32.3 million and (ii) 2024 Warrants to purchase up to 15.6 million shares of Common Stock pursuant to the 2024 Securities Purchase Agreement (following adjustment in connection with the Company’s Reverse Split). As of September 30, 2024, $9.4 million aggregate principal amount remained outstanding under the 2024 Notes, and no shares had been issued pursuant to the 2024 Warrants.

No 2024 Notes may be converted and no 2024 Warrants may be exercised to the extent that such conversion or exercise would cause the then holder of such 2024 Notes or 2024 Warrants to become the beneficial owner of more than 9.99% of the Company’s then outstanding Common Stock, after giving effect to such conversion or exercise.

2024 Notes

The 2024 Notes were issued with original issue discount of 12.5%, resulting in $28.3 million of net proceeds to the Company before fees and expenses for the nine months ended September 30, 2024. The 2024 Notes are or will be senior, secured obligations of the Company, ranking senior to all other unsecured indebtedness, subject to certain limitations and are unconditionally guaranteed by each of the Company’s subsidiaries, pursuant to the terms of a certain security agreement and subsidiary guarantee. The 2024 Notes are issued pursuant to the Company’s Indenture (the “Base Indenture”) with U.S. Bank Trust Company, National Association, as trustee (the “Trustee”), and supplemental indentures thereto.

Each 2024 Notes bears interest at a rate of 9.0% per annum, payable in arrears on the first trading day of each calendar quarter, at the Company’s option, either in cash or in-kind by compounding and becoming additional principal. Upon the occurrence and during the continuance of an event of default, the interest rate will increase to 18.0% per annum. Unless earlier converted or redeemed, each 2024 Notes will mature on the one-year anniversary of the date hereof, subject to extension at the option of the holders in certain circumstances as provided therein.

All amounts due under any 2024 Notes are convertible at any time, in whole or in part, at the option of the holders into shares of Common Stock at a conversion price equal to the applicable Reference Price set forth in such 2024 Notes or (b) the greater of (x) the applicable Floor Price set forth in such 2024 Notes and (y) 87.5% of the volume weighted average price of the Common Stock during the ten trading days ending and including the trading day immediately preceding the delivery or deemed delivery of the applicable conversion notice, as elected by the converting holder. The Reference Price and Floor Price are subject to customary adjustments upon any stock split, stock dividend, stock combination, recapitalization or similar event. The Reference Price is also subject to full-ratchet adjustment in connection with a subsequent offering at a per share price less than the Reference Price then in effect. Subject to the rules and regulations of Nasdaq, we have the right, at any time, with the written consent of the Investor, to lower the reference price to any amount and for any period of time deemed appropriate by our board of directors. Upon the satisfaction of certain conditions, we may prepay any 2024 Notes upon 15 business days’ written notice by paying an amount equal to the greater of (i) the face value of the 2024 Notes at premium of 25% (or 75% premium, during the occurrence and continuance of an event of default, or in the event certain redemption conditions are not satisfied) and (ii) the equity value of the shares of Common Stock underlying the 2024 Notes. The equity value of our Common Stock underlying the 2024 Notes is calculated using the two greatest volume weighted average prices of our Common Stock during the period immediately preceding the date of such redemption and ending on the date we make the required payment.

The 2024 Notes contain customary affirmative and negative covenants, including certain limitations on debt, liens, restricted payments, asset transfers, changes in the business and transactions with affiliates. The 2024 Notes require the Company to maintain minimum liquidity on the last day of each fiscal quarter in the amount of either (i) $1.5 million if the sale leaseback transaction of Company’s manufacturing facility in Union City, Indiana (the “Sale Leaseback”) has not been consummated and
14

(ii) $4.0 million if the Sale Leaseback has been consummated, subject to certain conditions. The 2024 Notes also contain customary events of default.

Under certain circumstances, including a change of control, the holder may cause us to redeem all or a portion of the then-outstanding amount of principal and interest on any 2024 Notes in cash at the greater of (i) the face value of the amount of 2024 Notes to be redeemed at a 25% premium (or at a 75% premium, if certain redemption conditions are not satisfied or during the occurrence and continuance of an event of default), (ii) the equity value of our Common Stock underlying such amount of 2024 Notes to be redeemed and (iii) the equity value of the change of control consideration payable to the holder of our Common Stock underlying such 2024 Notes.

In addition, during an event of default, the holder may require us to redeem in cash all, or any portion, of any outstanding 2024 Notes at the greater of (i) the face value of our Common Stock underlying such 2024 Notes at a 75% premium and (ii) the equity value of our Common Stock underlying such 2024 Notes. In addition, during a bankruptcy event of default, we shall immediately redeem in cash all amounts due under the 2024 Notes at a 75% premium unless the holder of such 2024 Notes waives such right to receive payment. Further, upon the sale of certain assets, the holder may cause a redemption at a premium, including upon consummation of the Sale Leaseback if the redemption conditions are not satisfied. The 2024 Notes also provide for purchase and participation rights in the event of a dividend or other purchase right being granted to the holders of Common Stock.

As of September 30, 2024, the contractual principal balance of the 2024 Notes was $9.4 million and the fair value was $13.2 million. During the three months ended September 30, 2024, the Investor converted $8.5 million of principal into Common Stock and we recorded a $5.3 million fair value net loss in Interest income (expense), net in the Condensed Consolidated Statements of Operations. During the nine months ended, September 30, 2024 the Investor converted 2024 Notes in the principal amount of $22.9 million into Common Stock and we recorded a $8.9 million fair value net loss in Interest income (expense), net in the Condensed Consolidated Statements of Operations. No fair value adjustments related to the 2024 Notes attributable to changes in credit risk were recorded during the three and nine months ended September 30, 2024. Going forward, any future fair value adjustments attributable to changes in credit risk will be recorded in Other comprehensive loss.

The September 30, 2024 estimated fair value of the 2024 Notes totaled $13.2 million. The fair value was computed using a Monte Carlo Simulation Model which incorporates significant inputs that are not observable in the market, and thus represents a Level 3 fair value measurement. The unobservable inputs utilized for measuring the fair value of the 2024 Notes reflect our assumptions about the assumptions that market participants would use in valuing the 2024 Notes as of the issuance date and subsequent reporting period.

We determined the fair value by using the following key inputs to the Monte Carlo Simulation Model:
Issuance DateMarch 15, 2024
Maturity DateMarch 15, 2025
Principal Balance as of the Valuation Date$9,000,000 
Risk-Free Rate (Annual)5.3 %
Corporate Bond Yield15.8 %
Volatility (Annual)85.0 %
Issuance DateMay 10, 2024
Maturity DateMay 10, 2025
Principal Balance as of the Valuation Date$6,285,714 
Risk-Free Rate (Annual)5.3 %
Corporate Bond Yield15.6 %
Volatility (Annual)95.0 %

15

Issuance DateMay 29, 2024
Maturity DateMay 29, 2025
Principal Balance as of the Valuation Date$7,000,000 
Risk-Free Rate (Annual)5.3 %
Corporate Bond Yield15.6 %
Volatility (Annual)90.0 %
Issuance DateJuly 18, 2024
Maturity DateJuly 18, 2025
Principal Balance as of the Valuation Date$4,000,000 
Risk-Free Rate (Annual)4.8 %
Corporate Bond Yield17.4 %
Volatility (Annual)80.0 %
Issuance DateAugust 23, 2024
Maturity DateAugust 23, 2025
Principal Balance as of the Valuation Date$2,600,000 
Risk-Free Rate (Annual)4.3 %
Corporate Bond Yield17.8 %
Volatility (Annual)90.0 %
Issuance Date
September 30, 2024
Maturity Date
September 30, 2025
Principal Balance as of the Valuation Date
$3,400,000 
Risk-Free Rate (Annual)
3.9 %
Corporate Bond Yield
15.9 %
Volatility (Annual)
100.0 %

As of September 30, 2024, the Company was in compliance with the debt terms and associated covenants under the 2024 Notes. As of November 18, 2024, $5.4 million in aggregate principal amount remained outstanding under the 2024 Notes.
2024 Warrants

The Investor has a purchase right that allows the Investor to participate in transactions in which the Company issues or sells certain securities or other property to holders of Common Stock, allowing the Investor to acquire, on the terms and conditions applicable to such purchase rights, the aggregate purchase rights which the Investor would have been able to acquire if the Investor held the number of shares of Common Stock acquirable upon exercise of the 2024 Warrants.

In the event of a Fundamental Transaction (as defined in the 2024 Warrants) that is not a change of control or corporate event as described in the 2024 Warrants, the surviving entity would be required to assume the Company’s obligations under the 2024 Warrants. In addition, if the Company engages in certain transactions that result in the holders of the Common Stock receiving consideration, a holder of the 2024 Warrants will have the option to either (i) exercise the 2024 Warrants prior to the consummation of such transaction and receive the consideration to be issued or distributed in connection with such transaction or (ii) cause the Company to repurchase the 2024 Warrants for its then Black Scholes Value (as defined in the 2024 Warrants).
Warrants Exercisable

During the three and nine months ended September 30, 2024, the Company issued 2024 Warrants to purchase 10.1 million and 15.6 million shares of Common Stock respectively at an exercise price ranging from $1.11 to $7.00 per share (following adjustment in connection with the Company’s Reverse Split). As of September 30, 2024, no shares have been issued pursuant to
16

the 2024 Warrants. In connection with the October 16, 2024 limited waiver to the 2024 Securities Purchase Agreement (the “Waiver”), the Investor agreed to waive its right to receive warrants in connection with future 2024 Notes issuances up to $14.8 million.

The September 30, 2024 estimated fair value of the 2024 Warrants as of each respective issuance date totaled $7.2 million. During the three and nine months ended September 30, 2024, we recorded a $2.6 million and $7.1 million net fair value loss, respectively, in the Condensed Consolidated Statements of Operations related to the 2024 Warrants. The fair value of the 2024 Warrants was measured using the Black Scholes model approach.


Significant inputs to the model at each respective issuance date and September 30, 2024 were as follows:
Valuation AssumptionsSeptember 30, 2024Initial Recognition on March 15, 2024
Fair Value $688,611 $4,749,754 
Stock Price$0.87$5.32
Strike Price$7.0000$7.0000
Volatility (annual)75.0%45.0%
Risk-Free Rate3.7%4.2%
Estimated time to expiration (years)9.5010
Dividend Yield0.0%0.0%
Valuation AssumptionsSeptember 30, 2024Initial Recognition on May 10, 2024
Fair Value $758,360 $3,706,121 
Stock Price$0.87$3.60
Strike Price$5.8860$5.8860
Volatility (annual)70.0%50.0%
Risk-Free Rate3.7%4.4%
Estimated time to expiration (years)9.610
Dividend Yield0.0%0.0%
Valuation AssumptionsSeptember 30, 2024Initial Recognition on May 29, 2024
Fair Value $849,041 $4,099,389 
Stock Price$0.87$3.80
Strike Price$5.8880$5.8880
Volatility (annual)70.0%45.0%
Risk-Free Rate3.7%4.5%
Estimated time to expiration (years)9.710
Dividend Yield0.0%0.0%
17

Valuation AssumptionsSeptember 30, 2024
Initial Recognition on July 18, 2024
Fair Value$1,296,378 $2,901,545 
Stock Price$0.87$1.89
Strike Price$2.9300$2.9300
Volatility (annual)65.0%50.0%
Risk-Free Rate3.7%4.1%
Estimated time to expiration (years)9.810
Dividend Yield0.0%0.0%
Valuation AssumptionsSeptember 30, 2024
Initial Recognition on August 24, 2024
Fair Value$1,384,743 $1,200,626 
Stock Price$0.87$0.78
Strike Price$1.1100$1.1100
Volatility (annual)45.0%45.0%
Risk-Free Rate3.7%3.7%
Estimated time to expiration (years)9.910
Dividend Yield0.0%0.0%
Valuation AssumptionsSeptember 30, 2024
Initial Recognition on September 30, 2024
Fair Value$2,252,786 $2,252,786 
Stock Price$0.87$0.87
Strike Price$1.2700$1.2700
Volatility (annual)50.0%50.0%
Risk-Free Rate3.7%3.7%
Estimated time to expiration (years)1010
Dividend Yield0.0%0.0%
The Company determines the accounting classification of warrants it issues as either liability or equity classified by first assessing whether the warrants meet liability classification in accordance with ASC 480-10, Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity (“ASC 480”), then in accordance with ASC 815-40 (“ASC 815”), Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock. In order for a warrant to be classified in stockholders’ equity (deficit), the warrant must be (i) indexed to the Company’s equity and (ii) meet the conditions for equity classification.

If a warrant does not meet the conditions for stockholders’ equity (deficit) classification, it is carried in the Condensed Consolidated Balance Sheets as a warrant liability measured at fair value, with subsequent changes in the fair value of the warrant recorded in other non-operating losses (gains) in the Consolidated Statements of Operations. If a warrant meets both conditions for equity classification, the warrant is initially recorded, at its relative fair value on the date of issuance, in stockholders’ equity (deficit) in the Condensed Consolidated Balance Sheets, and the amount initially recorded is not subsequently remeasured at fair value.
2023 Securities Purchase Agreement (Green Senior Convertible Notes Due 2026)
18

On December 12, 2023, the Company entered into a securities purchase agreement (the “2023 Securities Purchase Agreement”) under which the Company issued, pursuant to the Base Indenture and a First Supplemental Indenture between the Company and the Trustee, $20.0 million principal amount of green senior convertible notes (the “2026 Notes”) due October 1, 2026. The 2026 Notes were a senior secured obligation of the Company and ranked senior to all unsecured debt of the Company. The 2026 Notes were guaranteed by all the Company’s current subsidiaries and were secured by substantially all the assets of the Company and its subsidiaries. The 2026 Notes were issued with an original issue discount of 12.5%.
The Company paid fees in connection with the issuance of the 2026 Notes of $0.6 million, resulting in net proceeds of $16.9 million. We have elected to account for the 2026 Notes using the fair value option under GAAP. All direct costs related to the issuance of our convertible notes were recognized in Interest income (expense), net in the Consolidated Statements of Operations for the year ended December 31, 2023.
During the first quarter of 2024, the Company repaid the 2026 Notes in full.
Warrants Under the 2023 Securities Purchase Agreement
On December 12, 2023, as part of the 2023 Securities Purchase Agreement, the Company issued warrants (the “2023 Warrants”) to purchase 25.6 million** shares of Common Stock at an exercise price of $8.984 per share**.
The fair value of the components of the 2023 Securities Purchase Agreement was allocated between the 2026 Notes and the 2023 Warrants. As of December 31, 2023, the fair value of the 2023 Warrants was $5.6 million. During the six months ended June 30, 2024, in connection with a First Amendment to Green Senior Secured Convertible Note Due 2026, the Company entered into an agreement to exchange the 2023 Warrants for a total of 0.4 million shares of Common Stock for a total value of $2.8 million, whereupon the 2023 Warrant was cancelled. The Company recorded a gain in the quarter ended March 31, 2024 of $2.7 million in connection with this exchange in Interest income (expense), net in the Condensed Consolidated Statements of Operations related to the 2023 Warrants. The transaction occurred in the quarter ended March 30, 2024.
** Prior periods presented have been adjusted to reflect the 1-for-20 reverse stock split which was effective on June 17, 2024. Additional information regarding the reverse stock split may be found in Note 1 Summary of Business and Significant Accounting Principles


8.    LEASES
We have entered into various operating and finance lease agreements for offices, manufacturing and warehouse facilities. We determine if an arrangement is a lease, or contains a lease provision, at inception and record the leases in our financial statements upon lease commencement, which is the date when the underlying asset is made available for our use by the lessor.
We have elected not to record in the Condensed Consolidated Balance Sheets leases with a lease term of 12 months or less at lease inception that do not contain a purchase option or renewal term provision we are reasonably certain to exercise. All other lease right-of-use assets and lease liabilities are recognized based on the present value of lease payments over the lease term at commencement date. Because most of our leases do not provide an implicit rate of return, we used our incremental borrowing rate based on the information available at lease commencement date in determining the present value of lease payments.
Our leases may include options to extend the lease term for up to 5 years. Some of our leases also include options to terminate the lease prior to the end of the agreed upon lease term. For the purpose of calculating lease liabilities, lease terms include options to extend or terminate the lease when it is reasonably certain we will exercise such options.

Lease expense for operating leases is recognized on a straight-line basis over the lease term as either cost of sales or operating expenses depending on the nature of the leased asset. In connection with the Aero Divestiture, we entered into an agreement for an operating lease associated with the Aero business whereby the buyer agreed to reimburse the Company for the monthly operating lease payment of approximately $52,000 per month. In connection with the Waiver, we agreed to waive the buyer’s obligation to reimburse these amounts going forward and, accordingly, we will not realize these savings in future periods through the remaining term of the lease.
19

Three Months Ended
September 30,		Nine Months Ended
September 30,
2024202320242023
Short-term lease expense$63,428 $74,058 $200,858 $200,733 
Operating lease expense385,933 614,060 1,750,431 1,754,557 
Total lease expense$449,361 $688,118 $1,951,289 $1,955,290 
The Company was reimbursed by the buyer of the Aero business for operating lease payments of $156,927 and $210,136 for the three and nine months ended September 30, 2024, respectively.
Lease right-of-use assets consisted of the following:
September 30, 2024December 31, 2023
Operating leases$3,465,637 $4,174,800 
Finance leases5,470,933 5,621,181 
Total lease right-of-use assets$8,936,570 $9,795,981 

Lease liabilities consisted of the following:
September 30, 2024December 31, 2023
Operating lease liabilities, current$1,001,120 $1,012,428 
Finance lease liabilities, current2,100,635 2,548,184 
Operating lease liabilities, long term4,556,738 5,280,526 
Total Lease Liabilities$7,658,493 $8,841,138 

9. FAIR VALUE MEASUREMENTS

We estimate the fair value of the 2024 Notes, 2024 Warrants, 2026 Notes and 2023 Warrants using commonly accepted valuation methodologies upon issuance and at each reporting date. Considerable judgment was required in interpreting market data to develop the estimates of fair value. Accordingly, the Company’s estimates are not necessarily indicative of the amounts that the Company, or holders of the instruments, could realize in a current market exchange. Significant assumptions used in the fair value model included estimates of the redemption dates, credit spreads and the market price and volatility of the Company’s Common Stock. The use of different assumptions and/or estimation methodologies could have a material effect on the estimated fair values. The following table presents the estimated fair values:
September 30, 2024December 31, 2023
Fair ValueLevel 1Level 2Level 3Fair ValueLevel 1Level 2Level 3
Warrant liability$7,229,919 $— $— $7,229,919 $5,605,325 $— $— $5,605,325 
Convertible notes$13,182,467 $— $— $13,182,467 $20,180,100 $— $— $20,180,100 


10.    STOCK-BASED COMPENSATION
We maintain, as approved by the board of directors and the stockholders, the 2017 Incentive Stock Plan, the 2019 Incentive Stock Plan, and 2023 Long-Term Incentive Plan (collectively, the “Plans”) providing for the issuance of stock-based awards to employees, officers, directors or consultants of the Company. Non-qualified stock options may only be granted with an exercise price equal to the market value of our Common Stock on the grant date. Shares reserved for stock awards under the plans total 17.5 million. Total shares remaining available for stock incentive grants under the Plans totaled approximately 3.0 million as of September 30, 2024. We have granted stock options, restricted stock awards (“RSAs”), restricted stock units (“RSUs”), and performance share units (“PSUs”) under the Plans.
20

On June 17, 2024, the Company effected the Reverse Split. The authorized number of shares of Common Stock was not affected by the Reverse Split.
The Company adjusted the exercise price, number of shares issuable on exercise or vesting and/or other terms of its outstanding stock options, warrants, restricted stock, and restricted stock units to reflect the effects of the Reverse Split. The number of shares of Common Stock available for issuance under the Company’s equity incentive plans was not affected.

Stock-based compensation expense
The following table summarizes stock-based compensation expense for the periods indicated:

Three Months Ended
September 30,		Nine Months Ended
September 30,
2024202320242023
Stock options$167,700 $244,887 $652,168 $727,996 
Restricted stock awards1,459,282 2,385,352 5,333,433 6,952,424 
Restricted stock units(38,075)— 101,601 — 
Performance-based restricted stock awards351,349 890,166 2,119,471 2,641,470 
Total stock-based compensation expense$1,940,256 $3,520,405 $8,206,673 $10,321,890 

Stock options
A summary of stock option activity for the nine months ended September 30, 2024 is as follows:

Number of OptionsWeighted
Average
Exercise Price
per Option		Weighted
Average
Remaining
Contractual Life
(Years)
Balance, December 31, 202314,822 $205.4 8.0
Exercised— — — 
Balance, September 30, 202414,822 $205.4 7.25
Number of options exercisable at September 30, 2024
14,822 $205.4 7.25

As of September 30, 2024, unrecognized compensation expense was $0.0 for unvested options which is expected to be recognized over the next 0 years.

Restricted stock awards
A summary of restricted stock award activity for the nine months ended September 30, 2024 is as follows:

Number of Unvested Shares Weighted Average Grant Date Fair Value per Share
Balance, December 31, 2023256,416 $52.3 
Granted— — 
Vested(105,793)66.6 
Forfeited(23,595)48.3
Balance, September 30, 2024127,028 $41.1 

21

As of September 30, 2024, unrecognized compensation expense was $2.7 million for unvested restricted stock awards which is expected to be recognized over the next 1 year.

Restricted stock units
A summary of restricted stock unit activity for the nine months ended September 30, 2024 is as follows:

Number of Unvested Shares Weighted Average Grant Date Fair Value per Share
Balance, December 31, 2023— $— 
Granted759,120 6.34 
Vested(98,582)6.34 
Forfeited(83,067)6.34 
Balance, September 30, 2024577,471  

As of September 30, 2024, unrecognized compensation expense was $0.4 million for unvested restricted stock units which is expected to be recognized over the next 2.4 years.


Performance share units

As of September 30, 2024, the number of unvested PSUs was 0.7 million. The vesting of PSUs is conditioned upon achievement of certain performance objectives over a performance period ending December 31, 2024, 2025 and 2026 as defined in each award agreement. For the PSUs issued in 2022 and 2023 with a performance period ending December 31, 2024 and 2025, fifty percent of the PSUs vest based upon the Company’s total shareholder return as compared to a group of peer companies (“TSR PSUs”), and fifty percent of the PSUs vest based upon our performance on certain measures including a cumulative adjusted EBITDA target (“EBITDA PSUs”). For the PSUs issued in 2024 with a performance period ending December 31, 2026, one hundred percent of the PSUs vest based upon our performance on a cumulative revenue target (“Revenue PSUs”). Depending on the actual achievement on the performance objectives, the grantee may earn between 0% and 200% of the target PSUs.

A summary of the activity for PSU awards with total shareholder return performance objectives for the nine months ended September 30, 2024 is as follows:
Number of Unvested SharesWeighted Average Grant Date Fair Value per Share
Balance, December 31, 202383,598 $88.00 
Granted— — 
Forfeited(7,772)63.67
Balance, September 30, 2024
75,826 $90.77 
As of September 30, 2024, unrecognized compensation expense was $1.3 million performance measures are expected to be met and vest and be recognized over the next 0.7 years.

A summary of the PSU awards with cumulative adjusted EBITDA targets for the nine months ended September 30, 2024 is as follows:
22

Number of Unvested Shares
Balance, December 31, 202368,288 
Granted— 
Forfeited(7,772)
Balance, September 30, 2024
60,516 
The fair value of PSUs is calculated based on the stock price on the date of grant. The stock-based compensation expense recognized each period is dependent upon our estimate of the number of shares that will ultimately vest based on the achievement of EBITDA-based performance conditions. Future stock-based compensation expense for unvested EBITDA PSUs will be based on the fair value of the awards as of the grant date. During the quarter ended September 30, 2024, we recorded an expense of $0.1 million related to unvested 2022 issued EBITDA PSUs. This expense reflects the fair value of the EBITDA PSUs that is expected to vest based on the achievement of the established performance targets. The future stock-based compensation expense for the 2023 issued unvested revenue PSUs will be based on the fair value of the awards as of the grant date which has not yet occurred, as the cumulative adjusted EBITDA target condition is not yet defined.
As of September 30, 2024, there were no PSU awards expensed as cumulative revenue targets have yet to be determined. The stock-based compensation expense recognized each period is dependent upon our estimate of the number of shares that will ultimately vest based on the achievement of revenue-based performance conditions. Future stock-based compensation expense for unvested revenue PSUs will be based on the fair value of the awards as of the grant date, which has not yet occurred, as the cumulative adjusted revenue target condition is not yet defined.


11.    STOCKHOLDERS’ EQUITY
Common Stock
We have one class of Common Stock, par value $0.001 per share. Each share of our Common Stock is entitled to one vote on all matters submitted to stockholders. The Company effected the Reverse Stock Split of the Company’s then issued and outstanding shares of Common Stock. The Reverse Stock Split did not affect the number of authorized shares of Common Stock for issuance, and, as of September 30, 2024, our authorized shares of Common Stock for issuance was 450.0 million with a par value $0.001 per share.
At-The-Market Sales Agreement
On March 10, 2022, we established an at-the-market equity program (the “ATM Program”). Under the ATM Program, we may offer and sell shares of our Common Stock having an aggregate sales price of up to $175.0 million.
During the three months ended September 30, 2024 no shares were issued under the ATM Program and during the nine months ended September 30, 2024, we issued 0.5 million shares under the ATM Program for net proceeds of $2.7 million. The remaining aggregate sales available under the ATM Program is $95.6 million as of September 30, 2024. Certain of our other existing financing arrangements place certain conditions and restrictions on the use of our ATM Program.
Equity Line of Credit
On December 12, 2023, the Company entered into an equity line of credit purchase agreement (the “ELOC Purchase Agreement”) with Lincoln Park Capital Fund, LLC (the “Purchaser”) which provides that, upon the terms and subject to the conditions and limitations set forth therein, the Company may sell to the Purchaser up to $50.0 million of shares of Common Stock over the 24-month term of the ELOC Purchase Agreement.
In connection with the ELOC Purchase Agreement, the Company paid a non-cash commitment fee to the Purchaser in the amount of 188,755 shares of Common Stock of the Company (valued at $1.5 million). The Company reflected the commitment fee as an expense in Interest expense in the consolidated statements of operations based on the fair value on the issuance date. Under applicable rules of the Nasdaq Capital Market, the Company cannot issue or sell more than 19.99% of the shares of Common Stock outstanding immediately prior to the execution of the ELOC Purchase Agreement to the Purchaser under the
23

ELOC Purchase Agreement without stockholder approval. During nine months ended September 30, 2024, the Company sold 600,000 shares of common stock at prices ranging between $4.42 and $6.86 pursuant to the ELOC Purchase Agreement and received proceeds of $3.1 million. This activity occurred in the quarter ended March 31, 2024. The Company’s other financing arrangements substantially limit our ability to use the ELOC Purchase Agreement in the future.
The Company evaluated the contract that includes the right to require the Purchaser to purchase shares of common stock in the future (“purchased put right”) considering the guidance in ASC 815-40, “Derivatives and Hedging - Contracts on an Entity’s Own Equity” (“ASC 815-40”) and concluded that it is an equity-linked contract that does not qualify for equity classification, and therefore requires fair value accounting as a derivative asset. The Company has analyzed the terms of the freestanding purchased put right and has concluded that it had insignificant value as of September 30, 2024.
Preferred Stock
Workhorse has authorized 75.0 million shares of Series A Preferred Stock, par value $0.001 per share. Our certificate of incorporation provides that shares of preferred stock may be issued from time to time in one or more series. Our Board of Directors is authorized to fix the voting rights, if any, designations, powers, preferences, qualification, limitations and restrictions thereof, applicable to the shares of preferred stock. As of September 30, 2024, there were no shares of Series A Preferred Stock issued and outstanding.
Warrants
In connection with the issuance of debt and Common Stock, we issued equity-classified warrants to purchase shares of our Common Stock. As of September 30, 2024 there were approximately 15.6 million 2024 Warrants outstanding.

12.    INCOME TAXES
As of September 30, 2024 and December 31, 2023, our deferred tax liability was zero. Cumulative deferred tax assets are fully reserved as there is not sufficient evidence to conclude it is more likely than not the deferred tax assets are realizable. No current liability for federal or state income taxes has been included in these Condensed Consolidated Financial Statements due to the loss for the periods.


13.    LOSS PER SHARE
Basic loss per share of Common Stock is calculated by dividing net loss by the weighted-average shares outstanding for the period. Potentially dilutive shares, which are based on the weighted-average shares of Common Stock underlying outstanding stock-based awards and warrants using the treasury stock method, and convertible notes using the if-converted method, are included when calculating the diluted net loss per share of Common Stock when their effect is dilutive.

The following table presents the potentially dilutive shares that were excluded from the computation of diluted net loss per share of Common Stock, because their effect was anti-dilutive:

Three Months Ended
September 30,		Nine Months Ended
September 30,
20242023*20242023*
Stock-based awards and warrants16,548,518 504,707 16,548,518 504,707 
Convertible notes10,812,454 — 10,812,454 — 
* Prior periods presented have been adjusted to reflect the 1-for-20 reverse stock split effective on June 17, 2024.



14.    RECENT ACCOUNTING PRONOUNCEMENTS

Accounting Standards and Pronouncements Recently Adopted
There are no accounting standards or pronouncements recently adopted impacting the Company.
24

Accounting Standards and Pronouncements Not Yet Adopted
ASU 2023-07, Segment Reporting - Improvements to Reportable Segment Disclosures. In November 2023, the FASB issued ASU 2023-07 related to disclosures about a public entity’s reportable segments and provides more detailed information about a reportable segment’s expenses. The new standard is effective for fiscal years beginning after December 15, 2023 and interim periods beginning after December 15, 2024, with retrospective application required. We are assessing the effect on our annual consolidated financial statement disclosures; however, adoption will not impact our consolidated balance sheets or statements of operations.
ASU 2023-09, Improvements to Income Tax Disclosures. In December 2023, the FASB issued ASU 2023-09 to enhance the transparency and decision usefulness of income tax disclosures. The new standard is effective for fiscal years beginning after December 15, 2024, with retrospective application permitted. We are assessing the effect on our annual consolidated financial statement disclosures; however, adoption will not impact our consolidated balance sheets or statements of operations.
All other ASUs issued but not yet adopted were assessed and determined to be not applicable or are not expected to have a material impact on our Consolidated Financial Statements or Financial Statement Disclosures.


15.    COMMITMENTS AND CONTINGENCIES

General Matters

The Company is party to various negotiations and legal proceedings arising in the normal course of business. The Company provides reserves for these matters when a loss is probable and reasonably estimable. The Company does not disclose a range of potential loss because the likelihood of such a loss is remote. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on the Company’s financial position, results of operations, cash flows or liquidity.

Legal Proceedings

CSI Litigation

On April 19, 2024, Coulomb Solutions Inc. (“CSI”), a supplier to the Company of certain of the batteries used in its trucks, filed a complaint against the Company in United States District Court for the Eastern District of Michigan (Case No. 2:24-cv-11048). In its complaint, CSI asserts two claims – a breach of contract claim and an alternative unjust enrichment claim – that are both based upon Workhorse’s alleged failure to pay amounts due under several invoices. CSI seeks to recover damages in excess of $4 million, including alleged past due amounts, interest, and collection costs. Workhorse filed its answer to the complaint on June 4, 2024. The parties are currently conducting discovery. The Company has accrued for these appropriate amounts as of September 30, 2024.

16.    SUBSEQUENT EVENTS 
The Company has evaluated subsequent events for potential recognition and disclosures through the date the accompanying Condensed Consolidated Financial Statements were filed.

Nasdaq Delisting Notice

On October 2, 2024, the Company received a written notice from Nasdaq indicating that the Company was no longer in compliance with the $1.00 minimum bid price requirement. The Company has been provided with a compliance period of 180 calendar days, or until March 31, 2025, to regain compliance with the bid price requirement. If the Company does not regain compliance by March 31, 2025, the Company may be eligible for an additional grace period, subject to certain conditions.
The Company is currently evaluating various courses of action to regain compliance. There can be no assurance that the Company will regain compliance with the bid price requirement during the 180-day compliance period ending March 31, 2025, secure an extension of the compliance period beyond March 31, 2025 or maintain compliance with any other Nasdaq listing requirement.

2024 Securities Purchase Agreement

25

Pursuant to the 2024 Securities Purchase Agreement, on October 16, 2024, the Company issued and sold to the Investor a (i) 2024 Notes in the original principal amount of $1.2 million (the "Sixth Additional Note”). The Investor has waived its right to receive 2024 Warrants in connection with the Sixth Additional Note.

The issuance and sale of the Sixth Additional Note was made in connection with, and were conditioned upon, the Waiver of certain provisions of the 2024 Securities Purchase Agreement affecting the 2024 Notes and the 2024 Warrants and a related amendment to the asset purchase agreement pursuant to which the Company made its previously disclosed divestiture of its Aero business (the “Aero APA”). Pursuant to the Waiver and related amendment: (i) the Investor waived its right to receive Warrants in connection with the issuance and sale of the Sixth Additional Note, (ii) the Investor waived its right to receive Warrants in connection with the issuance and sale, if any, of additional 2024 Notes in the aggregate principal amount of up to $14.8 million, (iii) for the period commencing on October 16, 2024 and ending on and including October 16, 2025, the Investor has waived certain provisions of the 2024 Securities Purchase Agreement to permit the Company to sell up to $5.0 million in shares of Common Stock pursuant to an at-the-market offering program without a price floor and without application of certain anti-dilution and participation provisions in the 2024 Notes and the 2024 Warrants, and (iv) the Company waived the obligation of an affiliate of the Investor to make certain ongoing lease payments under the Aero APA.

17.    SUPPLEMENTAL CASH FLOW INFORMATION 
During the nine months ended September 30, 2024, the Company repaid a portion of the 2024 Notes with a principal amount of $22.9 million through the issuance of 16.0 million shares of common stock. This transaction involved converting the debt into equity, which does not involve a cash outflow. However, this conversion resulted in an increase in shareholders' equity (deficit) and a reduction in long-term debt, which is reflected in the equity and liabilities sections of the Condensed Consolidated Balance Sheets.




26

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Overview
We are an American technology company with a vision to pioneer the transition to zero-emission commercial trucks. Our primary focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. We design and manufacture all-electric trucks, including the technology that optimizes the way these trucks operate. We are focused on our core competency of bringing our electric delivery truck platforms to serve the last mile delivery market.

We continue to seek opportunities to grow the business organically, and by expanding relationships with existing and new customers. We believe we are well positioned to take advantage of long-term opportunities and continue our efforts to bring product innovations to market.

Recent Developments

During the three months ended September 30, 2024, FedEx Corporation issued a purchase order for 15 W56 step vans to be delivered in 2024 (the “Ordered Step Vans”). On September 27, 2024, we completed our work on the Ordered Step Vans and made the Ordered Step Vans available for the purchaser’s upfitter to complete certain final customizations of the trucks for the purchaser. In connection with the completion of our work on the Ordered Step Vans in September 2024, we received payment in full for the Ordered Step Vans. We expect the Ordered Step Vans will be upfitted and delivered to the purchaser during the fourth quarter of 2024.

On October 15, 2024 our 208-inch extended wheelbase version of the W56 step van was certified to meet full FMVSS (Federal Motor Vehicle Safety Standards) and received HVIP (Hybrid and Zero-Emission Vehicle and Bus Voucher Incentive Project) certification. We believe these certifications not only validate the truck's safety and environmental compliance but also underscore our capability of providing reliable solutions for the electric commercial truck market.

Going Concern; Financing

As discussed more fully under Note 1, Summary of Business and Significant Accounting Principles; Liquidity, Capital Resources, and Going Concern, above, and Liquidity and Capital Resources; Going Concern, below, our ability to continue as a going concern is contingent upon successful execution of management’s intended plan over the next twelve months to improve the Company’s liquidity and working capital requirements. A vital component of such plan is the consummation of a financing to address these requirements in the short term.

On March 15, 2024, we entered into a securities purchase agreement (the “2024 Securities Purchase Agreement”) with an institutional investor (the “Investor”), under which we agreed to issue and sell, in one or more registered public offerings by the Company directly to the Investor, in multiple tranches over a period beginning on March 15, 2024, senior secured convertible notes (the "2024 Notes") for up to an aggregate principal amount of $139.0 million that are convertible into shares of the Company's Common Stock, par value of $0.001 per share (“Common Stock”) and warrants to purchase shares of Common Stock (the “2024 Warrants”).

During the three months ended September 30, 2024, we issued and sold to the Investor (i) 2024 Notes in the original principal amount of $10.0 million and (ii) 2024 Warrants to purchase up to 10.1 million shares of Common Stock. As of September 30, 2024 we had issued and sold to the Investor (i) 2024 Notes in aggregate original principal amount of $32.3 million and (ii) 2024 Warrants to purchase up to 15.6 million shares of Common Stock pursuant to the 2024 Securities Purchase Agreement (following adjustment in connection with the Company's 1-for-20 Reverse Split). In addition, on October 16, 2024, we issued and sold to the Investor an additional 2024 Notes in the original principal amount of $1.2 million. The Investor waived its right to receive warrants in connection with this issuance and sale.

The 2024 Securities Purchase Agreement contemplates additional closings as of November 18, 2024 of up to $105.5 million in aggregate principal amount of additional 2024 Notes and, if our share price makes such exercise feasible, the possible receipt of proceeds from the exercise of the corresponding 2024 Warrants pursuant to the 2024 Securities Purchase Agreement. However, we may not realize the full amount available under the 2024 Securities Purchase Agreement. Under the terms of the 2024 Securities Purchase Agreement, our ability to issue and sell additional 2024 Notes to the Investor is restricted if the Investor has not converted previous tranches of 2024 Notes into our Common Stock and sold the shares issued on conversion. Accordingly, the Investor’s ability to make such conversions and sales, and therefore our access to additional liquidity under the 2024 Securities Purchase Agreement, depends on there being a robust public trading market for our Common Stock. Since consummating the Reverse Split of our Common Stock in June 2024, the Nasdaq trading volume of our Common Stock has
27


generally been lower (on a Reverse Split-adjusted basis) than it was before we consummated the Reverse Split. In addition, on October 2, 2024, the Company received a written notice (the “Notice”) from the Listing Qualifications Department of Nasdaq Stock Market (“Nasdaq”) indicating that, because the closing bid price of the Company’s Common Stock had fallen below $1.00 per share for 30 consecutive trading days, the Company was no longer in compliance with the $1.00 Minimum Bid Price Requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the “Bid Price Requirement”). If these conditions continue, the $105.5 million aggregate amount of 2024 Notes (as of November 18, 2024) we can issue and sell under the 2024 Securities Purchase Agreement may be reduced, and the issuances and sales that we are able to make may be delayed.

If we are not able to complete the additional closings, receive proceeds from the exercise of 2024 Warrants or find another source of liquidity in the immediate future, we may be unable to continue our operations or may need to substantially reduce them. Additional information concerning the 2024 Securities Purchase Agreement, the 2024 Notes, and the 2024 Warrants is set forth in Note 1 and Note 7 to the Condensed Consolidated Financial Statements.

Liquidity Improvement Measures

Another vital component of management’s plan to improve our liquidity and working capital requirements is reducing our operating costs to, among other things, reduce demands on the liquidity that is available to us. Accordingly, in the first and second quarter of 2024 we took the measures described below and started to realize the full benefit of such measures during the third quarter ended September 30, 2024.

•We completed a reduction in force (the “RIF”) pursuant to which we terminated approximately 20% of our total workforce, excluding direct labor. We have not incurred and do not expect to incur additional material costs in connection with the RIF.
•Generating revenue by increasing sales of our trucks and other services.
•Reducing expenses and limiting non-contracted capital expenditures.
•Raising capital to fund operations through the issuance of debt or equity securities, including through our 2024 Securities Purchase Agreement (as defined above) and our At-the-Market Sales Agreement (“ATM Agreement”), the sale of assets, or other strategic transactions.

In addition, on April 22, 2024, we furloughed 73 employees at our Union City manufacturing facility without pay, and we have experienced voluntary attrition of personnel, including senior managers of the Company, during the third quarter of 2024. We expect the furloughs and voluntary attrition to continue to provide operational savings. We have not incurred, and do not expect to incur, material costs in connection with the furloughs. We are also currently working with certain of our vendors to extend or restructure the payment terms of past due accounts payable balances. The furloughs, salary deferrals and vendor discussions are part of our previously disclosed strategy to reduce costs.

During the third quarter of 2024, we continued to reinstate certain furloughed employees to fulfill truck production requirements for the W56. However, there is still no assurance that all furloughed employees, including key personnel will be available and willing to return to work or that we will be able to replace the employees who departed voluntarily.

Management plans to continue to seek additional opportunities to reduce costs and cash expenditures in a manner intended to minimize their adverse impact on our core operations. There can be no assurance that the measures described above, or any other cost-cutting measures we may implement in the future will be sufficient to address our immediate or longer-term liquidity and working capital needs. Moreover, it is possible that such measures will have an adverse effect on our operations.
Aero Drone Design and Manufacturing Operations

As previously disclosed and discussed above as part of our cost-saving measures, on June 6, 2024, we completed the previously disclosed divestiture of our Aero business (the “Aero Divestiture”) to a third party. We expect the Aero Divestiture to provide monthly cost savings of approximately $0.4 million and enhance our ability to concentrate on our commercial electric truck business. Under the agreement’s earn-out provisions, the Company will receive a portion of the proceeds if the Aero business realizes positive net cash flow but these contingencies are indeterminable at this time. The loss on the sale for this business was $0.7 million of which $0.4 million was included in the Selling, general and administrative expenses and $0.3 million in Cost of sales in the Condensed Consolidated Statements of Operations for the nine months ended September 30, 2024.





28


Nasdaq Listing Requirements

As previously disclosed, on October 2, 2024, we received notice from Nasdaq indicating that, the closing bid price for our Stock had fallen below Nasdaq’s $1.00 minimum bid price requirement (the “Minimum Bid Requirement”) for 30 consecutive trading days, and therefore we were no longer in compliance with the $1.00 Minimum Bid Requirement. In order for us to regain compliance, the closing bid price of our Common Stock must be equal to or above $1.00 for a period of 10 consecutive trading days prior to March 31, 2025.

Trucks in Production

We continue to focus on product quality, manufacturing capacity and operational planning, and engineering and design to enable increased deliveries and deployments of our products and future revenue growth. During the first nine months of 2024, we continued executing our strategic product roadmap for our electric truck offerings, including the production of the W4 CC, W56 and the development of the W56 208-inch wheelbase truck program in both strip chassis and step van variants. We continued to electrify the fleet of trucks being used in our Stables by Workhorse initiative, which operates FedEx Ground delivery routes in the greater Cincinnati area. The electrification of the fleet provides us with firsthand data on the benefits and challenges of independent fleet operators experience while executing last-mile delivery operations. The initiative also provides valuable insights into how our customers can plan for and manage the transition to EV operations, including how to develop adequate charging infrastructure, training and maintenance services. In addition to our ongoing production ramp in 2024-2025, we intend to continue to generate demand and brand awareness by improving our trucks’ performance and functionality, and by developing new truck programs, including new W56 variants. We expect to continue to benefit from ongoing electrification of the commercial truck market and in particular "last mile delivery" sector.

Recent Trends and Market Conditions

We continue to monitor macroeconomic conditions to remain flexible and to optimize and evolve our business as appropriate, in this tumultuous environment and we will endeavor to project demand and infrastructure requirements globally and deploy our production, workforce and other resources accordingly.

Market Demand. Our sales during the first nine months of 2024 were lower than the prior year period due to slower-than-anticipated industry wide electric truck adoption rates and lack of government subsidies and incentives available to our dealers as well as slower than expected roll-out of additional power to electric grids and the resulting effect on roll-outs of electric truck charging infrastructure, nationwide. Delayed governmental approvals in certain states and slower than expected proliferation of charging stations across the country have also adversely impacted demand. However, we expect adoption rates to accelerate in 2025, driven by more stringent state and federal emissions requirements and continued government subsidies and incentives that will continue to reduce cost barriers for EV ownership, including the approval for our W56 platform for the California’s Hybrid and Zero-Emission Truck and Bus Voucher Incentive Project ("HVIP") program through California Air Resource Board ("CARB"), providing buyers with an $85,000 base voucher per W56 truck purchased. The accelerated adoption rates are related to the enforcement of California’s Advanced Clean Fleets Regulation (“ACF Regulation”), which is contingent upon the Environmental Protection Agency (“EPA”) granting a waiver or determining that a waiver is not necessary. Under the Clean Air Act, California holds the unique authority to request a waiver of preemption, which typically restricts states from setting their own emissions standards for new motor trucks. The EPA’s role involves a thorough review of comments and an assessment to determine if the criteria for granting a waiver are satisfied. This regulatory landscape is a significant consideration for our operations and strategic planning.

Commodities. Prices for commodities remain volatile, and we expect to experience price increases for base metals and raw materials that are used in batteries for electric trucks (e.g., lithium, cobalt, and nickel) as well as steel, aluminum and other material inputs. Global demand and differences in output across sectors have generated divergence in price movements across different commodities. We expect the net impact on us overall will be higher material costs.

Supply Chain. We continue to develop relationships with suppliers of key parts, components and raw materials to be used in the manufacture of our products such as batteries, electronics, and truck chassis that are sourced from suppliers across the world. As we continue to execute on our new truck programs, we will continue to identify supplier relationship and truck program synergies which may allow us to take advantage of pricing efficiencies from economies of scale. Where available, we will utilize multiple supply sources for key parts, and we will work to qualify multiple supply sources to achieve pricing efficiencies and minimize potential production risks related to supply chain. As previously disclosed, we are currently working with certain of our vendors to extend or restructure the payment terms of past due accounts payable balances. We are also currently in litigation with one of our battery suppliers, Coulomb Solutions Inc. For more information concerning this matter, see Note 15, Commitments and Contingencies to the Condensed Consolidated Financial Statements included in this Form 10-Q.
29



Inflation. Inflation continues to impact our operations, resulting from both supply and demand imbalances as economies continue to face constraints as well as the impact on the availability and cost of energy and other commodities as a result of the ongoing conflicts in Ukraine and Israel. We are seeing a near-term impact on our business due to inflationary pressure. In an effort to dampen inflationary pressures, central bank interest rates continue to be higher, which would likely raise the cost of any financing the Company may undertake in the future.

Geopolitical: Our operations and results may be impacted due to uncertainty of the political environment and the new Presidential Administration. The new Presidential Administration could affect the support for the adoption of electric trucks, as well as the availability of government subsidies to fund the adoption of electric trucks and may implement additional tariffs on imports that affect us and our industry. In addition, recent U.S. Supreme Court decisions that purport to limit the authority of federal executive agencies, including the EPA, may affect our industry in ways we cannot yet predict.

The following section provides a narrative discussion about our financial condition and results of operations. The narrative should be read in conjunction with our Condensed Consolidated Financial Statements and related Notes thereto included in Item 1 of this Form 10-Q and in conjunction with our 2023 Form 10-K

Results of Operations
The following table sets forth, for the periods indicated, the components of the Company’s Condensed Consolidated Statements of Operations:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2024
2023
2024
2023
Sales, net of returns and allowances$2,509,717 $3,028,545 $4,691,451 $8,688,423 
Cost of sales6,642,549 6,557,358 21,386,676 20,312,854 
Gross loss(4,132,832)(3,528,813)(16,695,225)(11,624,431)
Operating expenses
Selling, general and administrative$7,722,014 $11,756,291 $33,883,845 $40,448,651 
Research and development2,313,423 5,771,588 7,834,113 18,056,182 
Total operating expenses10,035,437 17,527,879 41,717,958 58,504,833 
Loss from operations(14,168,269)(21,056,692)(58,413,183)(70,129,264)
Interest income (expense), net(8,317,813)410,980 (15,109,136)1,466,839 
Fair value adjustment (loss) on warrants(2,649,477)— (7,089,027)— 
Other income (loss)— (10,000,000)— (10,000,000)
Loss before provision for income taxes(25,135,559)(30,645,712)(80,611,346)(78,662,425)
Provision for income taxes— — — — 
Net loss$(25,135,559)$(30,645,712)$(80,611,346)$(78,662,425)

Sales, net of returns and allowances

Sales, net of returns and allowances for the three months ended September 30, 2024 and 2023 were $2.5 million and $3.0 million, respectively. The decrease in sales was primarily due to the non-recurrence of a $2.3 million sales allowance reversal related to W4 CC vehicle sales recognized in the prior period and an increase in W4 CC and W56 truck sales in the current period of $1.7 million.

Sales, net of returns and allowances for the nine months ended September 30, 2024 and 2023 were $4.7 million and $8.7 million, respectively. The decrease in sales was primarily due to lower W4 CC truck sales compared with the same period a year ago, which was offset by an increase in W56 truck sales, other service revenue generated from operating our Stables by Workhorse route, Drones as a Service before the Aero Divestiture and other service revenue.

30



Cost of sales

Cost of sales for the three months ended September 30, 2024 and 2023 were $6.6 million and $6.6 million, respectively. Cost of sales was primarily flat due to increase in costs related to direct materials due to higher sales volume, which was partially offset by lower inventory reserves of $1.1 million and lower direct and indirect labor costs of $1.0 million primarily due to lower headcount as a result of employee furloughs during the period.

Cost of sales for the nine months ended September 30, 2024 and 2023 were $21.4 million and $20.3 million, respectively. The increase in cost of sales was primarily due to a $3.5 million increase in inventory reserves and a $2.8 million increase in depreciation expense which was partially offset by a $2.3 million decrease in costs related to direct materials, $1.4 million reversal of warranty expenses previously accrued, and a decrease in consulting expenses of $1.4 million.

Selling, general and administrative expenses

Selling, general and administrative (“SG&A”) expenses during the three months ended September 30, 2024 and 2023 were $7.7 million and $11.8 million, respectively. The decrease in SG&A expenses was driven by a $1.8 million decrease in employee compensation and related expenses primarily due to lower headcount, a decrease of $1.1 million in consulting expenses, a decrease in legal and professional expenses of $0.3 million and lower corporate insurances of $0.3 million.

SG&A expenses during the nine months ended September 30, 2024 and 2023 were $33.9 million and $40.5 million, respectively. The decrease in SG&A expenses was primarily driven by a $5.5 million decrease in employee compensation and related expenses due to lower headcount, a decrease in consulting expenses of $0.7 million and lower marketing expenses of $0.6 million.

Research and development expenses

Research and development (“R&D”) expenses during the three months ended September 30, 2024 and 2023 were $2.3 million and $5.8 million, respectively. The decrease in R&D expenses was primarily driven by a $2.1 million decrease in employee compensation and related expenses due to lower headcount and a $0.8 million decrease in consulting expenses.

R&D expenses during the nine months ended September 30, 2024 and 2023 were $7.8 million and $18.1 million, respectively. The decrease in R&D expenses was primarily driven by a $5.2 million decrease in employee compensation and related expenses due to lower headcount, a $1.8 million decrease in prototype expenses related to development expenses for new products which launched in 2023, a $2.3 million decrease in consulting expenses related to the W56 program, and a reduction in other expenses of $0.9 million.

Interest income (expense), net

Net interest expense for the three months ended September 30, 2024 was $8.3 million compared to net interest income of $0.4 million for the three months ended September 30, 2023. The increase is primarily due to $2.9 million in financing fees related to funds received, a $5.3 million fair value net loss, partially offset by interest income of $0.4 million due to higher cash balances in the previous period.

During the three months ended September 30, 2024, the Investor converted $8.5 million of principal into Common Stock..

Net interest expense for the nine months ended September 30, 2024 was $15.1 million compared to net interest income $1.5 million for the nine months ended September 30, 2023. The increase is primarily due to $6.0 million in financing fees related to funds received, partially offset by interest income of $1.5 million due to higher cash balances in the previous periods.
During the nine months ended, September 30, 2024 the Investor converted 2024 Notes in the principal amount of $22.9 million into Common Stock and we recorded a $8.9 million fair value net loss in Interest income (expense), net in the Condensed Consolidated Statements of Operations.

Fair value adjustment (loss) on warrants

The September 30, 2024 estimated fair value of the 2024 Warrants totaled $7.2 million. During the three and nine months ended September 30, 2024, we recorded a $2.6 million and $7.0 million fair value net loss, respectively, in the Condensed Consolidated Statements of Operations related to the 2024 Warrants.
Other income (loss)

31


Other (loss) for the three and nine months ended September 30, 2023 was $10.0 million and represents the impairment of our investment in Tropos.

Benefit for income taxes

Benefit for income taxes during the three and nine months ended September 30, 2024 and 2023 was zero as all income tax benefits are reserved.

Liquidity and Capital Resources; Going Concern

We have financed our operations primarily through sales of equity securities and issuance of debt. We have utilized this capital for R&D to fund designing, building and delivering trucks to customers and for working capital purposes.

We had sales of $4.7 million, incurred a net loss of $80.6 million and used $40.1 million of cash in operating activities during the nine months ended September 30, 2024. As of September 30, 2024, the Company had $3.2 million of cash and cash equivalents, net accounts receivable of $0.7 million, other receivables of $3.0 million, inventory, net of $43.2 million and accounts payable of $10.6 million. As of September 30, 2024, the Company had working capital of $7.9 million and an accumulated deficit of $832.2 million.

Our ability to continue as a going concern is contingent upon successful execution of management’s intended plan over the next twelve months to improve our liquidity and working capital requirements. We have made progress executing on our revised strategic product roadmap for our electric truck offerings, and we expect to generate additional sales within the next twelve months which will help support our operations. Additionally, as previously disclosed, management reduced its discretionary spend related to non-contracted capital expenditures and, implemented cost-savings measures, including a 20% reduction in force, our executive officers deferring approximately 20% of their cash compensation into the third quarter of 2024, furloughing 73 employees at our Union City manufacturing facility without pay, of which 16 have already been reinstated as of September 30, 2024, and divesting our Aero business. We also experienced voluntary attrition during the nine months ended September 30, 2024, which has further reduced employee compensation and related costs. As previously disclosed, we are currently working with certain of our vendors to extend or restructure the payment terms of certain past due accounts payable balances. However, if the expected sales are not generated and management is not able to control capital expenditures and other expenses, we will continue to incur substantial operating losses and negative cash flows from operations. There can be no assurance that we will be successful in implementing our plans or acquiring additional funding, that our projections of our future capital needs will prove accurate, or that any additional funding would be sufficient to continue operations in future years.

Our future funding requirements will depend upon many factors, including, but not limited to:

•our ability to produce our current generation of trucks at required scale and to sell such trucks to customers;
•our ability to acquire or license other technologies we may seek to pursue;
•our ability to manage our growth and operational expenses; and
•competing technological and market developments.

To the extent revenues from operations are insufficient to meet our liquidity requirements, our ability to continue as a going concern will be dependent on effectively raising capital through private or public placement of our equity securities, including the continued access to the additional closings of, as of November 18, 2024 up to $105.5 million in aggregate principal amount of additional 2024 Notes. However, we may not realize the full amount available under the 2024 Securities Purchase Agreement. Under the terms of the 2024 Securities Purchase Agreement, our ability to issue and sell additional 2024 Notes to the Investor is restricted if the Investor has not converted previous tranches of 2024 Notes into our Common Stock and sold the shares issued on conversion. Accordingly, the Investor’s ability to make such conversions and sales, and therefore our access to additional liquidity under the 2024 Securities Purchase Agreement, depends on there being a robust public trading market for our Common Stock. Since consummating the Reverse Split of our Common Stock in June 2024, the Nasdaq trading volume of our Common Stock has generally been lower (on a Reverse Split-adjusted basis) than it was before we consummated the Reverse Split. If these conditions continue, the aggregate amount of 2024 Notes we can issue and sell under the 2024 Securities Purchase Agreement may be reduced, and the issuances and sales that we are able to make may be delayed.

In addition, if our share price makes such exercise feasible, we may receive proceeds from the exercise of the corresponding 2024 Warrants pursuant to the 2024 Securities Purchase Agreement and use of the ATM Agreement (as further described below), for which there can be no assurance we will be successful in such efforts. We will also rely on debt financing or other
32


sources of capital funding such as through the sale of assets to obtain sufficient financial resources to fund our operating activities. If we are unable to maintain sufficient financial resources, our business, financial condition and results of operations, as well as our ability to continue to develop, produce and market our new truck programs and satisfy our obligations as they become due, will be materially and adversely affected. This could affect future truck program production and sales. Failure to obtain additional financing will have a material, adverse impact on our business operations. There can be no assurance that we will be able to obtain the financing needed to achieve our goals on acceptable terms or at all. Additionally, any equity or equity-linked financings would likely have a dilutive effect on the holdings of our existing stockholders. Our current level of cash and cash equivalents are not sufficient to execute our business plan. For the foreseeable future, we will incur significant operating expenses, capital expenditures and working capital funding that will deplete our cash on hand.

Our ability to obtain additional financing is extremely limited under current market conditions including the significant amount of capital required, the market price of our stock and potential dilution from the issuance of any additional securities and our ability to regain compliance with the listing requirements of the Nasdaq Capital Market. If we are unable to identify other sources of funding, we may need to further adjust our operations, including and up to filing a voluntary petition for relief under the Bankruptcy Code. If this were to occur, the value available to our various stakeholders, including our creditors and stockholders, is uncertain and trading prices for our securities may bear little or no relationship to the actual recovery, if any, by holders of our securities in bankruptcy proceedings, if any.

As a result of all of the matters discussed above, including our losses, current liquidity level and our projected capital needs, substantial doubt exists about our ability to continue as a going concern over the next twelve months from the date of issuance of the accompanying Condensed Consolidated Financial Statements. The Condensed Consolidated Financial Statements do not include any adjustments to the carrying amounts and classification of assets, liabilities, and reported expenses that may be necessary if we were unable to continue as a going concern.

Under the ATM Agreement, we may offer and sell shares of our Common Stock having an aggregate sales price of up to $175.0 million, in amounts and at times determined by management. During the nine months ended September 30, 2024, we issued 0.5 million shares under the ATM Agreement for net proceeds of $2.7 million. As of September 30, 2024 we had approximately $95.6 million available through the issuance of shares of Common Stock under the ATM Agreement. Certain of our other existing financing arrangements, including our 2024 Securities Purchase Agreement, place certain conditions and restrictions on the use of our ATM Program.
Summary of Cash Flows
Nine Months Ended
September 30,
20242023
Net cash used in operating activities$(40,115,793)$(95,546,635)
Net cash used in investing activities$(4,027,565)$(16,527,317)
Net cash provided by financing activities
$11,542,249 $51,662,716 

Cash Flows from Operating Activities

Our cash flows from operating activities are affected by our cash investments to support the business in R&D, manufacturing, SG&A. Our operating cash flows are also affected by our working capital needs to support fluctuations in accounts receivable, inventory, accounts payable and other current assets and liabilities.

During the nine months ended September 30, 2024 and 2023, net cash used in operating activities was $40.1 million and $95.5 million, respectively. The decrease in net cash used in operations was primarily attributable to a decrease in spend related to inventory and the above mentioned cost saving measures as we slowed our inventory build due to slower than anticipated sales throughout 2023 and the first half of 2024. The decrease is also attributable to a $5.0 million decline in employee compensation and related expenses, excluding non-cash stock-based compensation, resulting from our reduction in force actions.

Cash Flows from Investing Activities

Cash used in investing activities related primarily to capital expenditures to upgrade our production and research and development facilities, were $4.0 million for the nine months ended September 30, 2024 and $16.5 million for the nine months ended September 30, 2023. The decrease is primarily driven by a decline in spending in tooling and equipment related to our truck programs at our Union City, Indiana manufacturing facility.
33



Cash Flows from Financing Activities

Net cash provided by financing activities during the nine months ended September 30, 2024 was $11.5 million, which was primarily attributable to the issuances of 2024 Notes and 2024 Warrants under our 2024 Securities Purchase Agreement and of Common Stock under our ATM Program offset by the payment of our 2026 Notes.

Net cash provided by financing activities during the nine months ended September 30, 2023 was $51.7 million, which was primarily attributable to issuances of Common Stock under our ATM Program offset by the payment of our 2023 Notes.


Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

Critical Accounting Estimates
A discussion of our critical accounting estimates is contained in the Form 10-K, under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

Recent Accounting Pronouncements
A description of recently issued and adopted accounting pronouncements is contained in Note 14, Recent Accounting Pronouncements, of the Condensed Consolidated Financial Statements.
34


ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
For a discussion of our quantitative and qualitative disclosures about market risk, see “Quantitative and Qualitative Disclosures About Market Risks” included in the Form 10-K, under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” There have been no material changes to the information provided in the Form 10-K.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures designed to ensure that information required to be disclosed in reports filed under the Exchange Act is recorded, processed, summarized and reported within the specified time periods and accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. An evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q was made under the supervision and with the participation of our management, including our principal executive officer and principal financial officer.

Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2024, the end of the period covered by this Quarterly Report on Form 10-Q. Based on such evaluation, our principal executive officer and principal financial officer have concluded that, as of such date, our disclosure controls and procedures were not effective because of a previously reported material weakness in our internal control over financial reporting, which we describe in Part II, Item 9A of our Form 10-K for the fiscal year ended December 31, 2023, and because of the material weakness affecting the fiscal quarter ended September 30, 2024 described below.

Management’s Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Securities Exchange Act Rules 13a-15(f) and 15d-15(f). Internal control over financial reporting is a process designed by, or under the supervision of, our Chief Executive Officer and Chief Financial Officer to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that (1) pertain to the maintenance of records in reasonable detail to accurately and fairly reflect the transactions and dispositions of our assets; (2) provide reasonable assurance transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and our receipts and expenditures are being made only in accordance with authorizations of our management and directors and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets could have a material effect on the financial statements.

As disclosed in our Form 10-K, management identified a material weakness in the design of one of our internal controls related to the review of the fair value calculation of the convertible note and warrant liability performed by a third-party valuation expert. The controls were not designed with a level of precision that would detect the use of an inappropriate input that could have a material impact on the valuation.

In addition, during the review process related to the quarter ended September 30, 2024, management identified a material weakness in the operation of the Company's internal controls over financial reporting related to the turnover of key accounting positions within the Company’s finance organization and the ability of Company accounting personnel who have recently assumed new and additional responsibilities, with the assistance of external accounting consultants, to identify, evaluate and address technical accounting and disclosure issues that affect our consolidated financial statements on a timely basis. As a result of the Company’s previously disclosed efforts to reduce costs and preserve liquidity, the Company was not able to attract, develop and retain sufficient resources to fulfill internal control responsibilities, resulting in the lack of a sufficient complement of personnel with an appropriate degree of knowledge and experience. Management has determined that this deficiency is related to employee turnover and insufficient internal resources in technical accounting and financial reporting impacting our internal control over financial reporting in the third quarter of 2024 and does not affect previously reported periods.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting, other than the remediation actions described below, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

35


Remediation of the Material Weakness

We have undertaken and are continuing to design and implement remediation measures intended to address the material weakness related to the review of the fair value calculation of our convertible note and warrant liability discussed above. These remediation measures are focused on our precision of review of complex valuation models performed by independent third-party valuation experts we use to value these types of complex financial instruments. The valuation procedures are to be reviewed and approved by responsible management of the Company. Under the supervision of the Audit Committee, we are working to remediate this material weakness and will continue to report regularly to the Audit Committee regarding the status of the implementation activities.

We are in the process of designing and implementing remediation measures intended to address the personnel-related material weakness discussed above. These remediation measures will be focused on ensuring that we have a sufficient number of accounting personnel and that such personnel have appropriate training and experience with our disclosure and financial reporting process. Staffing and training plans are to be reviewed and approved by responsible management of the Company. Under the supervision of the Audit Committee, responsible management will develop a comprehensive remediation plan, including a detailed plan and timetable for implementation, and will report regularly to the Audit Committee regarding the status of the implementation activities.

Management’s Conclusion on Internal Control Over Financial Reporting

Based on the results of its evaluation and the material weaknesses described above, management concluded that the Company’s internal control over financial reporting was not effective to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with GAAP as of September 30, 2024.
36


PART II – OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS

For a description of certain material legal proceedings, please see Note 15, Commitments and Contingencies, to the Condensed Consolidated Financial Statements included elsewhere in this Quarterly Report on Form 10-Q.

ITEM 1A. RISK FACTORS

For a detailed discussion of risk factors affecting us, see “Part I – Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023. Except as set forth below, there have been no material changes in the current period regarding our risk factors.

If we cannot generate or obtain additional capital, we may be unable to meet the needs of our current and prospective customers or to expand our operations.

A lack of sufficient capital beyond cash on hand and funds available under our financing arrangements could significantly impair our ability to take on new customers and limit the size of the orders we can take from existing customers. We had negative cash flow from operating activities of $123.0 million and $93.8 million for the years ended December 31, 2023 and 2022, respectively, and we expect to continue to have negative cash flow from operating and investing activities through 2024. Our working capital requirements and the cash flow provided by future operating activities, if any, will vary greatly from quarter to quarter, depending on the volume of business during the period and payment terms with our customers and suppliers. We may also underestimate our capital requirements and other expenditures or overestimate our future cash flows.

In the event that we receive a purchase order that exceeds our inventory, we may lack sufficient working capital to purchase the components necessary to fulfill the order on a timely basis, or at all. We also may have to repay previously owed amounts to our suppliers before they sell us new components. If we are unable to purchase components from our suppliers, our truck shipments could be prevented or delayed, which could result in a loss of sales. If we are unable to meet existing orders or to enter into new orders because of a shortage in components, we will likely lose net revenue, risk losing customers and risk harm to our reputation in the marketplace, which could adversely affect our business, financial condition or results of operations. In addition, we may be unable to implement our long-term business plan, develop or enhance our product offerings, take advantage of future opportunities or respond to competitive pressures on a timely basis. In addition, a lack of additional financing could force us to substantially curtail or cease operations. As a result, our business, operating results, liquidity and financial position would be adversely affected.

We are currently out of compliance with the Nasdaq’s continuing listing requirements, and if we fail to satisfy all such applicable Nasdaq continued listing requirements, our common stock may be delisted from Nasdaq, which could adversely affect the liquidity and market price of our common stock.

Our common stock is currently listed on The Nasdaq Capital Market, which has qualitative and quantitative continued listing requirements, including corporate governance requirements, public float requirements and a $1.00 minimum closing bid price requirement. Our common stock price has been and may in the future be below the minimum bid price for continued listing on Nasdaq. On October 2, 2024, we received notice from Nasdaq indicating that the closing bid price for our common stock had fallen below the minimum bid price for continued listing for 30 consecutive trading days and was no longer in compliance with the minimum bid price requirement. In order to regain compliance, the closing bid price of our common stock must be equal to or above $1.00 for a period of 10 consecutive trading days prior to March 31, 2025. In the event the Company fails to meet this requirement by such date, the Company may be eligible for an additional grace period of 180 days, so long as it meets the applicable market value of publicly held shares requirement and other applicable listing standards for the Nasdaq Capital Market, other than the minimum bid price requirement, on the trading date prior to the deadline, and informs Nasdaq of its intent to cure this deficiency. If we fail to meet these requirements or fail to satisfy any other continued listing requirements, Nasdaq may take steps to delist our common stock.

In addition, Nasdaq has recently adopted new rules and proposed new rules that could hinder our ability to cure our deficiency and maintain the continued listing of our common stock. These new rules and rule proposals would provide for the immediate delisting with no grace period of any listed company that falls out of compliance with the minimum bid price requirement twice in a twelve-month period, provide for the immediate delisting if a listed company effects a reverse stock split that causes it to fall out of compliance with certain other listing requirements, and limits the ratio of reverse stock splits to a cumulative ratio of 1-to-250 in any two-year period. Delisting would likely have an adverse effect on the liquidity of our common stock, decrease the market price of our common stock, result in the potential loss of confidence by investors, suppliers, customers, and employees, and fewer business development opportunities, and adversely affect our ability to obtain financing for our continuing operations, including our ability to issue and sell additional notes to the Investor party to the 2024 Securities Purchase Agreement
37



Uncertain global macro-economic and political conditions could materially adversely affect our results of operations and financial condition.

Electric truck sales and production are cyclical and are materially affected by macroeconomic, geopolitical and industry conditions that are outside of our control and the control of our customers and suppliers, including monetary fiscal policy, economic recessions, inflation, deflation, interest rates, tariffs, political instability, labor relations issues, energy prices, regulatory requirements, government initiatives, capital and liquidity constraints, acts of war and terrorism, and natural and man-made disasters. Our operational costs are similarly impacted by such macroeconomic, geopolitical and industry conditions, which has and may continue to adversely impact our margins and profitability, such as the announcement of potential increased tariffs on imports from China and elsewhere following the U.S. presidential election which could have a significant impact on us, particularly our ability to source cost-efficient batteries for use in our trucks. Current or potential customers may delay or decrease spending on our products and services as their business and/or budgets are impacted by economic conditions. The inability of current and potential customers to pay us for our products and services may adversely affect our earnings and cash flows. In addition, deterioration of conditions in worldwide credit markets could limit our ability to obtain financing to fund our operations and capital expenditures

We have identified material weaknesses in our internal control over financial reporting. If we are unable to remediate the material weaknesses, or if we identify additional material weaknesses in the future or otherwise fail to maintain an effective system of internal controls, we may not be able to accurately or timely report our financial condition or results of operations, which may adversely affect our business.

As more fully described in Item 4. Controls and Procedures, of this Quarterly Report on Form 10-Q, we have identified a material weakness that existed as of December 31, 2023 related to our review of third-party valuation deliverables regarding our convertible note and warrant liability and a material weakness that existed as of September 30, 2024 related to the sufficiency and competency our accounting personnel. As a result of these material weaknesses, management concluded that our disclosure controls and procedures and internal control over financial reporting were not effective as of September 30, 2024.

Unless and until these material weaknesses have been remediated, or if new material weaknesses arise in the future, material misstatements could occur and go undetected in our interim or annual consolidated financial statements, and we may be required to restate our financial statements. In addition, we may experience delays in satisfying our reporting obligations or to comply with Securities and Exchange Commission rules and regulations, which could result in, among other things, regulatory or enforcement actions, securities litigation, limitations on our ability to access capital markets, debt rating agency downgrades or rating withdrawals, or loss in confidence of our investors, any one of which could adversely affect the valuation of our common stock and our business prospects. We can give no assurance that the measures we have taken and plan to take in the future will remediate the material weakness identified or that any additional material weaknesses will not arise in the future due to a failure to implement and maintain adequate internal control over financial reporting.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

Executive Compensation: On November 13, 2024, the Company’s Board of Directors approved the termination of the previously disclosed 20% deferral of cash compensation by our executive officers, effective for the pay period beginning on October 28, 2024. All previously deferred compensation through the pay period ending October 27, 2024 will continue to be deferred and will not be paid until the Company’s liquidity position improves.

Insider Trading Arrangements

38


During the three and nine months ended September 30, 2024, none of our officers or directors adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement.” However, certain of our directors and officers may adopt 10b5-1 Plans or non-Rule 10b5-1 trading arrangements in the future.
39


ITEM 6. EXHIBITS
Exhibit No.Description
10.1
10.2
10.3Form of Fifth Supplemental Indenture (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on July 18, 2024)
10.4Form of Sixth Supplemental Indenture (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on August 23, 2024)
10.5Form of Seventh Supplemental Indenture (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on October 1, 2024)
31.1*
31.2*
32.1*
32.2*
101.INSInline XBRL INSTANCE DOCUMENT
101.SCHInline XBRL Taxonomy Extension Schema Document
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document
101.LABInline XBRL Taxonomy Extension Labels Linkbase Document
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document
104Inline XBRL Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
*Filed herewith.

40


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
WORKHORSE GROUP INC.
Dated: November 19, 2024By:/s/ Richard Dauch
Name: Richard Dauch
Title:   Chief Executive Officer
(Principal Executive Officer)

Dated: November 19, 2024By:/s/ Robert M. Ginnan
Name: Robert M. Ginnan
Title:   Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)


41

EXHIBIT 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002
I, Richard Dauch, Chief Executive Officer, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Workhorse Group Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant) and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting;
5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal controls over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent function):
a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial data information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.
Date: November 19, 2024/s/ Richard Dauch
 Richard Dauch,
Chief Executive Officer
(Principal Executive Officer)



EXHIBIT 31.2
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002
I, Robert M. Ginnan, Chief Financial Officer, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Workhorse Group Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant) and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting;
5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal controls over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent function):
a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial data information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.
Date: November 19, 2024/s/ Robert M. Ginnan
Robert M. Ginnan,
Chief Financial Officer
(Principal Financial Officer)




Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly report of Workhorse Group Inc. (the "Company") on Form 10-Q for the period ended September 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Richard Dauch, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: November 19, 2024/s/ Richard Dauch
Richard Dauch,
Chief Executive Officer
(Principal Executive Officer)



Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly report of Workhorse Group Inc. (the "Company") on Form 10-Q for the period ended September 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Robert M. Ginnan, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: November 19, 2024/s/ Robert M. Ginnan
Robert M. Ginnan,
Chief Financial Officer
(Principal Financial Officer)


v3.24.3
Cover Page - shares
 9 Months Ended
Sep. 30, 2024
Nov. 19, 2024
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2024  
Document Transition Report false  
Entity File Number 001-37673  
Entity Registrant Name WORKHORSE GROUP INC.  
Entity Incorporation, State or Country Code NV  
Entity Tax Identification Number 26-1394771  
Entity Address, Address Line One 3600 Park 42 Drive  
Entity Address, Address Line Two Suite 160E  
Entity Address, City or Town Sharonville  
Entity Address, State or Province OH  
Entity Address, Postal Zip Code 45241  
City Area Code 888  
Local Phone Number 646-5205  
Title of 12(b) Security Common Stock, $0.001 par value per share  
Trading Symbol WKHS  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   40,981,553
Entity Central Index Key 0001425287  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q3  
Amendment Flag false  
v3.24.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 3,244,806 $ 25,845,915
Restricted cash 0 10,000,000
Accounts receivable, less allowance for credit losses of $0.2 million and $0.2 million as of September 30, 2024 and December 31, 2023, respectively 682,673 2,326,774
Other receivables 3,002,143 2,143,435
Inventory, net 43,186,462 45,408,192
Prepaid expenses and other current assets 7,357,838 8,101,162
Total current assets 57,473,922 93,825,478
Property, plant and equipment, net 34,825,810 37,876,955
Operating lease right-of-use assets, net 3,465,637 4,174,800
Finance lease right-of-use assets, net 5,470,933 5,621,181
Other assets 176,310 176,310
Total Assets 101,412,612 141,674,724
Current liabilities:    
Accounts payable 10,572,525 12,456,272
Accrued and other current liabilities 8,384,321 4,862,740
Deferred revenue 6,350,581 4,714,331
Warranty liability 776,423 1,902,647
Operating lease liabilities, current 1,001,120 1,012,428
Finance lease liabilities, current 2,100,635 2,548,184
Warrant liability 7,229,919 5,605,325
Current portion of convertible notes 13,182,467 20,180,100
Total current liabilities 49,597,991 53,282,027
Operating lease liabilities, long-term 4,556,738 5,280,526
Total Liabilities 54,154,729 58,562,553
Commitments and contingencies
Stockholders’ Equity:    
Common stock, par value $0.001 per share, 450,000,000 shares authorized, 31,862,091 shares issued and outstanding as of September 30, 2024 and 14,299,042 shares issued and outstanding as of December 31, 2023 (presented on a reverse stock split-adjusted basis) 31,862 14,299
Additional paid-in capital 879,405,617 834,666,123
Accumulated deficit (832,179,596) (751,568,251)
Total stockholders’ equity 47,257,883 83,112,171
Total Liabilities and Stockholders’ Equity $ 101,412,612 $ 141,674,724
v3.24.3
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts $ 0.2 $ 0.2
Common stock, par value (in usd per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 450,000,000 450,000,000
Common stock, shares issued (in shares) 31,862,091 14,299,042
Common stock, shares outstanding (in shares) 31,862,091 14,299,042
v3.24.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Sales, net of returns and allowances $ 2,509,717 $ 3,028,545 $ 4,691,451 $ 8,688,423
Cost of sales 6,642,549 6,557,358 21,386,676 20,312,854
Gross loss (4,132,832) (3,528,813) (16,695,225) (11,624,431)
Operating expenses        
Selling, general and administrative 7,722,014 11,756,291 33,883,845 40,448,651
Research and development 2,313,423 5,771,588 7,834,113 18,056,182
Total operating expenses 10,035,437 17,527,879 41,717,958 58,504,833
Loss from operations (14,168,269) (21,056,692) (58,413,183) (70,129,264)
Interest income (expense), net (8,317,813) 410,980 (15,109,136) 1,466,839
Fair value adjustment (loss) on warrants (2,649,477) 0 (7,089,027) 0
Other income (loss) 0 (10,000,000) 0 (10,000,000)
Loss before benefit for income taxes (25,135,559) (30,645,712) (80,611,346) (78,662,425)
Benefit for income taxes 0 0 0 0
Net loss $ (25,135,559) $ (30,645,712) $ (80,611,346) $ (78,662,425)
Net loss per share of common stock        
Basic (in usd per share) [1] $ (0.98) $ (2.84) $ (4.06) $ (8.29)
Diluted (in usd per share) [1] $ (0.98) $ (2.84) $ (4.06) $ (8.29)
Weighted average shares used in computing net loss per share of common stock        
Basic (in shares) [1] 25,589,725 10,793,926 19,879,290 9,487,842
Diluted (in shares) [1] 25,589,725 10,793,926 19,879,290 9,487,842
[1] Prior periods presented have been adjusted to reflect the 1-for-20 reverse stock split which was effective on June 17, 2024. Additional information regarding the reverse stock split may be found in Note 1 Summary of Business and Significant Accounting Principles.
v3.24.3
Condensed Consolidated Statements of Operations (Unaudited) (Parenthetical)
Jun. 17, 2024
Income Statement [Abstract]  
Reverse split ratio 0.05
v3.24.3
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
Total
At The Market Offering
Private Placement
2026 Notes
2024 Securities Purchase Agreement
2023 Warrants
Common Stock
Common Stock
At The Market Offering
Common Stock
Private Placement
Common Stock
2026 Notes
Common Stock
2024 Securities Purchase Agreement
Common Stock
2023 Warrants
Additional Paid-in Capital
Additional Paid-in Capital
At The Market Offering
 [1]
Additional Paid-in Capital
Private Placement
 [1]
Additional Paid-in Capital
2026 Notes
 [3]
Additional Paid-in Capital
2024 Securities Purchase Agreement
 [3]
Additional Paid-in Capital
2023 Warrants
 [3]
Accumulated Deficit
Common stock, beginning balance (in shares) at Dec. 31, 2022 [1]             8,280,268                        
Beginning balance at Dec. 31, 2022 $ 108,586,931           $ 8,280 [1]           $ 736,227,713 [1]           $ (627,649,062)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Common stock issued for securities litigation settlement (in shares) [1] 1,269,036                                    
Common stock issued for securities litigation settlement $ 20,000,000           $ 1,269 [1]           19,998,731 [1]            
Common stock issued (in shares) [1]               3,166,168 5,817                    
Common stock issued   $ 52,789,512 $ 200,000         $ 3,166 [1] $ 6 [1]         $ 52,786,346 $ 199,994        
Stock options and vesting of restricted shares (in shares) [1],[2]             47,818                        
Stock options and vesting of restricted shares [2] (467,214)           $ 48 [1]           (467,262) [1]            
Stock-based compensation 10,321,889                       10,321,889 [1]            
Net loss (78,662,425)                                   (78,662,425)
Common stock, ending balance (in shares) at Sep. 30, 2023 [1]             12,769,107                        
Ending balance at Sep. 30, 2023 112,768,693           $ 12,769 [1]           819,067,411 [1]           (706,311,487)
Common stock, beginning balance (in shares) at Jun. 30, 2023 [1]             10,261,058                        
Beginning balance at Jun. 30, 2023 107,387,721           $ 10,261 [1]           783,043,235 [1]           (675,665,775)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Common stock issued for securities litigation settlement (in shares) [1]             1,269,036                        
Common stock issued for securities litigation settlement 20,000,000           $ 1,269 [1]           19,998,731 [1]            
Common stock issued (in shares) [1]               1,231,961                      
Common stock issued   $ 12,497,904           $ 1,232 [1]           $ 12,496,672          
Stock options and vesting of restricted shares (in shares) [1],[2]             7,052                        
Stock options and vesting of restricted shares [2] 8,376           $ 7 [1]           8,369 [1]            
Stock-based compensation 3,520,404                       3,520,404 [1]            
Net loss (30,645,712)                                   (30,645,712)
Common stock, ending balance (in shares) at Sep. 30, 2023 [1]             12,769,107                        
Ending balance at Sep. 30, 2023 $ 112,768,693           $ 12,769 [1]           819,067,411 [1]           (706,311,487)
Common stock, beginning balance (in shares) at Dec. 31, 2023 14,299,042           14,299,042 [3]                        
Beginning balance at Dec. 31, 2023 $ 83,112,171           $ 14,299 [3]           834,666,123 [3]           (751,568,251)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Common stock issued, convertible securities           $ 2,800,000                          
Common stock, ending balance (in shares) at Jun. 30, 2024 [3]             20,738,091                        
Ending balance at Jun. 30, 2024 $ 58,636,957           $ 20,738 [3]           865,660,256 [3]           (807,044,037)
Common stock, beginning balance (in shares) at Dec. 31, 2023 14,299,042           14,299,042 [3]                        
Beginning balance at Dec. 31, 2023 $ 83,112,171           $ 14,299 [3]           834,666,123 [3]           (751,568,251)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Common stock issued (in shares) [3]             490,445                        
Common stock issued 1,242,649           $ 490 [3]           1,242,159 [3]            
Common stock issued, convertible securities (in shares) [3]                     16,111,989 425,000              
Common stock issued, convertible securities         $ 29,691,574 $ 2,847,500         $ 16,112 [3] $ 425 [3]         $ 29,675,462 $ 2,847,075  
Issuance of common stock under ELOC Purchase Agreement (in shares) [3]                   600,000                  
Issuance of common stock under ELOC Purchase Agreement       $ 3,124,000           $ 600 [3]           $ 3,123,400      
Stock options and vesting of restricted shares (in shares) [3],[4]             206,993                        
Stock options and vesting of restricted shares [4] (171,043)           $ 207 [3]           (171,250) [3]            
Stock-based compensation 8,022,851                       8,022,851 [3]            
Treasury Stock (in shares) [3]             (271,378)                        
Other (474)           $ (271) [3]           (203) [3]            
Net loss $ (80,611,346)                                   (80,611,346)
Common stock, ending balance (in shares) at Sep. 30, 2024 31,862,091           31,862,091 [3]                        
Ending balance at Sep. 30, 2024 $ 47,257,883           $ 31,862 [3]           879,405,617 [3]           (832,179,596)
Common stock, beginning balance (in shares) at Jun. 30, 2024 [3]             20,738,091                        
Beginning balance at Jun. 30, 2024 58,636,957           $ 20,738 [3]           865,660,256 [3]           (807,044,037)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Common stock issued, convertible securities (in shares) [3]                     11,162,343                
Common stock issued, convertible securities         $ 11,781,059           $ 11,162 [3]           $ 11,769,897    
Stock options and vesting of restricted shares (in shares) [3],[4]             105,001                        
Stock options and vesting of restricted shares [4] (2,761)           $ 105 [3]           (2,866) [3]            
Stock-based compensation 1,978,330                       1,978,330 [3]            
Other (in shares) [3]             (143,344)                        
Other (143)           $ (143) [3]                        
Net loss $ (25,135,559)                                   (25,135,559)
Common stock, ending balance (in shares) at Sep. 30, 2024 31,862,091           31,862,091 [3]                        
Ending balance at Sep. 30, 2024 $ 47,257,883           $ 31,862 [3]           $ 879,405,617 [3]           $ (832,179,596)
[1] Prior periods presented have been adjusted to reflect the 1-for-20 reverse stock split which was effective on June 17, 2024. Additional information regarding the reverse stock split may be found in Note 1 Summary of Business and Significant Accounting Principles.
[2] Net of tax payments related to shares withheld for option exercises and vested stock.
[3] Prior periods presented have been adjusted to reflect the 1-for-20 reverse stock split which was effective on June 17, 2024. Additional information regarding the reverse stock split may be found in Note 1 Summary of Business and Significant Accounting Principles.
[4] Net of tax payments related to shares withheld for option exercises and vested stock.
v3.24.3
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) (Parenthetical)
Jun. 17, 2024
Statement of Financial Position [Abstract]  
Reverse split ratio 0.05
v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net loss $ (80,611,346) $ (78,662,425)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 5,959,822 2,468,832
Deferred revenue 1,636,250 (143,169)
Stock-based compensation 8,206,673 10,321,889
Change in inventory and prepaid purchases reserve 1,084,906 550,090
Non-cash lease expense 580,123 583,348
Other non-cash items 2,917,251 200,000
Impairment of investment in Tropos 0 10,000,000
Effects of changes in operating assets and liabilities:    
Accounts receivable 785,394 (5,295,003)
Inventory, net 1,238,803 (28,492,532)
Prepaid expenses and other current assets 641,345 (1,083,886)
Accounts payable, accrued liabilities and other 2,570,035 (5,563,625)
Warranty liability (1,126,224) (430,154)
Net cash used in operating activities (40,115,793) (95,546,635)
Cash flows from investing activities:    
Capital expenditures (4,027,565) (16,527,317)
Net cash used in investing activities (4,027,565) (16,527,317)
Cash flows from financing activities:    
Proceeds on convertible notes 28,250,000 0
Payments on convertible notes (20,000,000) 0
Proceeds from issuance of common stock 4,366,649 52,789,512
Payments on finance lease (903,357) (659,582)
Exercise of options and restricted share award activity (171,043) (467,214)
Net cash provided by financing activities 11,542,249 51,662,716
Change in cash and cash equivalents (32,601,109) (60,411,236)
Cash and cash equivalents, beginning of the period 35,845,915 99,276,301
Cash and cash equivalents, end of the period 3,244,806 38,865,065
2023 Warrants    
Adjustments to reconcile net loss to net cash used in operating activities:    
Change in fair value and gain on conversion of 2026 Notes and exchange of 2023 Warrants (2,937,925) 0
2024 Warrants    
Adjustments to reconcile net loss to net cash used in operating activities:    
Change in fair value and gain on conversion of 2026 Notes and exchange of 2023 Warrants $ 18,939,100 $ 0
v3.24.3
SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING PRINCIPLES
 9 Months Ended
Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING PRINCIPLES SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING PRINCIPLES
Overview

Workhorse Group Inc. (“Workhorse”, the “Company”, “we”, “us”, or “our”) is an American technology company with a vision to pioneer the transition to zero-emission commercial trucks. We design, develop, manufacture and sell fully electric trucks.

Liquidity, Capital Resources, and Going Concern

The accompanying Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) applicable to a going concern. The going concern basis of presentation assumes that the Company will continue in operation one year after the date these Condensed Consolidated Financial Statements are issued and will be able to realize assets and discharge its liabilities and commitments in the normal course of business. The Condensed Consolidated Financial Statements do not include any adjustments to the carrying amounts and classification of assets, liabilities, and reported expenses that may be necessary if the Company were unable to continue as a going concern.

Pursuant to the requirements of the Financial Accounting Standard Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 205-40, Presentation of Financial Statements - Going Concern (“ASC 205-40”), management must evaluate whether there are conditions and events, considered in aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for one year after the date these Condensed Consolidated Financial Statements are issued. In accordance with ASC 205-40, management’s analysis can only include the potential mitigating impact of management’s plans that have not been fully implemented as of the issuance date if (a) it is probable that management’s plans will be effectively implemented on a timely basis, and (b) it is probable that the plans, when implemented, will alleviate the relevant conditions or events that raise substantial doubt about the Company’s ability to continue as a going concern.

We had sales of $4.7 million, incurred a net loss of $80.6 million and used $40.1 million of cash in operating activities during the nine months ended September 30, 2024. As of September 30, 2024, the Company had $3.2 million of cash and cash equivalents, net accounts receivable of $0.7 million, other receivables of $3.0 million, inventory, net of $43.2 million and accounts payable of $10.6 million. As of September 30, 2024, the Company had working capital of $7.9 million and an accumulated deficit of $832.2 million.

As a result of our recurring losses from operations, accumulated deficit, projected capital needs, and delays in bringing our trucks to market and lower than expected market demand, substantial doubt exists regarding our ability to continue as a going concern within one year after the issuance date of the accompanying Condensed Consolidated Financial Statements. Our ability to continue as a going concern is contingent upon successful execution of management’s intended plan over the next twelve months to improve the Company’s liquidity and working capital, which includes, but is not limited to:

•Generating revenue by increasing sales of our trucks and other services.
•Reducing expenses and limiting non-contracted capital expenditures.
•Raising capital to fund operations through the issuance of debt or equity securities, including through our 2024 Securities Purchase Agreement (as defined below) and our At-the-Market Sales Agreement (“ATM Agreement”), the sale of assets, or other strategic transactions.

It is essential that we have access to capital as we bring our existing line of trucks to market, scale up production and sales of such trucks and continue to develop additional variations of our existing trucks and our next generation of trucks. There is no assurance that we will be successful in implementing management’s plans to generate liquidity to fund these activities or other aspects of our short and long-term strategy, that our projections of our future capital needs will prove accurate or that any additional funding would be available or sufficient to continue operations in future periods.

To the extent revenues from operations are insufficient to meet our liquidity requirements, our ability to continue as a going concern will be dependent on effectively raising capital through private or public placement of our equity, debt and equity-linked securities, including the continued access to the additional closings of, as of November 18, 2024, up to $105.5 million in aggregate principal amount of additional 2024 Notes (as defined below) and, if our share price makes such exercise feasible, the possible receipt of proceeds from the exercise of the corresponding 2024 Warrants (as defined below) pursuant to the 2024 Securities Purchase Agreement (as defined below), and the continued use of the ATM Agreement, for which there can be no
assurance we will be successful in such efforts. We will also rely on other debt financing or other sources of capital funding such as through the sale of assets to obtain sufficient financial resources to fund our operating activities. If we are unable to maintain sufficient financial resources, our business, financial condition and results of operations, as well as our ability to continue to develop, produce and market our truck programs and satisfy our obligations as they become due, the Company will be materially and adversely affected. This could affect future truck program production and sales. Failure to obtain additional financing will have a material, adverse impact on our business operations. There can be no assurance that we will be able to obtain the financing needed to achieve our goals on acceptable terms or at all. Additionally, any equity or equity-linked financings would likely have a dilutive effect on the holdings of our existing stockholders. The Company’s current level of cash and cash equivalents are not sufficient to execute our business plan. For the foreseeable future, we will incur significant operating expenses, capital expenditures and working capital funding that will deplete our cash on hand. These conditions raise substantial doubt regarding the Company’s ability to continue as a going concern for a period of at least one year from the date of issuance of these Condensed Consolidated Financial Statements.

Our ability to obtain additional financing is extremely limited under current market conditions including the significant amount of capital required, the market price of our stock and potential dilution from the issuance of any additional securities and our ability to regain compliance with the listing requirements of the Nasdaq Capital Market. If we are unable to identify other sources of funding, we may need to further adjust our operations and seek protection by filing a voluntary petition for relief under the Bankruptcy Code. If this were to occur, the value available to our various stakeholders, including our creditors and stockholders, is uncertain and trading prices for our securities may bear little or no relationship to the actual recovery, if any, by holders of our securities in bankruptcy proceedings, if any.

Due to these uncertainties and continued delays in market adoption of commercial electric trucks, the Company identified a triggering event under ASC 360-35-21 that required further analysis and concluded that no impairment was required.

Additional actions taken by the Company with regards to liquidity and its plan to manage operating capital include the following:

Financings under the 2024 Securities Purchase Agreement

As part of management's plan to raise capital to fund operations, we have entered into a financing arrangement that makes liquidity available in both the short term and over time. On March 15, 2024, we have entered into a securities purchase agreement (the “2024 Securities Purchase Agreement”) with an institutional investor (the “Investor”) under which we agreed to issue and sell, in one or more registered public offerings by the Company directly to the Investor in multiple tranches over a period beginning on March 15, 2024, (i) senior secured convertible notes for up to an aggregate principal amount of $139.0 million (the “2024 Notes”) that are convertible into shares of the Company’s common stock, par value of $0.001 per share (the “Common Stock”) and (ii) warrants (the “ 2024 Warrants”) to purchase shares of Common Stock.

Pursuant to the 2024 Securities Purchase Agreement, during the three months ended September 30, 2024 the Company issued and sold to the Investor (i) 2024 Notes in the original principal amount of $10.0 million ($4.0 million on July 18; $2.6 million on August 23, and $3.4 million on September 30) and (ii) 2024 Warrants to purchase up to 10.1 million (2.7 million on July 18; 2.9 million on August 23; and 4.5 million on September 30) shares of Common Stock.

As of September 30, 2024, $9.4 million aggregate principal amount remained outstanding under the 2024 Notes, and no shares had been issued pursuant to the 2024 Warrants. Upon our filing of one or more additional prospectus supplements, and our satisfaction of certain other conditions, as of September 30, 2024, the 2024 Securities Purchase Agreement contemplates additional closings of 2024 Notes of up to $106.7 million in aggregate principal amount of additional 2024 Notes and corresponding 2024 Warrants.

Sale Leaseback of Union City, Indiana Manufacturing Facility

Another strategic opportunity identified by management to raise capital to fund operations was to enter into a sale leaseback for our Union City, Indiana manufacturing facility. As previously reported, on January 31, 2024, a subsidiary of the Company entered into a purchase and sale agreement (the “Purchase and Sale Agreement”) with William Repny LLC (the “Union City Purchaser”) for the sale of the Company’s Union City, Indiana manufacturing facility for a purchase price, before fees and expenses, of approximately $34.5 million, in connection with which the Company would lease the property back from the Union City Purchaser. Although the Purchase and Sale Agreement has not been terminated, the Company does not believe the transaction will be consummated at the current purchase price. Accordingly, the Company is currently discussing alternative sale and leaseback transactions with other potential purchasers, as well as possible changes to the terms of the Purchase and Sale Agreement with the Union City Purchaser or other strategic alternatives. The Company expects that if a sale and leaseback transaction for the Union City facility is consummated, whether with the Union City Purchaser or another party, the purchase price in such transaction will be materially lower than the price provided in the Purchase and Sale Agreement. Moreover,
because the Union City facility is currently operating at a very limited portion of its capacity, the Company believes that it may not be possible to consummate a sale leaseback of the facility on acceptable terms unless the Company or an additional occupant begins using a larger portion of the facility and sales ramp up.

Cost-saving Measures

As previously disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 as filed with the Securities and Exchange Commission (the “SEC”) on March 12, 2024 (the “Form 10-K”) a vital component of management’s intended plan to improve our liquidity and working capital requirements is reducing our operating costs to, among other things, reduce demands on our available liquidity. During the first quarter of 2024, we initiated a reduction in force (the “RIF”) pursuant to which we terminated the approximately 20% of our total workforce, excluding direct labor, and our executive officers agreed to defer approximately 20% of their cash compensation into the third quarter of 2024. Effective for the pay period beginning October 28, 2024 the Company will no longer defer approximately 20% of the cash compensation of our executive officers described above. However, the previously deferred compensation of $0.4 million in Accrued and other current liabilities in the Condensed Consolidated Balance Sheet will remain deferred and the Company does not expect to pay such deferred amounts until it has adequate liquidity to do so.

In April 2024, the Company initially furloughed 73 employees at its Union City manufacturing facility without pay and from these 16, have since been reinstated as of September 30, 2024. The Company has not incurred, and does not expect to incur, material costs in connection with the RIF and furloughs. The Company is also currently working with certain of its vendors to extend or restructure the payment terms of certain of its accounts payable. The Company currently intends to reinstate furloughed employees when the Company’s financial and operational position permits. However, there can be no assurance that such furloughed employees will be available and willing to return to work.

Aero Drone Design and Manufacturing Operations

Management’s plan also included a decision to cease the production operations of our drone design and manufacturing business and transition exclusively to operating as a Drones as a Service business, as previously disclosed in the 2023 Form 10-K. On June 6, 2024, the Company completed the previously disclosed divestiture of its Aero business (the “Aero Divestiture”) to a third party. The Company expects the Aero Divestiture to provide monthly cost savings of approximately $0.4 million and enhance its ability to concentrate on its commercial electric truck business. Under the agreement’s earn-out provisions, the Company will receive a portion of the proceeds if the Aero business realizes positive net cash flow but these contingencies are indeterminable at this time. The loss on the Aero Divestiture was $0.7 million of which $0.4 million was included in Selling, general and administrative expenses and $0.3 million in Cost of sales in the Condensed Consolidated Statement of Operations for the nine months ended September 30, 2024.

NASDAQ Listing Requirements and Reverse Stock Split

In order to regain compliance with the Listing Requirements of Nasdaq, on June 17, 2024, the Company effected a 1-for-20 reverse stock split (the “Reverse Split”) of the Company’s then issued and outstanding shares of common stock, par value $0.001 per share (the “Common Stock”). The authorized number of shares of Common Stock was not affected by the Reverse Split. The Company adjusted the exercise price, number of shares issuable on exercise or vesting and/or other terms of its outstanding stock options, warrants, restricted stock, and restricted stock units to reflect the effects of the Reverse Split. Prior periods presented have also been adjusted to reflect this change. On July 3, 2024, Nasdaq confirmed that we were in compliance with the Minimum Bid Requirement.

On October 2, 2024, the Company received a second written notice from Nasdaq indicating that the Company was no longer in compliance with the $1.00 minimum bid price requirement.

The Company has been provided with a compliance period of 180 calendar days, or until March 31, 2025, to regain compliance with the minimum bid price. If the Company does not regain compliance by March 31, 2025, the Company may be eligible for an additional grace period subject to certain conditions.

The Company is currently evaluating various courses of action to regain compliance. There can be no assurance that the Company will regain compliance with the bid price requirement during the 180-day compliance period ending March 31, 2025, secure an extension of the compliance period beyond March 31, 2025 or maintain compliance with any other Nasdaq listing requirement.

In addition, Nasdaq has recently adopted new rules and proposed new rules that could hinder our ability to cure our deficiency
and maintain the continued listing of our common stock. These new rules and rule proposals would provide for the immediate
delisting with no grace period of any listed company that falls out of compliance with the minimum bid price requirement twice
in a twelve-month period, provide for the immediate delisting if a listed company effects a reverse stock split that causes it to
fall out of compliance with certain other listing requirements, and limits the ratio of reverse stock splits to a cumulative ratio of
1-to-250 in any two-year period. Delisting would likely have an adverse effect on the liquidity of our common stock, decrease
the market price of our common stock, result in the potential loss of confidence by investors, suppliers, customers, and
employees, and fewer business development opportunities, and adversely affect our ability to obtain financing for our
continuing operations, including our ability to issue and sell additional notes to the investors party to the 2024 Securities Purchase Agreement or secure other future financing agreements.

Basis of Presentation and Consolidation

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the SEC regarding interim financial reporting and include the accounts and operations of the Company and those of our wholly-owned subsidiaries. Accordingly, they do not include all of the information and footnotes required by GAAP for annual audited financial statements. All intercompany balances and transactions have been eliminated upon consolidation.
During the period, the Company identified that certain items in its prior year Condensed Consolidated Balance Sheets were presented as combined totals, including right-of-use (ROU) assets and lease liabilities related to operating and finance leases, accounts receivable and other receivables. The Company has reclassified these amounts to separately disclose the relevant components in the accompanying financial statements. These changes in presentation do not impact total assets, total liabilities, net income, or cash flows.
The Company has elected the fair value option for its convertible debt and associated warrants. This election was made to align the measurement of these financial instruments with their market values and simplify the accounting for the components. Changes in fair value are recognized in Interest income (loss) and Fair value adjustment (loss) on warrants, respectively in the Condensed Consolidated Statement of Operations.

In the opinion of our management, the unaudited Condensed Consolidated Financial Statements have been prepared on a basis consistent with the audited Consolidated Financial Statements and include all adjustments necessary for the fair presentation of Workhorse’s financial condition, results of operations and cash flows for the interim periods presented. Such adjustments are of a normal, recurring nature. The results of operations and cash flows for the interim periods presented may not necessarily be indicative of full-year results. Reference should be made to the financial statements contained in our 2023 Form 10-K.

Revenue Recognition

The Company recognizes revenue in accordance with Accounting Standards Codification 606, Revenue from Contracts with Customers.

Revenue is recognized when the Company transfers promised goods or services to customers in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. In determining the appropriate amount of revenue to be recognized as the Company fulfills its obligations under the agreement, the Company performs the following steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including any constraints on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. The Company only applies the five-step model to contracts when it is probable that it will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer.

The Company generates revenue through the sale of electric trucks (Workhorse W4 CC, W56 and W750) as well as service and parts directly to dealership customers and route revenue from the Company’s Stables by Workhorse. The Company reviews the performance obligations in the Company’s agreements, which is the Company’s promise to transfer the Company’s product to customers based on the performance of services, transfer of title or shipping terms in the arrangement and any other variable considerations. The revenue is allocated based on the Company's performance obligation, and an estimate of Sales returns and allowances are recognized. The Company offers concessions to certain customers and estimates the variable consideration based on historical sales activity. In addition, the Company considers the extent to which revenue should be constrained such that there is not a significant reversal of revenue in the future. In the current quarter, the Company constrained approximately $1.1 million of revenue.

On or before shipment of the trucks, the Company bills its customers the total consideration of its obligations under the agreement. Consistent with industry practice, the Company generally offers customers a limited warranty for work performed
on the truck under the builds/sales contract. The customers do not have a contractual right of return. The Company only offers a limited warranty for the work performed on the truck. If a customer disputes any work performed, the Company will attempt to remedy the work, however, it shall not be required to discount the transaction price. The Company considers this an assurance-type warranty and not a separate performance obligation.

The Company's agreements do not allow customers to return products. However, under certain conditions, such as defects or non-compliance with specifications, or other allowances, the Company may elect to allow limited returns in special situations. To account for these returns, the Company estimates and records a sales returns allowance as a reduction of gross revenue. This allowance is based on historical return rates and expectations of future returns, adjusted for any known factors that may affect return rates, such as changes in product quality or customer mix.

The Company provides for the estimated cost of product warranties at the time revenue is recognized. While the Company engages in product quality programs and processes, including quality control test driving trucks, the warranty obligation is calculated by historical warranty costs per truck. Should actual costs differ from the Company’s estimates, revisions to increase or decrease the estimated warranty liability may be required.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses and related disclosures in the accompanying notes.
v3.24.3
INVENTORY, NET
 9 Months Ended
Sep. 30, 2024
Inventory Disclosure [Abstract]  
INVENTORY, NET INVENTORY, NET
Inventory, net consisted of the following:

September 30, 2024December 31, 2023
Raw materials$46,097,429 $32,682,324 
Work in process4,123,097 2,892,329 
Finished goods5,476,095 18,309,829 
55,696,621 53,884,482 
Less: inventory reserves(12,510,159)(8,476,290)
Inventory, net$43,186,462 $45,408,192 
We reserve inventory for any excess or obsolete inventories or when we believe the net realizable value of inventories is less than the carrying value.
Inventory reserves represents the Company’s best estimate in value lost due to excessive inventory level, physical deterioration, obsolescence, changes in price levels, or other causes based on individual facts and circumstances. Inventory reserves relate to inventory items including finished goods, work-in-process and raw materials. Reductions to inventory reserves are recognized only when the related inventory has been consumed, sold, disposed or scrapped.
As of September 30, 2024 and December 31, 2023, we carried inventory reserves of $12.5 million and $8.5 million, respectively. The increase in inventory reserves was primarily attributable to excess inventory due to slower than anticipated truck sales.
v3.24.3
CONTRACT MANUFACTURING SERVICES AND INVESTMENT IN TROPOS
 9 Months Ended
Sep. 30, 2024
Related Party Transactions [Abstract]  
CONTRACT MANUFACTURING SERVICES AND INVESTMENT IN TROPOS CONTRACT MANUFACTURING SERVICES AND INVESTMENT IN TROPOS
We have a minority ownership investment in Tropos Technologies, Inc. (“Tropos”). The investment was acquired during the third quarter of 2022 in exchange for a cash payment of $5.0 million and a $5.0 million contribution of non-cash consideration representing a deposit from Tropos for future assembly services under an Assembly Services Agreement. The $5.0 million non-cash consideration was recorded as deferred revenue and is recognized as revenue over time as assembly service performance obligations are satisfied.

We recorded our investment at cost less impairment, if applicable. In accordance with FASB ASC Topic 321, Investments - Equity Securities, we assessed our investment for impairment at each reporting period to determine if the fair value declined below its cost basis and if the impairment is other-than-temporary.
During the third quarter of 2023, we determined that our investment in Tropos was impaired based on the economic conditions and uncertainties that have significantly affected Tropos’ performance and financial position. The impairment is considered other-than-temporary as the decline in fair value of the investment is not expected to recover in the foreseeable future.

The impairment loss recognized for our investment was $10.0 million, which represents the difference between the original cost of the investment and its fair value as of the impairment assessment date. The impairment loss was recognized in Other income (loss) in the Consolidated Statements of Operations in the previous period.

The impairment of our investment did not release the Company from its obligation to perform assembly services under the Assembly Services Agreement and, accordingly, the Company continues to be obligated to perform assembly services and carry the balance of such obligations in Deferred revenue in the Condensed Consolidated Balance Sheets. As of September 30, 2024 and December 31, 2023, deferred revenue related to the Assembly Services Agreement was $4.7 million.
v3.24.3
PREPAID EXPENSES AND OTHER CURRENT ASSETS
 9 Months Ended
Sep. 30, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
PREPAID EXPENSES AND OTHER CURRENT ASSETS PREPAID EXPENSES AND OTHER CURRENT ASSETS
Prepaid expenses and other current assets consisted of the following:

September 30, 2024December 31, 2023
Prepaid purchases(1)
$6,824,168 $7,908,087 
Less: prepaid purchases reserve(2)
(1,943,969)(1,999,068)
Prepaid purchases, net4,880,199 5,909,019 
Prepaid insurance864,110 1,283,146 
Other1,613,529 908,997 
Prepaid expenses and other current assets$7,357,838 $8,101,162 

(1) Our prepaid purchases consist of deposits made to our suppliers for non-recurring production parts and engineering costs. As of September 30, 2024 and December 31, 2023, net prepaid purchases primarily consisted of deposits for direct materials associated with our W4 CC and W750 trucks. The decrease in prepaid purchases as of September 30, 2024 as compared to December 31, 2023 is primarily due to receipts of direct materials associated with our W4 CC and W750 trucks.
(2) We record reserves on prepaid purchases that are significantly aged and for balances specifically identified as having a carrying value in excess of net realizable value. The prepaid purchases reserve represents our best estimate of deposits on orders that we do not expect to recover.
v3.24.3
REVENUE
 9 Months Ended
Sep. 30, 2024
Revenue from Contract with Customer [Abstract]  
REVENUE REVENUE
The following table provides a summary of sales activity for the periods indicated:
Three Months Ended September 30,Nine Months Ended
September 30,
2024202320242023
Sales, net of returns and allowances$2,169,769 $2,570,250 $2,753,384 $7,292,417 
Other sales339,948 458,295 1,938,067 1,396,006 
Total sales, net of returns and allowances$2,509,717 $3,028,545 $4,691,451 $8,688,423 

Sales, net of returns and allowances, for the three and nine months ended September 30, 2024 consisted primarily of truck sales. Other sales for the three and nine months ended September 30, 2024 consisted of non-warranty after-sales truck services, parts and accessories and revenue generated from operating our Stables by Workhorse route, Drones as a Service prior to the Aero Divestiture, and other service revenue.
Deferred revenue was $6.4 million and $4.7 million as of September 30, 2024 and December 31, 2023, respectively, consisting of the total service fee allocated to the assembly service performance obligations under the Tropos Assembly Services Agreement of $4.7 million and certain performance obligations related to the sale of W4 CC trucks in the second quarter of 2024 that were unsatisfied as of September 30, 2024 of $1.7 million. The Company expects to recognize a portion of deferred revenue related to the sale of W4 CC trucks as revenue during the remainder of 2024.
v3.24.3
ACCRUED AND OTHER CURRENT LIABILITIES
 9 Months Ended
Sep. 30, 2024
Payables and Accruals [Abstract]  
ACCRUED AND OTHER CURRENT LIABILITIES ACCRUED AND OTHER CURRENT LIABILITIES
Accrued and other current liabilities consisted of the following:

September 30, 2024December 31, 2023
Compensation and related costs$3,935,226 $2,083,808 
Accrued interest114,438 — 
Sales returns and allowances
1,102,005 — 
Other
3,232,652 2,778,932 
Total accrued and other current liabilities$8,384,321 $4,862,740 

Warranties

We provide a manufacturer's warranty on all new trucks we sell. We record a warranty liability for the products sold by us, which includes our best estimate of the projected costs to repair or replace items under warranties and recalls if identified. The amount of warranty liability accrued reflects management’s best estimate of the nature, frequency, and costs of future claims. Historically, the cost of fulfilling the warranty obligations has principally involved replacement parts, towing and transportation costs, labor and sometimes travel for any field retrofit campaigns. Our estimates are based on historical experience, the extent of pre-production testing, the number of units involved and the extent of features/components included in product models. Although we believe the estimates and judgments discussed herein are reasonable, actual results could differ and we may be exposed to increases or decreases in our warranty liability accrual that could be material.

Accrued warranty liability activity consisted of the following for the periods indicated:

Three Months Ended
September 30,		Nine Months Ended
September 30,
2024202320242023
Warranty liability, beginning of period$642,326 $1,922,580 $1,902,647 $2,207,674 
Warranty costs incurred(61,611)(289,404)(189,904)(884,717)
Provision for warranty(1)
195,708 144,344 (936,320)454,563 
Warranty liability, end of period$776,423 $1,777,520 $776,423 $1,777,520 

(1) We record a warranty liability for the products sold by us, which includes our best estimate of the projected costs to repair or replace items under warranties and recalls if identified. The negative provision for warranty for the nine months ended September 30, 2024, is driven by the expiration of the warranty liability related to non-current truck models.
v3.24.3
DEBT
 9 Months Ended
Sep. 30, 2024
Debt Disclosure [Abstract]  
DEBT DEBT
A reconciliation of the fair value of the convertible notes is as follows:
Nine Months Ended September 30, 2024
Fair value of convertible notes, beginning of period$20,180,100 
Fair value of convertible notes issued during period45,829,120 
Payments on convertible notes
(20,180,100)
Change in fair value of convertible notes (1)
(1,488,754)
Fair value of convertible notes exchanged for common stock(31,157,899)
Fair value of convertible notes, end of period$13,182,467 
(1) The Company recognizes changes in fair value of convertible notes for Common Stock in Interest income (expense), net in the Condensed Consolidated Statements of Operations. The negative provision for warranty for the nine months ended September 30, 2024, is driven by the expiration of the warranty liability related to non-current truck models.
Senior Secured Convertible Notes
2024 Securities Purchase Agreement

On March 15, 2024, we entered into the 2024 Securities Purchase Agreement with the Investor under which the Company agreed to issue and sell, in one or more registered public offerings by the Company directly to the Investor in multiple tranches over a period beginning on March 15, 2024, (i) 2024 Notes for up to an aggregate principal amount of $139.0 million that will be convertible into shares of the Company’s Common Stock and (ii) 2024 Warrants to purchase shares of Common Stock.

During the three months ended September 30, 2024, the Company issued and sold to the Investor (i) 2024 Notes in the original principal amount of $10.0 million ($4.0 million on July 18; $2.6 million on August 23, and $3.4 million on September 30) and (ii) 2024 Warrants to purchase up to 10.1 million (2.7 million on July 18; 2.9 million on August 23; and 4.5 million on September 30) shares of Common Stock.

During the nine months ended September 30, 2024, the Company issued and sold to the Investor (i) 2024 Notes in aggregate original principal amount of $32.3 million and (ii) 2024 Warrants to purchase up to 15.6 million shares of Common Stock pursuant to the 2024 Securities Purchase Agreement (following adjustment in connection with the Company’s Reverse Split). As of September 30, 2024, $9.4 million aggregate principal amount remained outstanding under the 2024 Notes, and no shares had been issued pursuant to the 2024 Warrants.

No 2024 Notes may be converted and no 2024 Warrants may be exercised to the extent that such conversion or exercise would cause the then holder of such 2024 Notes or 2024 Warrants to become the beneficial owner of more than 9.99% of the Company’s then outstanding Common Stock, after giving effect to such conversion or exercise.

2024 Notes

The 2024 Notes were issued with original issue discount of 12.5%, resulting in $28.3 million of net proceeds to the Company before fees and expenses for the nine months ended September 30, 2024. The 2024 Notes are or will be senior, secured obligations of the Company, ranking senior to all other unsecured indebtedness, subject to certain limitations and are unconditionally guaranteed by each of the Company’s subsidiaries, pursuant to the terms of a certain security agreement and subsidiary guarantee. The 2024 Notes are issued pursuant to the Company’s Indenture (the “Base Indenture”) with U.S. Bank Trust Company, National Association, as trustee (the “Trustee”), and supplemental indentures thereto.

Each 2024 Notes bears interest at a rate of 9.0% per annum, payable in arrears on the first trading day of each calendar quarter, at the Company’s option, either in cash or in-kind by compounding and becoming additional principal. Upon the occurrence and during the continuance of an event of default, the interest rate will increase to 18.0% per annum. Unless earlier converted or redeemed, each 2024 Notes will mature on the one-year anniversary of the date hereof, subject to extension at the option of the holders in certain circumstances as provided therein.

All amounts due under any 2024 Notes are convertible at any time, in whole or in part, at the option of the holders into shares of Common Stock at a conversion price equal to the applicable Reference Price set forth in such 2024 Notes or (b) the greater of (x) the applicable Floor Price set forth in such 2024 Notes and (y) 87.5% of the volume weighted average price of the Common Stock during the ten trading days ending and including the trading day immediately preceding the delivery or deemed delivery of the applicable conversion notice, as elected by the converting holder. The Reference Price and Floor Price are subject to customary adjustments upon any stock split, stock dividend, stock combination, recapitalization or similar event. The Reference Price is also subject to full-ratchet adjustment in connection with a subsequent offering at a per share price less than the Reference Price then in effect. Subject to the rules and regulations of Nasdaq, we have the right, at any time, with the written consent of the Investor, to lower the reference price to any amount and for any period of time deemed appropriate by our board of directors. Upon the satisfaction of certain conditions, we may prepay any 2024 Notes upon 15 business days’ written notice by paying an amount equal to the greater of (i) the face value of the 2024 Notes at premium of 25% (or 75% premium, during the occurrence and continuance of an event of default, or in the event certain redemption conditions are not satisfied) and (ii) the equity value of the shares of Common Stock underlying the 2024 Notes. The equity value of our Common Stock underlying the 2024 Notes is calculated using the two greatest volume weighted average prices of our Common Stock during the period immediately preceding the date of such redemption and ending on the date we make the required payment.

The 2024 Notes contain customary affirmative and negative covenants, including certain limitations on debt, liens, restricted payments, asset transfers, changes in the business and transactions with affiliates. The 2024 Notes require the Company to maintain minimum liquidity on the last day of each fiscal quarter in the amount of either (i) $1.5 million if the sale leaseback transaction of Company’s manufacturing facility in Union City, Indiana (the “Sale Leaseback”) has not been consummated and
(ii) $4.0 million if the Sale Leaseback has been consummated, subject to certain conditions. The 2024 Notes also contain customary events of default.

Under certain circumstances, including a change of control, the holder may cause us to redeem all or a portion of the then-outstanding amount of principal and interest on any 2024 Notes in cash at the greater of (i) the face value of the amount of 2024 Notes to be redeemed at a 25% premium (or at a 75% premium, if certain redemption conditions are not satisfied or during the occurrence and continuance of an event of default), (ii) the equity value of our Common Stock underlying such amount of 2024 Notes to be redeemed and (iii) the equity value of the change of control consideration payable to the holder of our Common Stock underlying such 2024 Notes.

In addition, during an event of default, the holder may require us to redeem in cash all, or any portion, of any outstanding 2024 Notes at the greater of (i) the face value of our Common Stock underlying such 2024 Notes at a 75% premium and (ii) the equity value of our Common Stock underlying such 2024 Notes. In addition, during a bankruptcy event of default, we shall immediately redeem in cash all amounts due under the 2024 Notes at a 75% premium unless the holder of such 2024 Notes waives such right to receive payment. Further, upon the sale of certain assets, the holder may cause a redemption at a premium, including upon consummation of the Sale Leaseback if the redemption conditions are not satisfied. The 2024 Notes also provide for purchase and participation rights in the event of a dividend or other purchase right being granted to the holders of Common Stock.

As of September 30, 2024, the contractual principal balance of the 2024 Notes was $9.4 million and the fair value was $13.2 million. During the three months ended September 30, 2024, the Investor converted $8.5 million of principal into Common Stock and we recorded a $5.3 million fair value net loss in Interest income (expense), net in the Condensed Consolidated Statements of Operations. During the nine months ended, September 30, 2024 the Investor converted 2024 Notes in the principal amount of $22.9 million into Common Stock and we recorded a $8.9 million fair value net loss in Interest income (expense), net in the Condensed Consolidated Statements of Operations. No fair value adjustments related to the 2024 Notes attributable to changes in credit risk were recorded during the three and nine months ended September 30, 2024. Going forward, any future fair value adjustments attributable to changes in credit risk will be recorded in Other comprehensive loss.

The September 30, 2024 estimated fair value of the 2024 Notes totaled $13.2 million. The fair value was computed using a Monte Carlo Simulation Model which incorporates significant inputs that are not observable in the market, and thus represents a Level 3 fair value measurement. The unobservable inputs utilized for measuring the fair value of the 2024 Notes reflect our assumptions about the assumptions that market participants would use in valuing the 2024 Notes as of the issuance date and subsequent reporting period.

We determined the fair value by using the following key inputs to the Monte Carlo Simulation Model:
Issuance DateMarch 15, 2024
Maturity DateMarch 15, 2025
Principal Balance as of the Valuation Date$9,000,000 
Risk-Free Rate (Annual)5.3 %
Corporate Bond Yield15.8 %
Volatility (Annual)85.0 %
Issuance DateMay 10, 2024
Maturity DateMay 10, 2025
Principal Balance as of the Valuation Date$6,285,714 
Risk-Free Rate (Annual)5.3 %
Corporate Bond Yield15.6 %
Volatility (Annual)95.0 %
Issuance DateMay 29, 2024
Maturity DateMay 29, 2025
Principal Balance as of the Valuation Date$7,000,000 
Risk-Free Rate (Annual)5.3 %
Corporate Bond Yield15.6 %
Volatility (Annual)90.0 %
Issuance DateJuly 18, 2024
Maturity DateJuly 18, 2025
Principal Balance as of the Valuation Date$4,000,000 
Risk-Free Rate (Annual)4.8 %
Corporate Bond Yield17.4 %
Volatility (Annual)80.0 %
Issuance DateAugust 23, 2024
Maturity DateAugust 23, 2025
Principal Balance as of the Valuation Date$2,600,000 
Risk-Free Rate (Annual)4.3 %
Corporate Bond Yield17.8 %
Volatility (Annual)90.0 %
Issuance Date
September 30, 2024
Maturity Date
September 30, 2025
Principal Balance as of the Valuation Date
$3,400,000 
Risk-Free Rate (Annual)
3.9 %
Corporate Bond Yield
15.9 %
Volatility (Annual)
100.0 %

As of September 30, 2024, the Company was in compliance with the debt terms and associated covenants under the 2024 Notes. As of November 18, 2024, $5.4 million in aggregate principal amount remained outstanding under the 2024 Notes.
2024 Warrants

The Investor has a purchase right that allows the Investor to participate in transactions in which the Company issues or sells certain securities or other property to holders of Common Stock, allowing the Investor to acquire, on the terms and conditions applicable to such purchase rights, the aggregate purchase rights which the Investor would have been able to acquire if the Investor held the number of shares of Common Stock acquirable upon exercise of the 2024 Warrants.

In the event of a Fundamental Transaction (as defined in the 2024 Warrants) that is not a change of control or corporate event as described in the 2024 Warrants, the surviving entity would be required to assume the Company’s obligations under the 2024 Warrants. In addition, if the Company engages in certain transactions that result in the holders of the Common Stock receiving consideration, a holder of the 2024 Warrants will have the option to either (i) exercise the 2024 Warrants prior to the consummation of such transaction and receive the consideration to be issued or distributed in connection with such transaction or (ii) cause the Company to repurchase the 2024 Warrants for its then Black Scholes Value (as defined in the 2024 Warrants).
Warrants Exercisable

During the three and nine months ended September 30, 2024, the Company issued 2024 Warrants to purchase 10.1 million and 15.6 million shares of Common Stock respectively at an exercise price ranging from $1.11 to $7.00 per share (following adjustment in connection with the Company’s Reverse Split). As of September 30, 2024, no shares have been issued pursuant to
the 2024 Warrants. In connection with the October 16, 2024 limited waiver to the 2024 Securities Purchase Agreement (the “Waiver”), the Investor agreed to waive its right to receive warrants in connection with future 2024 Notes issuances up to $14.8 million.

The September 30, 2024 estimated fair value of the 2024 Warrants as of each respective issuance date totaled $7.2 million. During the three and nine months ended September 30, 2024, we recorded a $2.6 million and $7.1 million net fair value loss, respectively, in the Condensed Consolidated Statements of Operations related to the 2024 Warrants. The fair value of the 2024 Warrants was measured using the Black Scholes model approach.


Significant inputs to the model at each respective issuance date and September 30, 2024 were as follows:
Valuation AssumptionsSeptember 30, 2024Initial Recognition on March 15, 2024
Fair Value $688,611 $4,749,754 
Stock Price$0.87$5.32
Strike Price$7.0000$7.0000
Volatility (annual)75.0%45.0%
Risk-Free Rate3.7%4.2%
Estimated time to expiration (years)9.5010
Dividend Yield0.0%0.0%
Valuation AssumptionsSeptember 30, 2024Initial Recognition on May 10, 2024
Fair Value $758,360 $3,706,121 
Stock Price$0.87$3.60
Strike Price$5.8860$5.8860
Volatility (annual)70.0%50.0%
Risk-Free Rate3.7%4.4%
Estimated time to expiration (years)9.610
Dividend Yield0.0%0.0%
Valuation AssumptionsSeptember 30, 2024Initial Recognition on May 29, 2024
Fair Value $849,041 $4,099,389 
Stock Price$0.87$3.80
Strike Price$5.8880$5.8880
Volatility (annual)70.0%45.0%
Risk-Free Rate3.7%4.5%
Estimated time to expiration (years)9.710
Dividend Yield0.0%0.0%
Valuation AssumptionsSeptember 30, 2024
Initial Recognition on July 18, 2024
Fair Value$1,296,378 $2,901,545 
Stock Price$0.87$1.89
Strike Price$2.9300$2.9300
Volatility (annual)65.0%50.0%
Risk-Free Rate3.7%4.1%
Estimated time to expiration (years)9.810
Dividend Yield0.0%0.0%
Valuation AssumptionsSeptember 30, 2024
Initial Recognition on August 24, 2024
Fair Value$1,384,743 $1,200,626 
Stock Price$0.87$0.78
Strike Price$1.1100$1.1100
Volatility (annual)45.0%45.0%
Risk-Free Rate3.7%3.7%
Estimated time to expiration (years)9.910
Dividend Yield0.0%0.0%
Valuation AssumptionsSeptember 30, 2024
Initial Recognition on September 30, 2024
Fair Value$2,252,786 $2,252,786 
Stock Price$0.87$0.87
Strike Price$1.2700$1.2700
Volatility (annual)50.0%50.0%
Risk-Free Rate3.7%3.7%
Estimated time to expiration (years)1010
Dividend Yield0.0%0.0%
The Company determines the accounting classification of warrants it issues as either liability or equity classified by first assessing whether the warrants meet liability classification in accordance with ASC 480-10, Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity (“ASC 480”), then in accordance with ASC 815-40 (“ASC 815”), Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock. In order for a warrant to be classified in stockholders’ equity (deficit), the warrant must be (i) indexed to the Company’s equity and (ii) meet the conditions for equity classification.

If a warrant does not meet the conditions for stockholders’ equity (deficit) classification, it is carried in the Condensed Consolidated Balance Sheets as a warrant liability measured at fair value, with subsequent changes in the fair value of the warrant recorded in other non-operating losses (gains) in the Consolidated Statements of Operations. If a warrant meets both conditions for equity classification, the warrant is initially recorded, at its relative fair value on the date of issuance, in stockholders’ equity (deficit) in the Condensed Consolidated Balance Sheets, and the amount initially recorded is not subsequently remeasured at fair value.
2023 Securities Purchase Agreement (Green Senior Convertible Notes Due 2026)
On December 12, 2023, the Company entered into a securities purchase agreement (the “2023 Securities Purchase Agreement”) under which the Company issued, pursuant to the Base Indenture and a First Supplemental Indenture between the Company and the Trustee, $20.0 million principal amount of green senior convertible notes (the “2026 Notes”) due October 1, 2026. The 2026 Notes were a senior secured obligation of the Company and ranked senior to all unsecured debt of the Company. The 2026 Notes were guaranteed by all the Company’s current subsidiaries and were secured by substantially all the assets of the Company and its subsidiaries. The 2026 Notes were issued with an original issue discount of 12.5%.
The Company paid fees in connection with the issuance of the 2026 Notes of $0.6 million, resulting in net proceeds of $16.9 million. We have elected to account for the 2026 Notes using the fair value option under GAAP. All direct costs related to the issuance of our convertible notes were recognized in Interest income (expense), net in the Consolidated Statements of Operations for the year ended December 31, 2023.
During the first quarter of 2024, the Company repaid the 2026 Notes in full.
Warrants Under the 2023 Securities Purchase Agreement
On December 12, 2023, as part of the 2023 Securities Purchase Agreement, the Company issued warrants (the “2023 Warrants”) to purchase 25.6 million** shares of Common Stock at an exercise price of $8.984 per share**.
The fair value of the components of the 2023 Securities Purchase Agreement was allocated between the 2026 Notes and the 2023 Warrants. As of December 31, 2023, the fair value of the 2023 Warrants was $5.6 million. During the six months ended June 30, 2024, in connection with a First Amendment to Green Senior Secured Convertible Note Due 2026, the Company entered into an agreement to exchange the 2023 Warrants for a total of 0.4 million shares of Common Stock for a total value of $2.8 million, whereupon the 2023 Warrant was cancelled. The Company recorded a gain in the quarter ended March 31, 2024 of $2.7 million in connection with this exchange in Interest income (expense), net in the Condensed Consolidated Statements of Operations related to the 2023 Warrants. The transaction occurred in the quarter ended March 30, 2024.
** Prior periods presented have been adjusted to reflect the 1-for-20 reverse stock split which was effective on June 17, 2024. Additional information regarding the reverse stock split may be found in Note 1 Summary of Business and Significant Accounting Principles
v3.24.3
LEASES
 9 Months Ended
Sep. 30, 2024
Leases [Abstract]  
LEASES LEASES
We have entered into various operating and finance lease agreements for offices, manufacturing and warehouse facilities. We determine if an arrangement is a lease, or contains a lease provision, at inception and record the leases in our financial statements upon lease commencement, which is the date when the underlying asset is made available for our use by the lessor.
We have elected not to record in the Condensed Consolidated Balance Sheets leases with a lease term of 12 months or less at lease inception that do not contain a purchase option or renewal term provision we are reasonably certain to exercise. All other lease right-of-use assets and lease liabilities are recognized based on the present value of lease payments over the lease term at commencement date. Because most of our leases do not provide an implicit rate of return, we used our incremental borrowing rate based on the information available at lease commencement date in determining the present value of lease payments.
Our leases may include options to extend the lease term for up to 5 years. Some of our leases also include options to terminate the lease prior to the end of the agreed upon lease term. For the purpose of calculating lease liabilities, lease terms include options to extend or terminate the lease when it is reasonably certain we will exercise such options.

Lease expense for operating leases is recognized on a straight-line basis over the lease term as either cost of sales or operating expenses depending on the nature of the leased asset. In connection with the Aero Divestiture, we entered into an agreement for an operating lease associated with the Aero business whereby the buyer agreed to reimburse the Company for the monthly operating lease payment of approximately $52,000 per month. In connection with the Waiver, we agreed to waive the buyer’s obligation to reimburse these amounts going forward and, accordingly, we will not realize these savings in future periods through the remaining term of the lease.
Three Months Ended
September 30,		Nine Months Ended
September 30,
2024202320242023
Short-term lease expense$63,428 $74,058 $200,858 $200,733 
Operating lease expense385,933 614,060 1,750,431 1,754,557 
Total lease expense$449,361 $688,118 $1,951,289 $1,955,290 
The Company was reimbursed by the buyer of the Aero business for operating lease payments of $156,927 and $210,136 for the three and nine months ended September 30, 2024, respectively.
Lease right-of-use assets consisted of the following:
September 30, 2024December 31, 2023
Operating leases$3,465,637 $4,174,800 
Finance leases5,470,933 5,621,181 
Total lease right-of-use assets$8,936,570 $9,795,981 

Lease liabilities consisted of the following:
September 30, 2024December 31, 2023
Operating lease liabilities, current$1,001,120 $1,012,428 
Finance lease liabilities, current2,100,635 2,548,184 
Operating lease liabilities, long term4,556,738 5,280,526 
Total Lease Liabilities$7,658,493 $8,841,138 
LEASES LEASES
We have entered into various operating and finance lease agreements for offices, manufacturing and warehouse facilities. We determine if an arrangement is a lease, or contains a lease provision, at inception and record the leases in our financial statements upon lease commencement, which is the date when the underlying asset is made available for our use by the lessor.
We have elected not to record in the Condensed Consolidated Balance Sheets leases with a lease term of 12 months or less at lease inception that do not contain a purchase option or renewal term provision we are reasonably certain to exercise. All other lease right-of-use assets and lease liabilities are recognized based on the present value of lease payments over the lease term at commencement date. Because most of our leases do not provide an implicit rate of return, we used our incremental borrowing rate based on the information available at lease commencement date in determining the present value of lease payments.
Our leases may include options to extend the lease term for up to 5 years. Some of our leases also include options to terminate the lease prior to the end of the agreed upon lease term. For the purpose of calculating lease liabilities, lease terms include options to extend or terminate the lease when it is reasonably certain we will exercise such options.

Lease expense for operating leases is recognized on a straight-line basis over the lease term as either cost of sales or operating expenses depending on the nature of the leased asset. In connection with the Aero Divestiture, we entered into an agreement for an operating lease associated with the Aero business whereby the buyer agreed to reimburse the Company for the monthly operating lease payment of approximately $52,000 per month. In connection with the Waiver, we agreed to waive the buyer’s obligation to reimburse these amounts going forward and, accordingly, we will not realize these savings in future periods through the remaining term of the lease.
Three Months Ended
September 30,		Nine Months Ended
September 30,
2024202320242023
Short-term lease expense$63,428 $74,058 $200,858 $200,733 
Operating lease expense385,933 614,060 1,750,431 1,754,557 
Total lease expense$449,361 $688,118 $1,951,289 $1,955,290 
The Company was reimbursed by the buyer of the Aero business for operating lease payments of $156,927 and $210,136 for the three and nine months ended September 30, 2024, respectively.
Lease right-of-use assets consisted of the following:
September 30, 2024December 31, 2023
Operating leases$3,465,637 $4,174,800 
Finance leases5,470,933 5,621,181 
Total lease right-of-use assets$8,936,570 $9,795,981 

Lease liabilities consisted of the following:
September 30, 2024December 31, 2023
Operating lease liabilities, current$1,001,120 $1,012,428 
Finance lease liabilities, current2,100,635 2,548,184 
Operating lease liabilities, long term4,556,738 5,280,526 
Total Lease Liabilities$7,658,493 $8,841,138 
v3.24.3
FAIR VALUE MEASUREMENTS
 9 Months Ended
Sep. 30, 2024
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS FAIR VALUE MEASUREMENTS
We estimate the fair value of the 2024 Notes, 2024 Warrants, 2026 Notes and 2023 Warrants using commonly accepted valuation methodologies upon issuance and at each reporting date. Considerable judgment was required in interpreting market data to develop the estimates of fair value. Accordingly, the Company’s estimates are not necessarily indicative of the amounts that the Company, or holders of the instruments, could realize in a current market exchange. Significant assumptions used in the fair value model included estimates of the redemption dates, credit spreads and the market price and volatility of the Company’s Common Stock. The use of different assumptions and/or estimation methodologies could have a material effect on the estimated fair values. The following table presents the estimated fair values:
September 30, 2024December 31, 2023
Fair ValueLevel 1Level 2Level 3Fair ValueLevel 1Level 2Level 3
Warrant liability$7,229,919 $— $— $7,229,919 $5,605,325 $— $— $5,605,325 
Convertible notes$13,182,467 $— $— $13,182,467 $20,180,100 $— $— $20,180,100 
v3.24.3
STOCK-BASED COMPENSATION
 9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION STOCK-BASED COMPENSATION
We maintain, as approved by the board of directors and the stockholders, the 2017 Incentive Stock Plan, the 2019 Incentive Stock Plan, and 2023 Long-Term Incentive Plan (collectively, the “Plans”) providing for the issuance of stock-based awards to employees, officers, directors or consultants of the Company. Non-qualified stock options may only be granted with an exercise price equal to the market value of our Common Stock on the grant date. Shares reserved for stock awards under the plans total 17.5 million. Total shares remaining available for stock incentive grants under the Plans totaled approximately 3.0 million as of September 30, 2024. We have granted stock options, restricted stock awards (“RSAs”), restricted stock units (“RSUs”), and performance share units (“PSUs”) under the Plans.
On June 17, 2024, the Company effected the Reverse Split. The authorized number of shares of Common Stock was not affected by the Reverse Split.
The Company adjusted the exercise price, number of shares issuable on exercise or vesting and/or other terms of its outstanding stock options, warrants, restricted stock, and restricted stock units to reflect the effects of the Reverse Split. The number of shares of Common Stock available for issuance under the Company’s equity incentive plans was not affected.

Stock-based compensation expense
The following table summarizes stock-based compensation expense for the periods indicated:

Three Months Ended
September 30,		Nine Months Ended
September 30,
2024202320242023
Stock options$167,700 $244,887 $652,168 $727,996 
Restricted stock awards1,459,282 2,385,352 5,333,433 6,952,424 
Restricted stock units(38,075)— 101,601 — 
Performance-based restricted stock awards351,349 890,166 2,119,471 2,641,470 
Total stock-based compensation expense$1,940,256 $3,520,405 $8,206,673 $10,321,890 

Stock options
A summary of stock option activity for the nine months ended September 30, 2024 is as follows:

Number of OptionsWeighted
Average
Exercise Price
per Option		Weighted
Average
Remaining
Contractual Life
(Years)
Balance, December 31, 202314,822 $205.4 8.0
Exercised— — — 
Balance, September 30, 202414,822 $205.4 7.25
Number of options exercisable at September 30, 2024
14,822 $205.4 7.25

As of September 30, 2024, unrecognized compensation expense was $0.0 for unvested options which is expected to be recognized over the next 0 years.

Restricted stock awards
A summary of restricted stock award activity for the nine months ended September 30, 2024 is as follows:

Number of Unvested Shares Weighted Average Grant Date Fair Value per Share
Balance, December 31, 2023256,416 $52.3 
Granted— — 
Vested(105,793)66.6 
Forfeited(23,595)48.3
Balance, September 30, 2024127,028 $41.1 
As of September 30, 2024, unrecognized compensation expense was $2.7 million for unvested restricted stock awards which is expected to be recognized over the next 1 year.

Restricted stock units
A summary of restricted stock unit activity for the nine months ended September 30, 2024 is as follows:

Number of Unvested Shares Weighted Average Grant Date Fair Value per Share
Balance, December 31, 2023— $— 
Granted759,120 6.34 
Vested(98,582)6.34 
Forfeited(83,067)6.34 
Balance, September 30, 2024577,471  

As of September 30, 2024, unrecognized compensation expense was $0.4 million for unvested restricted stock units which is expected to be recognized over the next 2.4 years.


Performance share units

As of September 30, 2024, the number of unvested PSUs was 0.7 million. The vesting of PSUs is conditioned upon achievement of certain performance objectives over a performance period ending December 31, 2024, 2025 and 2026 as defined in each award agreement. For the PSUs issued in 2022 and 2023 with a performance period ending December 31, 2024 and 2025, fifty percent of the PSUs vest based upon the Company’s total shareholder return as compared to a group of peer companies (“TSR PSUs”), and fifty percent of the PSUs vest based upon our performance on certain measures including a cumulative adjusted EBITDA target (“EBITDA PSUs”). For the PSUs issued in 2024 with a performance period ending December 31, 2026, one hundred percent of the PSUs vest based upon our performance on a cumulative revenue target (“Revenue PSUs”). Depending on the actual achievement on the performance objectives, the grantee may earn between 0% and 200% of the target PSUs.

A summary of the activity for PSU awards with total shareholder return performance objectives for the nine months ended September 30, 2024 is as follows:
Number of Unvested SharesWeighted Average Grant Date Fair Value per Share
Balance, December 31, 202383,598 $88.00 
Granted— — 
Forfeited(7,772)63.67
Balance, September 30, 2024
75,826 $90.77 
As of September 30, 2024, unrecognized compensation expense was $1.3 million performance measures are expected to be met and vest and be recognized over the next 0.7 years.

A summary of the PSU awards with cumulative adjusted EBITDA targets for the nine months ended September 30, 2024 is as follows:
Number of Unvested Shares
Balance, December 31, 202368,288 
Granted— 
Forfeited(7,772)
Balance, September 30, 2024
60,516 
The fair value of PSUs is calculated based on the stock price on the date of grant. The stock-based compensation expense recognized each period is dependent upon our estimate of the number of shares that will ultimately vest based on the achievement of EBITDA-based performance conditions. Future stock-based compensation expense for unvested EBITDA PSUs will be based on the fair value of the awards as of the grant date. During the quarter ended September 30, 2024, we recorded an expense of $0.1 million related to unvested 2022 issued EBITDA PSUs. This expense reflects the fair value of the EBITDA PSUs that is expected to vest based on the achievement of the established performance targets. The future stock-based compensation expense for the 2023 issued unvested revenue PSUs will be based on the fair value of the awards as of the grant date which has not yet occurred, as the cumulative adjusted EBITDA target condition is not yet defined.
As of September 30, 2024, there were no PSU awards expensed as cumulative revenue targets have yet to be determined. The stock-based compensation expense recognized each period is dependent upon our estimate of the number of shares that will ultimately vest based on the achievement of revenue-based performance conditions. Future stock-based compensation expense for unvested revenue PSUs will be based on the fair value of the awards as of the grant date, which has not yet occurred, as the cumulative adjusted revenue target condition is not yet defined.
v3.24.3
STOCKHOLDERS' EQUITY
 9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
STOCKHOLDERS' EQUITY STOCKHOLDERS’ EQUITY
Common Stock
We have one class of Common Stock, par value $0.001 per share. Each share of our Common Stock is entitled to one vote on all matters submitted to stockholders. The Company effected the Reverse Stock Split of the Company’s then issued and outstanding shares of Common Stock. The Reverse Stock Split did not affect the number of authorized shares of Common Stock for issuance, and, as of September 30, 2024, our authorized shares of Common Stock for issuance was 450.0 million with a par value $0.001 per share.
At-The-Market Sales Agreement
On March 10, 2022, we established an at-the-market equity program (the “ATM Program”). Under the ATM Program, we may offer and sell shares of our Common Stock having an aggregate sales price of up to $175.0 million.
During the three months ended September 30, 2024 no shares were issued under the ATM Program and during the nine months ended September 30, 2024, we issued 0.5 million shares under the ATM Program for net proceeds of $2.7 million. The remaining aggregate sales available under the ATM Program is $95.6 million as of September 30, 2024. Certain of our other existing financing arrangements place certain conditions and restrictions on the use of our ATM Program.
Equity Line of Credit
On December 12, 2023, the Company entered into an equity line of credit purchase agreement (the “ELOC Purchase Agreement”) with Lincoln Park Capital Fund, LLC (the “Purchaser”) which provides that, upon the terms and subject to the conditions and limitations set forth therein, the Company may sell to the Purchaser up to $50.0 million of shares of Common Stock over the 24-month term of the ELOC Purchase Agreement.
In connection with the ELOC Purchase Agreement, the Company paid a non-cash commitment fee to the Purchaser in the amount of 188,755 shares of Common Stock of the Company (valued at $1.5 million). The Company reflected the commitment fee as an expense in Interest expense in the consolidated statements of operations based on the fair value on the issuance date. Under applicable rules of the Nasdaq Capital Market, the Company cannot issue or sell more than 19.99% of the shares of Common Stock outstanding immediately prior to the execution of the ELOC Purchase Agreement to the Purchaser under the
ELOC Purchase Agreement without stockholder approval. During nine months ended September 30, 2024, the Company sold 600,000 shares of common stock at prices ranging between $4.42 and $6.86 pursuant to the ELOC Purchase Agreement and received proceeds of $3.1 million. This activity occurred in the quarter ended March 31, 2024. The Company’s other financing arrangements substantially limit our ability to use the ELOC Purchase Agreement in the future.
The Company evaluated the contract that includes the right to require the Purchaser to purchase shares of common stock in the future (“purchased put right”) considering the guidance in ASC 815-40, “Derivatives and Hedging - Contracts on an Entity’s Own Equity” (“ASC 815-40”) and concluded that it is an equity-linked contract that does not qualify for equity classification, and therefore requires fair value accounting as a derivative asset. The Company has analyzed the terms of the freestanding purchased put right and has concluded that it had insignificant value as of September 30, 2024.
Preferred Stock
Workhorse has authorized 75.0 million shares of Series A Preferred Stock, par value $0.001 per share. Our certificate of incorporation provides that shares of preferred stock may be issued from time to time in one or more series. Our Board of Directors is authorized to fix the voting rights, if any, designations, powers, preferences, qualification, limitations and restrictions thereof, applicable to the shares of preferred stock. As of September 30, 2024, there were no shares of Series A Preferred Stock issued and outstanding.
Warrants
In connection with the issuance of debt and Common Stock, we issued equity-classified warrants to purchase shares of our Common Stock. As of September 30, 2024 there were approximately 15.6 million 2024 Warrants outstanding.
v3.24.3
INCOME TAXES
 9 Months Ended
Sep. 30, 2024
Income Tax Disclosure [Abstract]  
INCOME TAXES INCOME TAXES
As of September 30, 2024 and December 31, 2023, our deferred tax liability was zero. Cumulative deferred tax assets are fully reserved as there is not sufficient evidence to conclude it is more likely than not the deferred tax assets are realizable. No current liability for federal or state income taxes has been included in these Condensed Consolidated Financial Statements due to the loss for the periods.
v3.24.3
LOSS PER SHARE
 9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
LOSS PER SHARE LOSS PER SHARE
Basic loss per share of Common Stock is calculated by dividing net loss by the weighted-average shares outstanding for the period. Potentially dilutive shares, which are based on the weighted-average shares of Common Stock underlying outstanding stock-based awards and warrants using the treasury stock method, and convertible notes using the if-converted method, are included when calculating the diluted net loss per share of Common Stock when their effect is dilutive.

The following table presents the potentially dilutive shares that were excluded from the computation of diluted net loss per share of Common Stock, because their effect was anti-dilutive:

Three Months Ended
September 30,		Nine Months Ended
September 30,
20242023*20242023*
Stock-based awards and warrants16,548,518 504,707 16,548,518 504,707 
Convertible notes10,812,454 — 10,812,454 — 
* Prior periods presented have been adjusted to reflect the 1-for-20 reverse stock split effective on June 17, 2024.
v3.24.3
RECENT ACCOUNTING PRONOUNCEMENTS
 9 Months Ended
Sep. 30, 2024
Accounting Changes and Error Corrections [Abstract]  
RECENT ACCOUNTING PRONOUNCEMENTS RECENT ACCOUNTING PRONOUNCEMENTS
Accounting Standards and Pronouncements Recently Adopted
There are no accounting standards or pronouncements recently adopted impacting the Company.
Accounting Standards and Pronouncements Not Yet Adopted
ASU 2023-07, Segment Reporting - Improvements to Reportable Segment Disclosures. In November 2023, the FASB issued ASU 2023-07 related to disclosures about a public entity’s reportable segments and provides more detailed information about a reportable segment’s expenses. The new standard is effective for fiscal years beginning after December 15, 2023 and interim periods beginning after December 15, 2024, with retrospective application required. We are assessing the effect on our annual consolidated financial statement disclosures; however, adoption will not impact our consolidated balance sheets or statements of operations.
ASU 2023-09, Improvements to Income Tax Disclosures. In December 2023, the FASB issued ASU 2023-09 to enhance the transparency and decision usefulness of income tax disclosures. The new standard is effective for fiscal years beginning after December 15, 2024, with retrospective application permitted. We are assessing the effect on our annual consolidated financial statement disclosures; however, adoption will not impact our consolidated balance sheets or statements of operations.
All other ASUs issued but not yet adopted were assessed and determined to be not applicable or are not expected to have a material impact on our Consolidated Financial Statements or Financial Statement Disclosures.
v3.24.3
COMMITMENTS AND CONTINGENCIES
 9 Months Ended
Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES
General Matters

The Company is party to various negotiations and legal proceedings arising in the normal course of business. The Company provides reserves for these matters when a loss is probable and reasonably estimable. The Company does not disclose a range of potential loss because the likelihood of such a loss is remote. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on the Company’s financial position, results of operations, cash flows or liquidity.

Legal Proceedings

CSI Litigation

On April 19, 2024, Coulomb Solutions Inc. (“CSI”), a supplier to the Company of certain of the batteries used in its trucks, filed a complaint against the Company in United States District Court for the Eastern District of Michigan (Case No. 2:24-cv-11048). In its complaint, CSI asserts two claims – a breach of contract claim and an alternative unjust enrichment claim – that are both based upon Workhorse’s alleged failure to pay amounts due under several invoices. CSI seeks to recover damages in excess of $4 million, including alleged past due amounts, interest, and collection costs. Workhorse filed its answer to the complaint on June 4, 2024. The parties are currently conducting discovery. The Company has accrued for these appropriate amounts as of September 30, 2024.
v3.24.3
SUBSEQUENT EVENTS
 9 Months Ended
Sep. 30, 2024
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS SUBSEQUENT EVENTS 
The Company has evaluated subsequent events for potential recognition and disclosures through the date the accompanying Condensed Consolidated Financial Statements were filed.

Nasdaq Delisting Notice

On October 2, 2024, the Company received a written notice from Nasdaq indicating that the Company was no longer in compliance with the $1.00 minimum bid price requirement. The Company has been provided with a compliance period of 180 calendar days, or until March 31, 2025, to regain compliance with the bid price requirement. If the Company does not regain compliance by March 31, 2025, the Company may be eligible for an additional grace period, subject to certain conditions.
The Company is currently evaluating various courses of action to regain compliance. There can be no assurance that the Company will regain compliance with the bid price requirement during the 180-day compliance period ending March 31, 2025, secure an extension of the compliance period beyond March 31, 2025 or maintain compliance with any other Nasdaq listing requirement.

2024 Securities Purchase Agreement
Pursuant to the 2024 Securities Purchase Agreement, on October 16, 2024, the Company issued and sold to the Investor a (i) 2024 Notes in the original principal amount of $1.2 million (the "Sixth Additional Note”). The Investor has waived its right to receive 2024 Warrants in connection with the Sixth Additional Note.

The issuance and sale of the Sixth Additional Note was made in connection with, and were conditioned upon, the Waiver of certain provisions of the 2024 Securities Purchase Agreement affecting the 2024 Notes and the 2024 Warrants and a related amendment to the asset purchase agreement pursuant to which the Company made its previously disclosed divestiture of its Aero business (the “Aero APA”). Pursuant to the Waiver and related amendment: (i) the Investor waived its right to receive Warrants in connection with the issuance and sale of the Sixth Additional Note, (ii) the Investor waived its right to receive Warrants in connection with the issuance and sale, if any, of additional 2024 Notes in the aggregate principal amount of up to $14.8 million, (iii) for the period commencing on October 16, 2024 and ending on and including October 16, 2025, the Investor has waived certain provisions of the 2024 Securities Purchase Agreement to permit the Company to sell up to $5.0 million in shares of Common Stock pursuant to an at-the-market offering program without a price floor and without application of certain anti-dilution and participation provisions in the 2024 Notes and the 2024 Warrants, and (iv) the Company waived the obligation of an affiliate of the Investor to make certain ongoing lease payments under the Aero APA.
v3.24.3
SUPPLEMENTAL CASH FLOW INFORMATION
 9 Months Ended
Sep. 30, 2024
Supplemental Cash Flow Elements [Abstract]  
SUPPLEMENTAL CASH FLOW INFORMATION SUPPLEMENTAL CASH FLOW INFORMATION 
During the nine months ended September 30, 2024, the Company repaid a portion of the 2024 Notes with a principal amount of $22.9 million through the issuance of 16.0 million shares of common stock. This transaction involved converting the debt into equity, which does not involve a cash outflow. However, this conversion resulted in an increase in shareholders' equity (deficit) and a reduction in long-term debt, which is reflected in the equity and liabilities sections of the Condensed Consolidated Balance Sheets.
v3.24.3
Pay vs Performance Disclosure - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Pay vs Performance Disclosure        
Net loss $ (25,135,559) $ (30,645,712) $ (80,611,346) $ (78,662,425)
v3.24.3
Insider Trading Arrangements
 3 Months Ended
Sep. 30, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.24.3
SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING PRINCIPLES (Policies)
 9 Months Ended
Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Overview
Overview

Workhorse Group Inc. (“Workhorse”, the “Company”, “we”, “us”, or “our”) is an American technology company with a vision to pioneer the transition to zero-emission commercial trucks. We design, develop, manufacture and sell fully electric trucks.
The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the SEC regarding interim financial reporting and include the accounts and operations of the Company and those of our wholly-owned subsidiaries. Accordingly, they do not include all of the information and footnotes required by GAAP for annual audited financial statements. All intercompany balances and transactions have been eliminated upon consolidation.
During the period, the Company identified that certain items in its prior year Condensed Consolidated Balance Sheets were presented as combined totals, including right-of-use (ROU) assets and lease liabilities related to operating and finance leases, accounts receivable and other receivables. The Company has reclassified these amounts to separately disclose the relevant components in the accompanying financial statements. These changes in presentation do not impact total assets, total liabilities, net income, or cash flows.
The Company has elected the fair value option for its convertible debt and associated warrants. This election was made to align the measurement of these financial instruments with their market values and simplify the accounting for the components. Changes in fair value are recognized in Interest income (loss) and Fair value adjustment (loss) on warrants, respectively in the Condensed Consolidated Statement of Operations.
Liquidity, Capital Resources, and Going Concern
Liquidity, Capital Resources, and Going Concern

The accompanying Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) applicable to a going concern. The going concern basis of presentation assumes that the Company will continue in operation one year after the date these Condensed Consolidated Financial Statements are issued and will be able to realize assets and discharge its liabilities and commitments in the normal course of business. The Condensed Consolidated Financial Statements do not include any adjustments to the carrying amounts and classification of assets, liabilities, and reported expenses that may be necessary if the Company were unable to continue as a going concern.

Pursuant to the requirements of the Financial Accounting Standard Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 205-40, Presentation of Financial Statements - Going Concern (“ASC 205-40”), management must evaluate whether there are conditions and events, considered in aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for one year after the date these Condensed Consolidated Financial Statements are issued. In accordance with ASC 205-40, management’s analysis can only include the potential mitigating impact of management’s plans that have not been fully implemented as of the issuance date if (a) it is probable that management’s plans will be effectively implemented on a timely basis, and (b) it is probable that the plans, when implemented, will alleviate the relevant conditions or events that raise substantial doubt about the Company’s ability to continue as a going concern.

We had sales of $4.7 million, incurred a net loss of $80.6 million and used $40.1 million of cash in operating activities during the nine months ended September 30, 2024. As of September 30, 2024, the Company had $3.2 million of cash and cash equivalents, net accounts receivable of $0.7 million, other receivables of $3.0 million, inventory, net of $43.2 million and accounts payable of $10.6 million. As of September 30, 2024, the Company had working capital of $7.9 million and an accumulated deficit of $832.2 million.

As a result of our recurring losses from operations, accumulated deficit, projected capital needs, and delays in bringing our trucks to market and lower than expected market demand, substantial doubt exists regarding our ability to continue as a going concern within one year after the issuance date of the accompanying Condensed Consolidated Financial Statements. Our ability to continue as a going concern is contingent upon successful execution of management’s intended plan over the next twelve months to improve the Company’s liquidity and working capital, which includes, but is not limited to:

•Generating revenue by increasing sales of our trucks and other services.
•Reducing expenses and limiting non-contracted capital expenditures.
•Raising capital to fund operations through the issuance of debt or equity securities, including through our 2024 Securities Purchase Agreement (as defined below) and our At-the-Market Sales Agreement (“ATM Agreement”), the sale of assets, or other strategic transactions.

It is essential that we have access to capital as we bring our existing line of trucks to market, scale up production and sales of such trucks and continue to develop additional variations of our existing trucks and our next generation of trucks. There is no assurance that we will be successful in implementing management’s plans to generate liquidity to fund these activities or other aspects of our short and long-term strategy, that our projections of our future capital needs will prove accurate or that any additional funding would be available or sufficient to continue operations in future periods.

To the extent revenues from operations are insufficient to meet our liquidity requirements, our ability to continue as a going concern will be dependent on effectively raising capital through private or public placement of our equity, debt and equity-linked securities, including the continued access to the additional closings of, as of November 18, 2024, up to $105.5 million in aggregate principal amount of additional 2024 Notes (as defined below) and, if our share price makes such exercise feasible, the possible receipt of proceeds from the exercise of the corresponding 2024 Warrants (as defined below) pursuant to the 2024 Securities Purchase Agreement (as defined below), and the continued use of the ATM Agreement, for which there can be no
assurance we will be successful in such efforts. We will also rely on other debt financing or other sources of capital funding such as through the sale of assets to obtain sufficient financial resources to fund our operating activities. If we are unable to maintain sufficient financial resources, our business, financial condition and results of operations, as well as our ability to continue to develop, produce and market our truck programs and satisfy our obligations as they become due, the Company will be materially and adversely affected. This could affect future truck program production and sales. Failure to obtain additional financing will have a material, adverse impact on our business operations. There can be no assurance that we will be able to obtain the financing needed to achieve our goals on acceptable terms or at all. Additionally, any equity or equity-linked financings would likely have a dilutive effect on the holdings of our existing stockholders. The Company’s current level of cash and cash equivalents are not sufficient to execute our business plan. For the foreseeable future, we will incur significant operating expenses, capital expenditures and working capital funding that will deplete our cash on hand. These conditions raise substantial doubt regarding the Company’s ability to continue as a going concern for a period of at least one year from the date of issuance of these Condensed Consolidated Financial Statements.

Our ability to obtain additional financing is extremely limited under current market conditions including the significant amount of capital required, the market price of our stock and potential dilution from the issuance of any additional securities and our ability to regain compliance with the listing requirements of the Nasdaq Capital Market. If we are unable to identify other sources of funding, we may need to further adjust our operations and seek protection by filing a voluntary petition for relief under the Bankruptcy Code. If this were to occur, the value available to our various stakeholders, including our creditors and stockholders, is uncertain and trading prices for our securities may bear little or no relationship to the actual recovery, if any, by holders of our securities in bankruptcy proceedings, if any.

Due to these uncertainties and continued delays in market adoption of commercial electric trucks, the Company identified a triggering event under ASC 360-35-21 that required further analysis and concluded that no impairment was required.
NASDAQ Listing Requirements and Reverse Stock Split
NASDAQ Listing Requirements and Reverse Stock Split

In order to regain compliance with the Listing Requirements of Nasdaq, on June 17, 2024, the Company effected a 1-for-20 reverse stock split (the “Reverse Split”) of the Company’s then issued and outstanding shares of common stock, par value $0.001 per share (the “Common Stock”). The authorized number of shares of Common Stock was not affected by the Reverse Split. The Company adjusted the exercise price, number of shares issuable on exercise or vesting and/or other terms of its outstanding stock options, warrants, restricted stock, and restricted stock units to reflect the effects of the Reverse Split. Prior periods presented have also been adjusted to reflect this change. On July 3, 2024, Nasdaq confirmed that we were in compliance with the Minimum Bid Requirement.

On October 2, 2024, the Company received a second written notice from Nasdaq indicating that the Company was no longer in compliance with the $1.00 minimum bid price requirement.

The Company has been provided with a compliance period of 180 calendar days, or until March 31, 2025, to regain compliance with the minimum bid price. If the Company does not regain compliance by March 31, 2025, the Company may be eligible for an additional grace period subject to certain conditions.

The Company is currently evaluating various courses of action to regain compliance. There can be no assurance that the Company will regain compliance with the bid price requirement during the 180-day compliance period ending March 31, 2025, secure an extension of the compliance period beyond March 31, 2025 or maintain compliance with any other Nasdaq listing requirement.

In addition, Nasdaq has recently adopted new rules and proposed new rules that could hinder our ability to cure our deficiency
and maintain the continued listing of our common stock. These new rules and rule proposals would provide for the immediate
delisting with no grace period of any listed company that falls out of compliance with the minimum bid price requirement twice
in a twelve-month period, provide for the immediate delisting if a listed company effects a reverse stock split that causes it to
fall out of compliance with certain other listing requirements, and limits the ratio of reverse stock splits to a cumulative ratio of
1-to-250 in any two-year period. Delisting would likely have an adverse effect on the liquidity of our common stock, decrease
the market price of our common stock, result in the potential loss of confidence by investors, suppliers, customers, and
employees, and fewer business development opportunities, and adversely affect our ability to obtain financing for our
continuing operations, including our ability to issue and sell additional notes to the investors party to the 2024 Securities Purchase Agreement or secure other future financing agreements.
Consolidation
In the opinion of our management, the unaudited Condensed Consolidated Financial Statements have been prepared on a basis consistent with the audited Consolidated Financial Statements and include all adjustments necessary for the fair presentation of Workhorse’s financial condition, results of operations and cash flows for the interim periods presented. Such adjustments are of a normal, recurring nature. The results of operations and cash flows for the interim periods presented may not necessarily be indicative of full-year results. Reference should be made to the financial statements contained in our 2023 Form 10-K.
Revenue Recognition
Revenue Recognition

The Company recognizes revenue in accordance with Accounting Standards Codification 606, Revenue from Contracts with Customers.

Revenue is recognized when the Company transfers promised goods or services to customers in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. In determining the appropriate amount of revenue to be recognized as the Company fulfills its obligations under the agreement, the Company performs the following steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including any constraints on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. The Company only applies the five-step model to contracts when it is probable that it will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer.

The Company generates revenue through the sale of electric trucks (Workhorse W4 CC, W56 and W750) as well as service and parts directly to dealership customers and route revenue from the Company’s Stables by Workhorse. The Company reviews the performance obligations in the Company’s agreements, which is the Company’s promise to transfer the Company’s product to customers based on the performance of services, transfer of title or shipping terms in the arrangement and any other variable considerations. The revenue is allocated based on the Company's performance obligation, and an estimate of Sales returns and allowances are recognized. The Company offers concessions to certain customers and estimates the variable consideration based on historical sales activity. In addition, the Company considers the extent to which revenue should be constrained such that there is not a significant reversal of revenue in the future. In the current quarter, the Company constrained approximately $1.1 million of revenue.

On or before shipment of the trucks, the Company bills its customers the total consideration of its obligations under the agreement. Consistent with industry practice, the Company generally offers customers a limited warranty for work performed
on the truck under the builds/sales contract. The customers do not have a contractual right of return. The Company only offers a limited warranty for the work performed on the truck. If a customer disputes any work performed, the Company will attempt to remedy the work, however, it shall not be required to discount the transaction price. The Company considers this an assurance-type warranty and not a separate performance obligation.

The Company's agreements do not allow customers to return products. However, under certain conditions, such as defects or non-compliance with specifications, or other allowances, the Company may elect to allow limited returns in special situations. To account for these returns, the Company estimates and records a sales returns allowance as a reduction of gross revenue. This allowance is based on historical return rates and expectations of future returns, adjusted for any known factors that may affect return rates, such as changes in product quality or customer mix.

The Company provides for the estimated cost of product warranties at the time revenue is recognized. While the Company engages in product quality programs and processes, including quality control test driving trucks, the warranty obligation is calculated by historical warranty costs per truck. Should actual costs differ from the Company’s estimates, revisions to increase or decrease the estimated warranty liability may be required.
Use of Estimates
Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses and related disclosures in the accompanying notes.
Recent Accounting Pronouncements RECENT ACCOUNTING PRONOUNCEMENTS
Accounting Standards and Pronouncements Recently Adopted
There are no accounting standards or pronouncements recently adopted impacting the Company.
Accounting Standards and Pronouncements Not Yet Adopted
ASU 2023-07, Segment Reporting - Improvements to Reportable Segment Disclosures. In November 2023, the FASB issued ASU 2023-07 related to disclosures about a public entity’s reportable segments and provides more detailed information about a reportable segment’s expenses. The new standard is effective for fiscal years beginning after December 15, 2023 and interim periods beginning after December 15, 2024, with retrospective application required. We are assessing the effect on our annual consolidated financial statement disclosures; however, adoption will not impact our consolidated balance sheets or statements of operations.
ASU 2023-09, Improvements to Income Tax Disclosures. In December 2023, the FASB issued ASU 2023-09 to enhance the transparency and decision usefulness of income tax disclosures. The new standard is effective for fiscal years beginning after December 15, 2024, with retrospective application permitted. We are assessing the effect on our annual consolidated financial statement disclosures; however, adoption will not impact our consolidated balance sheets or statements of operations.
All other ASUs issued but not yet adopted were assessed and determined to be not applicable or are not expected to have a material impact on our Consolidated Financial Statements or Financial Statement Disclosures.
v3.24.3
INVENTORY, NET (Tables)
 9 Months Ended
Sep. 30, 2024
Inventory Disclosure [Abstract]  
Schedule of Inventory, Net
Inventory, net consisted of the following:

September 30, 2024December 31, 2023
Raw materials$46,097,429 $32,682,324 
Work in process4,123,097 2,892,329 
Finished goods5,476,095 18,309,829 
55,696,621 53,884,482 
Less: inventory reserves(12,510,159)(8,476,290)
Inventory, net$43,186,462 $45,408,192 
v3.24.3
PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)
 9 Months Ended
Sep. 30, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Schedule of Prepaid and Other Current Assets
Prepaid expenses and other current assets consisted of the following:

September 30, 2024December 31, 2023
Prepaid purchases(1)
$6,824,168 $7,908,087 
Less: prepaid purchases reserve(2)
(1,943,969)(1,999,068)
Prepaid purchases, net4,880,199 5,909,019 
Prepaid insurance864,110 1,283,146 
Other1,613,529 908,997 
Prepaid expenses and other current assets$7,357,838 $8,101,162 

(1) Our prepaid purchases consist of deposits made to our suppliers for non-recurring production parts and engineering costs. As of September 30, 2024 and December 31, 2023, net prepaid purchases primarily consisted of deposits for direct materials associated with our W4 CC and W750 trucks. The decrease in prepaid purchases as of September 30, 2024 as compared to December 31, 2023 is primarily due to receipts of direct materials associated with our W4 CC and W750 trucks.
(2) We record reserves on prepaid purchases that are significantly aged and for balances specifically identified as having a carrying value in excess of net realizable value. The prepaid purchases reserve represents our best estimate of deposits on orders that we do not expect to recover.
v3.24.3
REVENUE (Tables)
 9 Months Ended
Sep. 30, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Sales Activity
The following table provides a summary of sales activity for the periods indicated:
Three Months Ended September 30,Nine Months Ended
September 30,
2024202320242023
Sales, net of returns and allowances$2,169,769 $2,570,250 $2,753,384 $7,292,417 
Other sales339,948 458,295 1,938,067 1,396,006 
Total sales, net of returns and allowances$2,509,717 $3,028,545 $4,691,451 $8,688,423 
v3.24.3
ACCRUED AND OTHER CURRENT LIABILITIES - (Tables)
 9 Months Ended
Sep. 30, 2024
Payables and Accruals [Abstract]  
Schedule of Accrued and Other Current liabilities
Accrued and other current liabilities consisted of the following:

September 30, 2024December 31, 2023
Compensation and related costs$3,935,226 $2,083,808 
Accrued interest114,438 — 
Sales returns and allowances
1,102,005 — 
Other
3,232,652 2,778,932 
Total accrued and other current liabilities$8,384,321 $4,862,740 
Schedule of Warranty Liability Activity
Accrued warranty liability activity consisted of the following for the periods indicated:

Three Months Ended
September 30,		Nine Months Ended
September 30,
2024202320242023
Warranty liability, beginning of period$642,326 $1,922,580 $1,902,647 $2,207,674 
Warranty costs incurred(61,611)(289,404)(189,904)(884,717)
Provision for warranty(1)
195,708 144,344 (936,320)454,563 
Warranty liability, end of period$776,423 $1,777,520 $776,423 $1,777,520 

(1) We record a warranty liability for the products sold by us, which includes our best estimate of the projected costs to repair or replace items under warranties and recalls if identified. The negative provision for warranty for the nine months ended September 30, 2024, is driven by the expiration of the warranty liability related to non-current truck models.
v3.24.3
DEBT (Tables)
 9 Months Ended
Sep. 30, 2024
Debt Disclosure [Abstract]  
Schedule of Fair Value, Liabilities Measured on a Recurring Basis
A reconciliation of the fair value of the convertible notes is as follows:
Nine Months Ended September 30, 2024
Fair value of convertible notes, beginning of period$20,180,100 
Fair value of convertible notes issued during period45,829,120 
Payments on convertible notes
(20,180,100)
Change in fair value of convertible notes (1)
(1,488,754)
Fair value of convertible notes exchanged for common stock(31,157,899)
Fair value of convertible notes, end of period$13,182,467 
(1) The Company recognizes changes in fair value of convertible notes for Common Stock in Interest income (expense), net in the Condensed Consolidated Statements of Operations. The negative provision for warranty for the nine months ended September 30, 2024, is driven by the expiration of the warranty liability related to non-current truck models.
Schedule of Fair Value Measurement Inputs
We determined the fair value by using the following key inputs to the Monte Carlo Simulation Model:
Issuance DateMarch 15, 2024
Maturity DateMarch 15, 2025
Principal Balance as of the Valuation Date$9,000,000 
Risk-Free Rate (Annual)5.3 %
Corporate Bond Yield15.8 %
Volatility (Annual)85.0 %
Issuance DateMay 10, 2024
Maturity DateMay 10, 2025
Principal Balance as of the Valuation Date$6,285,714 
Risk-Free Rate (Annual)5.3 %
Corporate Bond Yield15.6 %
Volatility (Annual)95.0 %
Issuance DateMay 29, 2024
Maturity DateMay 29, 2025
Principal Balance as of the Valuation Date$7,000,000 
Risk-Free Rate (Annual)5.3 %
Corporate Bond Yield15.6 %
Volatility (Annual)90.0 %
Issuance DateJuly 18, 2024
Maturity DateJuly 18, 2025
Principal Balance as of the Valuation Date$4,000,000 
Risk-Free Rate (Annual)4.8 %
Corporate Bond Yield17.4 %
Volatility (Annual)80.0 %
Issuance DateAugust 23, 2024
Maturity DateAugust 23, 2025
Principal Balance as of the Valuation Date$2,600,000 
Risk-Free Rate (Annual)4.3 %
Corporate Bond Yield17.8 %
Volatility (Annual)90.0 %
Issuance Date
September 30, 2024
Maturity Date
September 30, 2025
Principal Balance as of the Valuation Date
$3,400,000 
Risk-Free Rate (Annual)
3.9 %
Corporate Bond Yield
15.9 %
Volatility (Annual)
100.0 %
Significant inputs to the model at each respective issuance date and September 30, 2024 were as follows:
Valuation AssumptionsSeptember 30, 2024Initial Recognition on March 15, 2024
Fair Value $688,611 $4,749,754 
Stock Price$0.87$5.32
Strike Price$7.0000$7.0000
Volatility (annual)75.0%45.0%
Risk-Free Rate3.7%4.2%
Estimated time to expiration (years)9.5010
Dividend Yield0.0%0.0%
Valuation AssumptionsSeptember 30, 2024Initial Recognition on May 10, 2024
Fair Value $758,360 $3,706,121 
Stock Price$0.87$3.60
Strike Price$5.8860$5.8860
Volatility (annual)70.0%50.0%
Risk-Free Rate3.7%4.4%
Estimated time to expiration (years)9.610
Dividend Yield0.0%0.0%
Valuation AssumptionsSeptember 30, 2024Initial Recognition on May 29, 2024
Fair Value $849,041 $4,099,389 
Stock Price$0.87$3.80
Strike Price$5.8880$5.8880
Volatility (annual)70.0%45.0%
Risk-Free Rate3.7%4.5%
Estimated time to expiration (years)9.710
Dividend Yield0.0%0.0%
Valuation AssumptionsSeptember 30, 2024
Initial Recognition on July 18, 2024
Fair Value$1,296,378 $2,901,545 
Stock Price$0.87$1.89
Strike Price$2.9300$2.9300
Volatility (annual)65.0%50.0%
Risk-Free Rate3.7%4.1%
Estimated time to expiration (years)9.810
Dividend Yield0.0%0.0%
Valuation AssumptionsSeptember 30, 2024
Initial Recognition on August 24, 2024
Fair Value$1,384,743 $1,200,626 
Stock Price$0.87$0.78
Strike Price$1.1100$1.1100
Volatility (annual)45.0%45.0%
Risk-Free Rate3.7%3.7%
Estimated time to expiration (years)9.910
Dividend Yield0.0%0.0%
Valuation AssumptionsSeptember 30, 2024
Initial Recognition on September 30, 2024
Fair Value$2,252,786 $2,252,786 
Stock Price$0.87$0.87
Strike Price$1.2700$1.2700
Volatility (annual)50.0%50.0%
Risk-Free Rate3.7%3.7%
Estimated time to expiration (years)1010
Dividend Yield0.0%0.0%
v3.24.3
LEASES (Tables)
 9 Months Ended
Sep. 30, 2024
Leases [Abstract]  
Schedule of Lease, Cost
Lease expense for operating leases is recognized on a straight-line basis over the lease term as either cost of sales or operating expenses depending on the nature of the leased asset. In connection with the Aero Divestiture, we entered into an agreement for an operating lease associated with the Aero business whereby the buyer agreed to reimburse the Company for the monthly operating lease payment of approximately $52,000 per month. In connection with the Waiver, we agreed to waive the buyer’s obligation to reimburse these amounts going forward and, accordingly, we will not realize these savings in future periods through the remaining term of the lease.
Three Months Ended
September 30,		Nine Months Ended
September 30,
2024202320242023
Short-term lease expense$63,428 $74,058 $200,858 $200,733 
Operating lease expense385,933 614,060 1,750,431 1,754,557 
Total lease expense$449,361 $688,118 $1,951,289 $1,955,290 
Lease right-of-use assets consisted of the following:
September 30, 2024December 31, 2023
Operating leases$3,465,637 $4,174,800 
Finance leases5,470,933 5,621,181 
Total lease right-of-use assets$8,936,570 $9,795,981 
Schedule of Lease Liabilities
Lease liabilities consisted of the following:
September 30, 2024December 31, 2023
Operating lease liabilities, current$1,001,120 $1,012,428 
Finance lease liabilities, current2,100,635 2,548,184 
Operating lease liabilities, long term4,556,738 5,280,526 
Total Lease Liabilities$7,658,493 $8,841,138 
v3.24.3
FAIR VALUE MEASUREMENTS (Tables)
 9 Months Ended
Sep. 30, 2024
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis The use of different assumptions and/or estimation methodologies could have a material effect on the estimated fair values. The following table presents the estimated fair values:
September 30, 2024December 31, 2023
Fair ValueLevel 1Level 2Level 3Fair ValueLevel 1Level 2Level 3
Warrant liability$7,229,919 $— $— $7,229,919 $5,605,325 $— $— $5,605,325 
Convertible notes$13,182,467 $— $— $13,182,467 $20,180,100 $— $— $20,180,100 
v3.24.3
STOCK-BASED COMPENSATION - (Tables)
 9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Based Compensation Activity
The following table summarizes stock-based compensation expense for the periods indicated:

Three Months Ended
September 30,		Nine Months Ended
September 30,
2024202320242023
Stock options$167,700 $244,887 $652,168 $727,996 
Restricted stock awards1,459,282 2,385,352 5,333,433 6,952,424 
Restricted stock units(38,075)— 101,601 — 
Performance-based restricted stock awards351,349 890,166 2,119,471 2,641,470 
Total stock-based compensation expense$1,940,256 $3,520,405 $8,206,673 $10,321,890 
Schedule of Stock Option Activity
A summary of stock option activity for the nine months ended September 30, 2024 is as follows:

Number of OptionsWeighted
Average
Exercise Price
per Option		Weighted
Average
Remaining
Contractual Life
(Years)
Balance, December 31, 202314,822 $205.4 8.0
Exercised— — — 
Balance, September 30, 202414,822 $205.4 7.25
Number of options exercisable at September 30, 2024
14,822 $205.4 7.25
Schedule of Restricted Stock Activity, Restricted stock units
A summary of restricted stock award activity for the nine months ended September 30, 2024 is as follows:

Number of Unvested Shares Weighted Average Grant Date Fair Value per Share
Balance, December 31, 2023256,416 $52.3 
Granted— — 
Vested(105,793)66.6 
Forfeited(23,595)48.3
Balance, September 30, 2024127,028 $41.1 
A summary of restricted stock unit activity for the nine months ended September 30, 2024 is as follows:

Number of Unvested Shares Weighted Average Grant Date Fair Value per Share
Balance, December 31, 2023— $— 
Granted759,120 6.34 
Vested(98,582)6.34 
Forfeited(83,067)6.34 
Balance, September 30, 2024577,471  
Schedule of Nonvested Performance-Based Units Activity
A summary of the activity for PSU awards with total shareholder return performance objectives for the nine months ended September 30, 2024 is as follows:
Number of Unvested SharesWeighted Average Grant Date Fair Value per Share
Balance, December 31, 202383,598 $88.00 
Granted— — 
Forfeited(7,772)63.67
Balance, September 30, 2024
75,826 $90.77 
A summary of the PSU awards with cumulative adjusted EBITDA targets for the nine months ended September 30, 2024 is as follows:
Number of Unvested Shares
Balance, December 31, 202368,288 
Granted— 
Forfeited(7,772)
Balance, September 30, 2024
60,516 
v3.24.3
LOSS PER SHARE - (Tables)
 9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following table presents the potentially dilutive shares that were excluded from the computation of diluted net loss per share of Common Stock, because their effect was anti-dilutive:

Three Months Ended
September 30,		Nine Months Ended
September 30,
20242023*20242023*
Stock-based awards and warrants16,548,518 504,707 16,548,518 504,707 
Convertible notes10,812,454 — 10,812,454 — 
* Prior periods presented have been adjusted to reflect the 1-for-20 reverse stock split effective on June 17, 2024.
v3.24.3
SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING PRINCIPLES - Additional Information (Details)
 1 Months Ended 3 Months Ended 9 Months Ended
Oct. 28, 2024
Jun. 17, 2024
Jun. 06, 2024
USD ($)
Apr. 30, 2024
employee
Sep. 30, 2024
USD ($)
$ / shares
shares
Mar. 31, 2024
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
employee
$ / shares
shares
Sep. 30, 2023
USD ($)
Nov. 18, 2024
USD ($)
Oct. 27, 2024
USD ($)
Aug. 23, 2024
USD ($)
shares
Jul. 18, 2024
USD ($)
shares
May 29, 2024
USD ($)
Mar. 15, 2024
USD ($)
$ / shares
Jan. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
$ / shares
Debt Instrument [Line Items]                                  
Sales, net of returns and allowances         $ 2,509,717   $ 3,028,545 $ 4,691,451 $ 8,688,423                
Net loss         25,135,559   $ 30,645,712 80,611,346 78,662,425                
Net cash used in operating activities               40,115,793 $ 95,546,635                
Cash and cash equivalents         3,244,806     3,244,806                 $ 25,845,915
Accounts receivable         682,673     682,673                 2,326,774
Other receivables         3,000,000     3,000,000                  
Inventory, net         43,186,462     43,186,462                 45,408,192
Accounts payable         10,572,525     10,572,525                 12,456,272
Working capital         7,900,000     7,900,000                  
Accumulated deficit         $ 832,179,596     $ 832,179,596                 $ 751,568,251
Common stock, par value (in usd per share) | $ / shares         $ 0.001     $ 0.001             $ 0.001   $ 0.001
Sale leaseback transaction, net book value                               $ 34,500,000  
Number of positions eliminated, period percent           20.00%                      
Restructuring and related cost, executive payment deferral percent           20.00%                      
Number of positions eliminated | employee       73                          
Number of positions reinstated | employee               16                  
Reverse split ratio   0.05                              
Discontinued Operations, Disposed of by Sale | Aero Divestiture                                  
Debt Instrument [Line Items]                                  
Expected monthly cost savings     $ 400,000                            
Loss on sale of business               $ 700,000                  
Discontinued Operations, Disposed of by Sale | Aero Divestiture | Selling, General and Administrative Expenses                                  
Debt Instrument [Line Items]                                  
Loss on sale of business               400,000                  
Discontinued Operations, Disposed of by Sale | Aero Divestiture | Cost of Sales                                  
Debt Instrument [Line Items]                                  
Loss on sale of business               $ 300,000                  
Subsequent Event                                  
Debt Instrument [Line Items]                                  
Restructuring and related cost, executive payment deferral percent 20.00%                                
Deferred compensation                     $ 400,000            
2024 Warrants, Issuance                                  
Debt Instrument [Line Items]                                  
Number of securities called by warrants or rights (in shares) | shares         10,100,000     10,100,000                  
July 18 Issuance                                  
Debt Instrument [Line Items]                                  
Number of securities called by warrants or rights (in shares) | shares                         2,700,000        
August 23 Issuance                                  
Debt Instrument [Line Items]                                  
Number of securities called by warrants or rights (in shares) | shares                       2,900,000          
September 30 Issuance                                  
Debt Instrument [Line Items]                                  
Number of securities called by warrants or rights (in shares) | shares         4,500,000     4,500,000                  
The Warrants                                  
Debt Instrument [Line Items]                                  
Number of securities called by warrants or rights (in shares) | shares         0     0                  
2024 Notes | Convertible notes                                  
Debt Instrument [Line Items]                                  
Debt instrument, face amount         $ 9,400,000     $ 9,400,000             $ 139,000,000    
2024 Notes | Convertible notes | Subsequent Event                                  
Debt Instrument [Line Items]                                  
Debt instrument, additional borrowing capacity                   $ 105,500,000              
Long-term debt, gross                   $ 5,400,000              
2024 Notes, Issuance | Convertible notes                                  
Debt Instrument [Line Items]                                  
Debt instrument, face amount                             $ 10,000,000.0    
July 18 Issuance | Convertible notes                                  
Debt Instrument [Line Items]                                  
Debt instrument, face amount                         $ 4,000,000.0 $ 4,000,000      
August 23 Issuance | Convertible notes                                  
Debt Instrument [Line Items]                                  
Debt instrument, face amount                       $ 2,600,000   2,600,000      
September 30 Issuance | Convertible notes                                  
Debt Instrument [Line Items]                                  
Debt instrument, face amount         3,400,000     3,400,000           $ 3,400,000      
Prior Notes | Convertible notes                                  
Debt Instrument [Line Items]                                  
Debt instrument, additional borrowing capacity         106,700,000     106,700,000                  
The Notes | Convertible notes                                  
Debt Instrument [Line Items]                                  
Long-term debt, gross         $ 9,400,000     $ 9,400,000                  
v3.24.3
INVENTORY, NET - Schedule of Inventory, Net (Details) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Inventory Disclosure [Abstract]    
Raw materials $ 46,097,429 $ 32,682,324
Work in process 4,123,097 2,892,329
Finished goods 5,476,095 18,309,829
Gross inventory 55,696,621 53,884,482
Less: inventory reserves (12,510,159) (8,476,290)
Inventory, net $ 43,186,462 $ 45,408,192
v3.24.3
INVENTORY, NET - Additional Information (Details) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Inventory Disclosure [Abstract]    
Inventory reserves $ 12,510,159 $ 8,476,290
v3.24.3
CONTRACT MANUFACTURING SERVICES AND INVESTMENT IN TROPOS (Details) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2024
Dec. 31, 2023
Short-Term Debt [Line Items]      
Deferred revenue   $ 6,400,000 $ 4,700,000
Assembly Service      
Short-Term Debt [Line Items]      
Deferred revenue   4,700,000 4,700,000
Tropos Trechnologies, Inc.      
Short-Term Debt [Line Items]      
Equity method investment, impairment loss     $ 10,000,000
Tropos Trechnologies, Inc. | Affiliated Entity      
Short-Term Debt [Line Items]      
Payment to acquire preferred stock $ 5,000,000    
Non-cash consideration   $ 5,000,000  
Tropos Trechnologies, Inc. | Affiliated Entity | Deposit For Future Services      
Short-Term Debt [Line Items]      
Amount of transaction $ 5,000,000    
v3.24.3
PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
Prepaid purchases $ 6,824,168 $ 7,908,087
Less: prepaid purchases reserve (1,943,969) (1,999,068)
Prepaid purchases, net 4,880,199 5,909,019
Prepaid insurance 864,110 1,283,146
Other 1,613,529 908,997
Prepaid expenses and other current assets $ 7,357,838 $ 8,101,162
v3.24.3
REVENUE - Schedule of Sales Activity (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Disaggregation of Revenue [Line Items]        
Total sales, net of returns and allowances $ 2,509,717 $ 3,028,545 $ 4,691,451 $ 8,688,423
Sales, net of returns and allowances        
Disaggregation of Revenue [Line Items]        
Total sales, net of returns and allowances 2,169,769 2,570,250 2,753,384 7,292,417
Other sales        
Disaggregation of Revenue [Line Items]        
Total sales, net of returns and allowances $ 339,948 $ 458,295 $ 1,938,067 $ 1,396,006
v3.24.3
REVENUE - Additional Information (Details) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Disaggregation of Revenue [Line Items]    
Deferred revenue $ 6,400,000 $ 4,700,000
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-10-01    
Disaggregation of Revenue [Line Items]    
Revenue, remaining performance obligation, expected timing of satisfaction, period 3 months  
Assembly Service    
Disaggregation of Revenue [Line Items]    
Deferred revenue $ 4,700,000 $ 4,700,000
Revenue, remaining performance obligation, amount $ 1,700,000  
v3.24.3
ACCRUED AND OTHER CURRENT LIABILITIES - Accrued And Other Current Liabilities (Details) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Payables and Accruals [Abstract]    
Compensation and related costs $ 3,935,226 $ 2,083,808
Accrued interest 114,438 0
Sales returns and allowances 1,102,005 0
Other 3,232,652 2,778,932
Total accrued and other current liabilities $ 8,384,321 $ 4,862,740
v3.24.3
ACCRUED AND OTHER CURRENT LIABILITIES - Accrued Warranty Activity (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Movement in Extended Product Warranty Accrual [Roll Forward]        
Standard Product Warranty Accrual, Beginning Balance $ 642,326 $ 1,922,580 $ 1,902,647 $ 2,207,674
Warranty costs incurred (61,611) (289,404) (189,904) (884,717)
Provision for warranty 195,708 144,344 (936,320) 454,563
Standard Product Warranty Accrual, Ending Balance $ 776,423 $ 1,777,520 $ 776,423 $ 1,777,520
v3.24.3
DEBT - Schedule of Fair Value, Liabilities Measured on a Recurring Basis (Details) - USD ($)
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Fair value of convertible notes issued during period $ 45,829,120  
Fair value, liability, recurring basis, unobservable input reconciliation, gain (loss), statement of income or comprehensive income [extensible enumeration] Interest income (expense), net Interest income (expense), net
Convertible notes    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Fair value of convertible notes, beginning of period $ 20,180,100  
Payments on convertible notes (20,180,100)  
Change in fair value of convertible notes (1,488,754)  
Fair value of convertible notes exchanged for common stock (31,157,899)  
Fair value of convertible notes, end of period $ 13,182,467  
v3.24.3
DEBT - 2024 Securities Purchase Agreement Additional Information (Details) - USD ($)
 9 Months Ended
Sep. 30, 2024
Aug. 23, 2024
Jul. 18, 2024
May 29, 2024
Mar. 15, 2024
Debt Instrument [Line Items]          
Warrants outstanding (in shares) 15,600,000        
2024 Warrants, Issuance          
Debt Instrument [Line Items]          
Number of securities called by warrants or rights (in shares) 10,100,000        
July 18 Issuance          
Debt Instrument [Line Items]          
Number of securities called by warrants or rights (in shares)     2,700,000    
August 23 Issuance          
Debt Instrument [Line Items]          
Number of securities called by warrants or rights (in shares)   2,900,000      
September 30 Issuance          
Debt Instrument [Line Items]          
Number of securities called by warrants or rights (in shares) 4,500,000        
The Warrants          
Debt Instrument [Line Items]          
Number of securities called by warrants or rights (in shares) 0        
Warrants outstanding (in shares) 15,600,000        
2024 Notes | Convertible notes          
Debt Instrument [Line Items]          
Debt instrument, face amount $ 9,400,000       $ 139,000,000
Debt conversion, post conversion ownership limitation         9.99%
2024 Notes, Issuance | Convertible notes          
Debt Instrument [Line Items]          
Debt instrument, face amount         $ 10,000,000.0
July 18 Issuance | Convertible notes          
Debt Instrument [Line Items]          
Debt instrument, face amount     $ 4,000,000.0 $ 4,000,000  
August 23 Issuance | Convertible notes          
Debt Instrument [Line Items]          
Debt instrument, face amount   $ 2,600,000   2,600,000  
September 30 Issuance | Convertible notes          
Debt Instrument [Line Items]          
Debt instrument, face amount 3,400,000     $ 3,400,000  
The Notes | Convertible notes          
Debt Instrument [Line Items]          
Proceeds from convertible notes 32,300,000        
Long-term debt, gross $ 9,400,000        
v3.24.3
DEBT - 2024 Notes Additional Information (Details)
 3 Months Ended 9 Months Ended
Mar. 15, 2024
USD ($)
Mar. 14, 2024
trading_day
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Nov. 18, 2024
USD ($)
Debt Instrument [Line Items]              
Fair value adjustments     $ (2,649,477) $ 0 $ (7,089,027) $ 0  
2024 Notes | Convertible notes              
Debt Instrument [Line Items]              
Original issuance discount percent 12.50%            
Proceeds from issuance of debt         28,300,000    
Interest rate 9.00%            
Stated interest in case of default 18.00%            
Percentage of stock price trigger   87.50%          
Debt instrument, convertible, threshold consecutive trading days | trading_day   10          
Debt instrument, convertible, written notice repayment period 15 days            
Debt instrument, redemption price, premium 25.00%            
Debt instrument, redemption price, premium, event of default 75.00%            
Debt covenant, liquidity requirement if sale leaseback transaction has not been consummated $ 1,500,000            
Debt covenant, liquidity requirement if sale leaseback transaction has been consummated 4.0            
Principal balance as of the valuation date $ 139,000,000   9,400,000   9,400,000    
Long-term debt, fair value     13,200,000   13,200,000    
Conversion of convertible note, amount     8,500,000   22,900,000    
Fair value adjustments     $ 5,300,000   $ 8,900,000    
2024 Notes | Convertible notes | Subsequent Event              
Debt Instrument [Line Items]              
Long-term debt, gross             $ 5,400,000
v3.24.3
DEBT - Schedule of Fair Value Measurement Inputs (Details) - Convertible notes
Sep. 30, 2024
USD ($)
Aug. 23, 2024
USD ($)
Jul. 18, 2024
USD ($)
May 29, 2024
USD ($)
May 10, 2024
USD ($)
Mar. 15, 2024
USD ($)
2026 Notes            
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Principal balance as of the valuation date           $ 9,000,000
2026 Notes | Risk-Free Rate            
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Debt instrument, measurement input           0.053
2026 Notes | Corporate Bond Yield            
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Debt instrument, measurement input           0.158
2026 Notes | Volatility (Annual)            
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Debt instrument, measurement input           0.850
2024 Notes            
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Principal balance as of the valuation date $ 9,400,000         $ 139,000,000
May 10 Issuance            
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Principal balance as of the valuation date         $ 6,285,714  
May 10 Issuance | Risk-Free Rate            
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Debt instrument, measurement input         0.053  
May 10 Issuance | Corporate Bond Yield            
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Debt instrument, measurement input         0.156  
May 10 Issuance | Volatility (Annual)            
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Debt instrument, measurement input         0.950  
May 29 Issuance            
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Principal balance as of the valuation date       $ 7,000,000    
May 29 Issuance | Risk-Free Rate            
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Debt instrument, measurement input       0.053    
May 29 Issuance | Corporate Bond Yield            
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Debt instrument, measurement input       0.156    
May 29 Issuance | Volatility (Annual)            
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Debt instrument, measurement input       0.900    
July 18 Issuance            
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Principal balance as of the valuation date     $ 4,000,000.0 $ 4,000,000    
July 18 Issuance | Risk-Free Rate            
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Debt instrument, measurement input       0.048    
July 18 Issuance | Corporate Bond Yield            
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Debt instrument, measurement input       0.174    
July 18 Issuance | Volatility (Annual)            
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Debt instrument, measurement input       0.800    
August 23 Issuance            
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Principal balance as of the valuation date   $ 2,600,000   $ 2,600,000    
August 23 Issuance | Risk-Free Rate            
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Debt instrument, measurement input       0.043    
August 23 Issuance | Corporate Bond Yield            
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Debt instrument, measurement input       0.178    
August 23 Issuance | Volatility (Annual)            
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Debt instrument, measurement input       0.900    
September 30 Issuance            
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Principal balance as of the valuation date $ 3,400,000     $ 3,400,000    
September 30 Issuance | Risk-Free Rate            
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Debt instrument, measurement input       0.039    
September 30 Issuance | Corporate Bond Yield            
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Debt instrument, measurement input       0.159    
September 30 Issuance | Volatility (Annual)            
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Debt instrument, measurement input       1.000    
v3.24.3
DEBT -Warrants Exercisable Additional Information (Details) - 2024 Warrants
$ / shares in Units, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
USD ($)
$ / shares
shares
Sep. 30, 2024
USD ($)
$ / shares
shares
Class of Warrant or Right [Line Items]    
Warrants issued in period (in shares) | shares 10,100,000 15,600,000
Number of securities called by warrants or rights (in shares) | shares 0 0
Amount waived   $ 14.8
Fair value of warrants $ 7.2 7.2
Fair value adjustment of warrants $ 2.6 $ 7.1
Minimum    
Class of Warrant or Right [Line Items]    
Exercise price of warrants (in usd per share) | $ / shares $ 1.11 $ 1.11
Maximum    
Class of Warrant or Right [Line Items]    
Exercise price of warrants (in usd per share) | $ / shares $ 7.00 $ 7.00
v3.24.3
DEBT - Warrants, Fair Value Inputs Additional Information (Details)
Sep. 30, 2024
USD ($)
$ / shares
Aug. 24, 2024
USD ($)
$ / shares
Jul. 18, 2024
USD ($)
$ / shares
May 29, 2024
USD ($)
$ / shares
May 10, 2024
USD ($)
$ / shares
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Stock Price (in usd per share) $ 0.87        
2024 Warrants          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Fair Value | $ $ 7,200,000        
2024 Warrants, May 10, 2024          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Fair Value | $ $ 758,360       $ 3,706,121
Stock Price (in usd per share) $ 0.87       $ 3.60
Strike Price (in usd per share) $ 5.8860       $ 5.8860
Estimated time to expiration (years) 9 years 7 months 6 days       10 years
2024 Warrants, May 2029, 2024          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Fair Value | $ $ 849,041     $ 4,099,389  
Stock Price (in usd per share) $ 0.87     $ 3.80  
Strike Price (in usd per share) $ 5.8880     $ 5.8880  
Estimated time to expiration (years) 9 years 8 months 12 days     10 years  
2024 Warrants, July 18, 2024          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Fair Value | $ $ 1,296,378   $ 2,901,545    
Stock Price (in usd per share) $ 0.87   $ 1.89    
Strike Price (in usd per share) $ 2.9300   $ 2.9300    
Estimated time to expiration (years) 9 years 9 months 18 days   10 years    
2024 Warrants, August 24, 2024          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Fair Value | $ $ 1,384,743 $ 1,200,626      
Stock Price (in usd per share) $ 0.87 $ 0.78      
Strike Price (in usd per share) $ 1.1100 $ 1.1100      
Estimated time to expiration (years) 9 years 10 months 24 days 10 years      
2024 Warrants, September 30, 2024          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Fair Value | $ $ 2,252,786        
Strike Price (in usd per share) $ 1.2700        
Estimated time to expiration (years) 10 years        
2024 Warrants, March 15 Issuance          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Fair Value | $ $ 688,611       $ 4,749,754
Stock Price (in usd per share) $ 0.87       $ 5.32
Strike Price (in usd per share) $ 7.0000       $ 7.0000
Estimated time to expiration (years) 9 years 6 months       10 years
Volatility (annual) | 2024 Warrants, May 10, 2024          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Warrants and rights outstanding, measurement input 0.700       0.500
Volatility (annual) | 2024 Warrants, May 2029, 2024          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Warrants and rights outstanding, measurement input 0.700     0.450  
Volatility (annual) | 2024 Warrants, July 18, 2024          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Warrants and rights outstanding, measurement input 0.650   0.500    
Volatility (annual) | 2024 Warrants, August 24, 2024          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Warrants and rights outstanding, measurement input 0.450 0.450      
Volatility (annual) | 2024 Warrants, September 30, 2024          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Warrants and rights outstanding, measurement input 0.500        
Volatility (annual) | 2024 Warrants, March 15 Issuance          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Warrants and rights outstanding, measurement input 0.750       0.450
Risk-Free Rate | 2024 Warrants, May 10, 2024          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Warrants and rights outstanding, measurement input 0.037       0.044
Risk-Free Rate | 2024 Warrants, May 2029, 2024          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Warrants and rights outstanding, measurement input 0.037     0.045  
Risk-Free Rate | 2024 Warrants, July 18, 2024          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Warrants and rights outstanding, measurement input 0.037   0.041    
Risk-Free Rate | 2024 Warrants, August 24, 2024          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Warrants and rights outstanding, measurement input 0.037 0.037      
Risk-Free Rate | 2024 Warrants, September 30, 2024          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Warrants and rights outstanding, measurement input 0.037        
Risk-Free Rate | 2024 Warrants, March 15 Issuance          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Warrants and rights outstanding, measurement input 0.037       0.042
Dividend Yield | 2024 Warrants, May 10, 2024          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Warrants and rights outstanding, measurement input 0.000       0.000
Dividend Yield | 2024 Warrants, May 2029, 2024          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Warrants and rights outstanding, measurement input 0.000     0.000  
Dividend Yield | 2024 Warrants, July 18, 2024          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Warrants and rights outstanding, measurement input 0.000   0.000    
Dividend Yield | 2024 Warrants, August 24, 2024          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Warrants and rights outstanding, measurement input 0.000 0.000      
Dividend Yield | 2024 Warrants, September 30, 2024          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Warrants and rights outstanding, measurement input 0.000        
Dividend Yield | 2024 Warrants, March 15 Issuance          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Warrants and rights outstanding, measurement input 0.000       0.000
v3.24.3
DEBT - 2023 Securities Purchase Agreement (Green Senior Convertible Notes Due 2026) Additional Information (Details) - 2026 Notes - Convertible notes
$ in Millions
Dec. 12, 2023
USD ($)
Debt Instrument [Line Items]  
Amount of debt extinguished $ 20.0
Original issuance discount percent 12.50%
Payments of debt issuance costs $ 0.6
Proceeds from convertible notes $ 16.9
v3.24.3
DEBT - Warrants Under the 2023 Securities Purchase Agreement Additional Information (Details) - 2023 Warrants - USD ($)
$ / shares in Units, shares in Millions
 6 Months Ended 9 Months Ended
Jun. 30, 2024
Sep. 30, 2024
Dec. 31, 2023
Dec. 12, 2023
Debt Instrument [Line Items]        
Number of securities called by warrants or rights (in shares) 0.4     25.6
Exercise price of warrants (in usd per share)       $ 8.984
Warrant liability, fair value disclosure     $ 5,600,000  
Common stock issued under convertible security $ 2,800,000 $ 2,847,500    
Fair value adjustment of warrants   $ 2,700,000    
v3.24.3
LEASES - Additional Information (Details)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
USD ($)
Sep. 30, 2024
USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Lessee, operating lease, renewal term 5 years 5 years
Aero Divestiture    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Monthly savings   $ 52,000
Operating lease, payments $ 156,927 $ 210,136
v3.24.3
LEASES - Schedule of Lease Expense For Operating Leases (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Leases [Abstract]        
Short-term lease expense $ 63,428 $ 74,058 $ 200,858 $ 200,733
Operating lease expense 385,933 614,060 1,750,431 1,754,557
Total lease expense $ 449,361 $ 688,118 $ 1,951,289 $ 1,955,290
v3.24.3
LEASES - Schedule of Right of Use Assets - (Details) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Leases [Abstract]    
Operating leases $ 3,465,637 $ 4,174,800
Finance leases 5,470,933 5,621,181
Total lease right-of-use assets $ 8,936,570 $ 9,795,981
v3.24.3
LEASES - Schedule of Lease Liabilities - (Details) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Leases [Abstract]    
Operating lease liabilities, current $ 1,001,120 $ 1,012,428
Finance lease liabilities, current 2,100,635 2,548,184
Operating lease liabilities, long-term 4,556,738 5,280,526
Total Lease Liabilities $ 7,658,493 $ 8,841,138
v3.24.3
FAIR VALUE MEASUREMENTS- Assets and Liabilities Measured at Fair Value (Details) - Fair Value, Recurring - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrant liability $ 7,229,919 $ 5,605,325
Convertible notes 13,182,467 20,180,100
Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrant liability 0 0
Convertible notes 0 0
Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrant liability 0 0
Convertible notes 0 0
Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrant liability 7,229,919 5,605,325
Convertible notes $ 13,182,467 $ 20,180,100
v3.24.3
STOCK BASED COMPENSATION - Additional Information (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares authorized (in shares) 17,500,000   17,500,000    
Shares available for grant (in shares) 3,000,000   3,000,000    
Total stock-based compensation expense $ 1,940,256 $ 3,520,405 $ 8,206,673 $ 10,321,890  
Stock options          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Unrecognized compensation expense, options 0.0   $ 0.0    
Unrecognized compensation expense, recognition period     0 years    
Total stock-based compensation expense 167,700 244,887 $ 652,168 727,996  
Restricted stock awards          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Unrecognized compensation expense, recognition period     1 year    
Unrecognized compensation expense $ 2,700,000   $ 2,700,000    
Unvested (in shares) 127,028   127,028   256,416
Total stock-based compensation expense $ 1,459,282 2,385,352 $ 5,333,433 6,952,424  
Restricted stock units          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Unrecognized compensation expense, recognition period     2 years 4 months 24 days    
Unrecognized compensation expense $ 400,000   $ 400,000    
Unvested (in shares) 577,471   577,471   0
Total stock-based compensation expense $ (38,075) $ 0 $ 101,601 $ 0  
Performance share units          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Unrecognized compensation expense, recognition period     7 years    
Unrecognized compensation expense $ 1,300,000   $ 1,300,000    
Unvested (in shares) 700,000   700,000    
Performance share units | Minimum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of awards ultimately vest     0.00%    
Performance share units | Maximum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of awards ultimately vest     200.00%    
Performance Share Units With Total Shareholder Return Performance Objective          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting percent     50.00%    
EBITDA target performance share units (EBITDA PSUs)          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Unvested (in shares) 60,516   60,516   68,288
Vesting percent     50.00%    
Total stock-based compensation expense $ 100,000        
Revenue Target Performance Share Units (Revenue PSUs)          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting percent     100.00%    
v3.24.3
STOCK BASED COMPENSATION - Schedule of Share Based Compensation Expense (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total stock-based compensation expense $ 1,940,256 $ 3,520,405 $ 8,206,673 $ 10,321,890
Stock options        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total stock-based compensation expense 167,700 244,887 652,168 727,996
Restricted stock awards        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total stock-based compensation expense 1,459,282 2,385,352 5,333,433 6,952,424
Restricted stock units        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total stock-based compensation expense (38,075) 0 101,601 0
Performance-based restricted stock awards        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total stock-based compensation expense $ 351,349 $ 890,166 $ 2,119,471 $ 2,641,470
v3.24.3
STOCK BASED COMPENSATION - Schedule of Stock Option Activity (Details) - $ / shares
 9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Number of Options    
Beginning balance (in shares) 14,822  
Exercised (in shares) 0  
Ending balance (in shares) 14,822 14,822
Number of options exercisable (in shares) 14,822  
Weighted Average Exercise Price per Option    
Beginning balance (in usd per share) $ 205.4  
Exercised (in usd per share) 0  
Ending balance (in usd per share) 205.4 $ 205.4
Number of options exercisable (in usd per share) $ 205.4  
Weighted Average Remaining Contractual Life (Years)    
Weighted average remaining contractual life, outstanding 7 years 3 months 8 years
Weighted average remaining contractual life, exercisable 7 years 3 months  
v3.24.3
STOCK BASED COMPENSATION - Restricted Stock (Details) - Restricted stock awards
 9 Months Ended
Sep. 30, 2024
$ / shares
shares
Number of Unvested Shares  
Beginning balance (in shares) | shares 256,416
Granted (in shares) | shares 0
Vested (in shares) | shares (105,793)
Forfeited (in shares) | shares (23,595)
Ending balance (in shares) | shares 127,028
Weighted Average Grant Date Fair Value per Share  
Beginning balance (in usd per share) | $ / shares $ 52.3
Granted (in usd per share) | $ / shares 0
Vested (in usd per share) | $ / shares 66.6
Forfeited (in usd per share) | $ / shares 48.3
Ending balance (in usd per share) | $ / shares $ 41.1
v3.24.3
STOCK BASED COMPENSATION - Schedule of Restricted stock units (Details) - Restricted stock units
 9 Months Ended
Sep. 30, 2024
$ / shares
shares
Number of Unvested Shares  
Beginning balance (in shares) | shares 0
Granted (in shares) | shares 759,120
Vested (in shares) | shares (98,582)
Forfeited (in shares) | shares (83,067)
Ending balance (in shares) | shares 577,471
Weighted Average Grant Date Fair Value per Share  
Beginning balance (in usd per share) | $ / shares $ 0
Granted (in usd per share) | $ / shares 6.34
Vested (in usd per share) | $ / shares 6.34
Forfeited (in usd per share) | $ / shares 6.34
Ending balance (in usd per share) | $ / shares
v3.24.3
STOCK BASED COMPENSATION - Schedule of Performance Shares, Outstanding Activity (Details) - Performance Shares With Total Shareholder Return Metric
 9 Months Ended
Sep. 30, 2024
$ / shares
shares
Number of Unvested Shares  
Beginning balance (in shares) | shares 83,598
Granted (in shares) | shares 0
Forfeited (in shares) | shares (7,772)
Ending balance (in shares) | shares 75,826
Weighted Average Grant Date Fair Value per Share  
Beginning balance (in usd per share) | $ / shares $ 88.00
Granted (in usd per share) | $ / shares 0
Forfeited (in usd per share) | $ / shares 63.67
Ending balance (in usd per share) | $ / shares $ 90.77
v3.24.3
STOCK BASED COMPENSATION - EBITDA PSUs (Details) - EBITDA target performance share units (EBITDA PSUs)
 9 Months Ended
Sep. 30, 2024
shares
Number of Unvested Shares  
Beginning balance (in shares) 68,288
Granted (in shares) 0
Forfeited (in shares) (7,772)
Ending balance (in shares) 60,516
v3.24.3
STOCKHOLDERS' EQUITY - Common Stock (Details)
Sep. 30, 2024
class_of_stock
vote
$ / shares
shares
Mar. 15, 2024
$ / shares
Dec. 31, 2023
$ / shares
shares
Equity [Abstract]      
Number of classes of stock | class_of_stock 1    
Common stock, par value (in usd per share) | $ / shares $ 0.001 $ 0.001 $ 0.001
Common stock, number of votes on each share | vote 1    
Common stock, shares authorized (in shares) | shares 450,000,000   450,000,000
v3.24.3
STOCKHOLDERS' EQUITY - At-The-Market Sales Agreement (Details) - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2024
Mar. 10, 2022
Equity [Abstract]      
Authorized amount     $ 175.0
Shares issued in public offering (in shares) 0.0 0.5  
Consideration received   $ 2.7  
Remaining authorized amount $ 95.6 $ 95.6  
v3.24.3
STOCKHOLDERS' EQUITY - Equity Line of Credit (Details) - USD ($)
 3 Months Ended 9 Months Ended
Dec. 12, 2023
Sep. 30, 2024
Sep. 30, 2024
Class of Stock [Line Items]      
Shares issued in public offering (in shares)   0 500,000
Consideration received     $ 2,700,000
Lincoln Park Capital Fund, LLC      
Class of Stock [Line Items]      
Amount authorized $ 50,000,000    
Sale of stock, period in force 24 months    
Issuance of common stock under ELOC Purchase Agreement $ 1,500,000    
Shares issued in public offering (in shares) 188,755   600,000
Consideration received     $ 3,100,000
Lincoln Park Capital Fund, LLC | Minimum      
Class of Stock [Line Items]      
Sale of stock (in usd per share)   $ 4.42 $ 4.42
Lincoln Park Capital Fund, LLC | Maximum      
Class of Stock [Line Items]      
Sale of stock (in usd per share)   $ 6.86 $ 6.86
v3.24.3
STOCKHOLDERS' EQUITY - Preferred Stock, and Warrants (Details)
Sep. 30, 2024
$ / shares
shares
Equity [Abstract]  
Preferred stock, shares authorized (in shares) 75,000,000
Preferred stock, par value (in usd per share) | $ / shares $ 0.001
Preferred stock, shares issued (in shares) 0
Preferred stock, shares outstanding (in shares) 0
Warrants outstanding (in shares) 15,600,000
v3.24.3
INCOME TAXES - (Details) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Income Tax Disclosure [Abstract]    
Deferred tax liability $ 0 $ 0
v3.24.3
LOSS PER SHARE - Computation of Diluted Net Loss Per Share of Common Stock, Because Their Effect was Anti-Dilutive- (Details)
 3 Months Ended 9 Months Ended
Jun. 17, 2024
Sep. 30, 2024
shares
Sep. 30, 2023
shares
Sep. 30, 2024
shares
Sep. 30, 2023
shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Reverse split ratio 0.05        
Stock-based awards and warrants          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Anti-dilutive options and warrants excluded from diluted average shares outstanding (in shares)   16,548,518 504,707 16,548,518 504,707
Convertible notes          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Anti-dilutive options and warrants excluded from diluted average shares outstanding (in shares)   10,812,454 0 10,812,454 0
v3.24.3
COMMITMENTS AND CONTINGENCIES (Details) - Pending Litigation
$ in Millions
 9 Months Ended
Apr. 19, 2024
USD ($)
Sep. 30, 2024
claim
Loss Contingencies [Line Items]    
Number of claims filed | claim   2
Damages sought | $ $ 4  
v3.24.3
SUBSEQUENT EVENTS  (Details) - USD ($)
shares in Millions, $ in Millions
Oct. 16, 2024
Sep. 30, 2024
Subsequent Event [Line Items]    
Warrants outstanding (in shares)   15.6
Subsequent Event | 2024 Warrants    
Subsequent Event [Line Items]    
Warrants outstanding (in shares) 5.0  
Sixth Additional Note | Convertible notes | Subsequent Event    
Subsequent Event [Line Items]    
Debt instrument, face amount $ 1.2  
Debt instrument, additional borrowing capacity $ 14.8  
v3.24.3
SUPPLEMENTAL CASH FLOW INFORMATION (Details)
shares in Millions, $ in Millions
 9 Months Ended
Sep. 30, 2024
USD ($)
shares
Supplemental Cash Flow Elements [Abstract]  
Principal amount | $ $ 22.9
Issuance of common stock (in shares) | shares 16.0
Grafico Azioni Workhorse (NASDAQ:WKHS)
Storico
Da Nov 2024 a Dic 2024 Clicca qui per i Grafici di Workhorse
Grafico Azioni Workhorse (NASDAQ:WKHS)
Storico
Da Dic 2023 a Dic 2024 Clicca qui per i Grafici di Workhorse